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Depression is one of the leading 
health concerns worldwide, and it 
significantly affects public health, 
quality of life and economics. Diet 
influences the risk of many non-
communicable diseases, but there is 
limited evidence on the association 
between diet and the risk of 
depression in general population. 
This is an epidemiological study 
that aims to clarify the association 
between diet and depression in 
cross-sectional, prospective and 
intervention settings.
 
 
 
 
 
 
ANU RUUSUNEN  
 
 
 
 
 
 
Diet and depression 
- An epidemiological study 
 
 
 
 
 
 
 
 
To be presented by permission of the Faculty of Health Sciences, University of Eastern Finland for 
public examination in Medistudia auditorium ML2, Kuopio, on Friday, September 13th  2013, at 12 
noon 
 
Publications of the University of Eastern Finland 
 Dissertations in Health Sciences  
Number 185 
 
 
Institute of Public Health and Clinical Nutrition, Faculty of Health Sciences,  
University of Eastern Finland 
Kuopio 
2013 
II 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Kopijyvä Oy, Kuopio, 2013 
 
Series Editors:  
Professor Veli-Matti Kosma, M.D., Ph.D. 
Institute of Clinical Medicine, Pathology 
Faculty of Health Sciences 
 
Professor Hannele Turunen, Ph.D. 
Department of Nursing Science 
Faculty of Health Sciences 
 
Professor Olli Gröhn, Ph.D. 
A.I. Virtanen Institute for Molecular Sciences 
Faculty of Health Sciences  
 
Professor Kai Kaarniranta, M.D., Ph.D. 
Institute of Clinical Medicine, Ophthalmology 
Faculty of Health Sciences  
 
Lecturer Veli-Pekka Ranta, Ph.D. (pharmacy) 
School of Pharmacy 
Faculty of Health Sciences 
 
Distributor:  
University of Eastern Finland 
Kuopio Campus Library 
P.O.Box 1627 
FI-70211 Kuopio, Finland 
http://www.uef.fi/kirjasto 
 
ISBN (print): 978-952-61-1200-8 
ISBN (pdf): 978-952-61-1201-5  
ISSN (print): 1798-5706 
ISSN (pdf): 1798-5714 
ISSN-L: 1798-5706 
III 
 
 
Author’s address: Institute of Public Health and Clinical Nutrition 
Department of Medicine 
University of Eastern Finland 
KUOPIO 
FINLAND 
 
Supervisors: Adjunct professor Sari Voutilainen, Ph.D. 
Institute of Public Health and Clinical Nutrition 
Department of Medicine 
University of Eastern Finland 
KUOPIO 
FINLAND 
 
Adjunct professor Tommi Tolmunen, M.D., Ph.D. 
Department of Psychiatry 
Kuopio University Hospital 
KUOPIO 
FINLAND 
 
Professor Tomi-Pekka Tuomainen, M.D., Ph.D. 
Institute of the Public Health and Clinical Nutrition 
Department of Medicine  
University of Eastern Finland 
KUOPIO 
FINLAND 
 
Reviewers: Adjunct professor Kirsi Suominen, M.D., Ph.D. 
Department of Social Services and Health Care 
City of Helsinki 
HELSINKI 
FINLAND 
 
Adjunct professor Satu Männistö, Ph.D. 
National Institute of Health and Welfare 
Department of Chronic Disease Prevention 
HELSINKI 
FINLAND 
 
Opponent: Research professor Timo Partonen, M.D., Ph.D. 
National Institute of Health and Welfare 
Department of Mental Health and Substance Abuse Services 
HELSINKI 
FINLAND 
IV 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
V 
 
 
Ruusunen, Anu 
Diet and depression – An epidemiological study 
University of Eastern Finland, Faculty of Health Sciences 
Publications of the University of Eastern Finland. Dissertations in Health Sciences 185. 2013. 117 p. 
 
ISBN (print): 978-952-61-1200-8 
ISBN (pdf): 978-952-61-1201-5  
ISSN (print): 1798-5706 
ISSN (pdf): 1798-5714 
ISSN-L: 1798-5706 
 
ABSTRACT:  
 
The association between diet and depression has previously mainly been studied in cross-
sectional studies, and only few prospective studies have been published. The evidence 
suggests that folate and long-chain n-3 polyunsaturated fatty acids (PUFAs) may be 
connected to the decreased risk of depression. Furthermore, only few studies have 
concentrated on the association between general dietary patterns and depression. 
The aim of this thesis was to investigate whether dietary intake of folate and vitamin B12, 
serum concentrations of n-3 PUFAs, consumption of coffee and tea, or caffeine intake are 
associated with the risk of getting a discharge diagnosis of severe depression in population-
based sample (the Kuopio Ischaemic Heart Disease Risk Factor (KIHD) Study, n=2,077-
2,313, works I, II and III) of middle-aged or older Eastern Finnish men during an average of 
13-20 years of follow-up. In addition, the study focused on examining if dietary patterns are 
associated with the prevalence of depressive symptoms or the risk of depression requiring 
hospital treatment (the KIHD Study, n=1,003, work IV). Finally, the aim was to investigate 
how an intensive lifestyle intervention affects the depressive symptoms in an intervention 
study design (the Finnish Diabetes Prevention Study (DPS), n=140, work V). 
It was observed that increased intake of folate and healthy dietary patterns 
(consumption of vegetables, fruits, berries, whole-grains, poultry, fish and low-fat cheese) 
were associated with a lower risk of depression. In addition, increased coffee consumption 
was non-linearly associated with a decreased risk of depression. Vitamin B12 intake, serum 
concentrations of n-3 PUFAs, serum ratio of n-6 to n-3 PUFAs, tea drinking and caffeine 
intake were not related to the risk of depression. Adherence to unhealthy dietary pattern 
(consumption of sausages, processed meats, sugar-containing desserts and snacks, sugary 
drinks, manufactured foods, French rolls and baked or processed potatoes) was associated 
with an increased prevalence of elevated depressive symptoms. In addition, participation in 
the three-year lifestyle intervention study improved depression scores with no specific 
group effect, although clinically non-significantly. Reduction of body weight was 
associated with a greater reduction in depressive symptoms.   
The results of this thesis indicate that diet, especially a healthy diet rich in folate, and a 
dietary pattern rich in vegetables, fruits, berries, whole-grains, poultry, fish and low-fat 
cheese, may be protective against depression. N-3 PUFAs may not have a role in the 
prevention of depression, at least not in middle-aged or older men with generally low 
circulating concentrations of n-3 PUFAs.  
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TIIVISTELMÄ:  
 
Ruokavalion yhteyttä masennukseen on selvitetty aikaisemmin lähinnä poikkileikkaus-
tutkimuksissa, ja prospektiivisiä seurantatutkimuksia aiheesta on vähän. Etenkin folaatin ja 
n-3-sarjan pitkäketjuisten monityydyttymättömien rasvahappojen on esitetty vähentävän 
masennusriskiä. Ruokavalion kokonaisuuden merkityksestä masennuksessa on vasta 
vähän tutkimustietoa. 
Tämän väitöskirjatyön tarkoituksena oli tutkia väestöaineistossa (Sepelvaltimotaudin 
vaaratekijätutkimus (SVVT), n=2077-2313, osatyöt I, II ja III), ovatko ravinnon folaatin ja B12-
vitamiinin saanti, seerumin rasvahappojen pitoisuus, sekä kahvin ja teen juominen ja 
kofeiinin saanti yhteydessä sairaalahoitoisen masennuksen riskiin keski-ikäisillä tai 
vanhemmilla itäsuomalaisilla miehillä 13-20 vuoden seurannan aikana. Lisäksi tutkittiin 
ruokavalion kokonaisuuden yhteyttä masennuksen esiintyvyyteen sekä masennusriskiin 
(n=1003, osatyö IV) ja selvitettiin kolmivuotisen elämäntapaintervention vaikutusta 
masennusoireisiin (Suomalainen Diabeteksen ehkäisytutkimus (DPS), n=140, osatyö V).   
Tutkimuksessa havaittiin, että runsas folaatin saanti ja terveelliset ruokailutottumukset 
(kasvisten, hedelmien, marjojen, täysjyväviljan, kanan, kalan ja vähärasvaisen juuston 
syöminen) vähensivät masennusriskiä. Myös kahvin käyttö oli yhteydessä pienempään 
masennusriskiin, tosin yhteys ei ollut lineaarinen. Sen sijaan B12-vitamiinin saannilla, n-3-
rasvahappojen seerumipitoisuuksilla, teen juonnilla tai kofeiinin saannilla ei ollut yhteyttä 
masennusriskiin. Epäterveellinen ruokavalio (makkaroiden, lihavalmisteiden, sokeroitujen 
jälkiruokien, sokeripitoisten juomien, valmisruokien, vaalean vehnäleivän ja 
perunavalmisteiden syöminen) oli yhteydessä suurempaan masennuksen esiintyvyyteen. 
Lisäksi tutkimuksessa havaittiin, että kolmivuotisen elämäntapaintervention aikana 
tutkittavien masennuspisteet laskivat riippumatta siitä, oliko tutkittava intensiivisen 
intervention ryhmässä vai tavanomaisen, ns. mini-intervention, ryhmässä. Pistelasku ei 
kuitenkaan ollut kliinisesti merkittävä. Masennuspisteiden laskua interventiossa selitti 
painon lasku. 
Väitöskirjatyön tulokset viittaavat siihen, että terveellisellä, runsaasti folaattia 
sisältävällä ravinnolla, ja ruokavaliolla, jossa on kasviksia, hedelmiä, marjoja, täysjyväviljaa, 
kanaa, kalaa ja vähärasvaista juustoa, saattaa olla merkitystä masennuksen 
ennaltaehkäisyssä. Sen sijaan seerumin rasvahappojen pitoisuuksilla ei havaittu yhteyttä 
masennusriskiin, ainakaan keski-ikäisillä tai ikääntyneillä miehillä, joilla n-3-rasvahappojen 
pitoisuudet olivat suhteellisen matalia.  
 
Luokitus: QT 235, OU 188, WD 120, WM 171 
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All will be well in the end. And if it is not, then trust me, it is not the end. 
Paolo Coelho 
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1 Introduction  
Major depressive disorder (MDD) is one of the leading health concerns in the world, with 
the average lifetime prevalence of 15-16% in high-income countries (1,2). In addition, MDD 
is predicted to hold the second position among diseases contributing to the global burden 
of diseases by 2030 (3), and there has been a 37% increase in disability-adjusted life years of 
depression from the year 1990 to 2010 (4). The effects of depression on public health and 
economics are extensive and on the increase.  
Depression is a multifactorial disease with plenty of risk factors, including 
environmental, genetic and psychological factors, rendering the etiology of depression 
challenging to study. The importance of lifestyle habits, such as diet and physical exercise, 
is still poorly studied, even though the significance has been established in many other 
diseases, such as cardiovascular diseases (CVD) and cancer. Prevention strategies of 
depression have achieved much less publicity compared to treatment strategies (5).  
Evidence slightly supports the notion that diet, certain foods or nutrients may have a 
role in the etiology and prevention of depression (6). However, there are relatively few 
prospective studies published, with inconsistent results. The inconsistency may be 
explained by methodological differences and by potential confounders and effect modifiers, 
like gender, age or smoking. In addition, the magnitude of total energy intake as a 
confounder has been shown to be remarkable, especially in cross-sectional studies. Diet 
measurements have mainly been valid, as long food frequency questionnaires (FFQs) or 
serum, plasma or red-cell concentrations have been the most common tools for assessment 
of food consumption or nutrient intakes.  
Intake or circulating concentrations of folate have been suggested to have an inverse 
association with the risk of depression in some (7-9), but not in all prospective studies (10-
12). In clinical trials, antidepressant augmentation with methylfolate or folic acid has 
improved recovery from depression (13,14).  
High consumption of fish or high intakes of polyunsaturated fatty acids (PUFAs), mainly 
long-chain eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), have been 
suggested to decrease the risk of depression (15-18). This association has been found 
especially in women (17,18). However, there are only few prospective studies conducted, 
and only one study to assess the association between circulating concentrations of n-3 
PUFAs and depression (19). In addition, the ratio of n-6 to n-3 PUFAs has increased in 
Western countries during the last decades (20), but there is a lack of prospective studies on 
the relation between the ratio of n-6 to n-3 PUFAs and the risk of depression. The results 
from the clinical trials slightly support possible treatment effects of n-3 fatty acids (21).  
The role of coffee consumption on mental health has been conflicting; in large amounts 
and in sensitive individuals, caffeine may increase depressive symptoms. On the other 
hand, caffeine relieves feeling of fatigue, and in short term, may be beneficial to mood (22). 
High coffee consumption has been associated with a decreased risk of many chronic 
diseases, such as type 2 diabetes mellitus (T2D) and Alzheimer’s disease (23). Nevertheless, 
there is a lack of prospective studies published on the association between coffee, tea or 
caffeine intake and the risk of depression.   
In addition to studying single food items or nutrients, the whole-diet approach is 
recommendable. Healthy dietary patterns have previously been connected to the decreased 
risk of depression in prospective studies conducted in the United Kingdom (24) and 
Australia (25), whereas unhealthy or Western dietary patterns have been associated with an 
elevated risk of depression in United Kingdom (24) and in France (26). However, this area 
of research is still quite new. Dietary patterns differ between study populations, and there 
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are no previous studies published on the association between Finnish dietary patterns and 
depression. 
The effects of lifestyle interventions, with a combination of diet and physical exercise, on 
depressive symptoms in non-clinical populations are still largely unknown. In theory, 
intensive lifestyle intervention should decrease depressive symptoms as the quality of diet 
improves (24), and increased physical activity usually improves mood (27). However, only 
few lifestyle intervention studies focusing on the change in depressive symptoms have 
been conducted. 
Taken together, a review of the literature clearly shows that there is a need of research on 
the association between diet and depression. Many of the previous studies are cross-
sectional, which may reflect more the disease’s effect on eating behavior and diet than the 
opposite. The aim of this thesis was to assess prospectively the associations between 
selected dietary factors (folate, vitamin B12, n-3 and n-6 PUFAs, coffee, tea and caffeine) and 
depression in a population-based sample of Finnish men. In addition, we wanted to 
investigate if dietary patterns are associated with the prevalent depressive symptoms or the 
risk of depression in Finnish men. Finally, the aim was to investigate if an intensive lifestyle 
intervention reduces depressive symptoms in middle-aged overweight men and women 
with impaired glucose tolerance (IGT).  
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2 Depression  
2.1 PUBLIC HEALTH RELEVANCY  
The lifetime prevalence of MDD has been estimated to be 15-16%, with a 12-month 
prevalence 6-7% in high income countries (1,2). In Finland, the prevalence of MDD is 
comparable to that found in other Western countries. In 2000, the 12-month prevalence of 
MDD was estimated to be 9% and the age-adjusted prevalences for females and males 11% 
and 7%, respectively, in Finnish population (28). In 2005, the 12-month prevalence of MDD, 
based on the fourth edition of Diagnostic and Statistical Manual of Mental Disorders (DSM-
IV), was 8% for females and 5% for males (6.5% for the whole population) in the Finnish 
Health 2000 Study (29). The earlier study included also younger age groups (15-30 years) 
(28), whereas the Health 2000 Study included only individuals over 30 years of age (29). It is 
also seen that female gender associates with the elevated prevalence of MDD (2,28,29).  
MDD is a recurrent disease and relapses are very common; 50% of the patients with one 
MDD episode have a relapse, and the recurrence rate is 90% for those with three or more 
occurrences. Among those who suffered from MDD within the last 12 months, about 30% 
(27% of the females and 36% of the males) reported multiple episodes (29). Due to this 
recurrent nature, MDD is listed in the second position after HIV/AIDS among diseases 
predicted to contribute to the global burden of diseases by 2030 (3). Since the year 1990, 
there has been a 37% increase in disability-adjusted life-years of MDD (4). 
MDD impairs working ability, increases the number of sick-leave days and predicts 
disability pensions (30). By the end of 2011, the number of disability pensions in Finland 
due to depression had almost doubled since the 1990s (31). Nevertheless, the previously 
increasing trend has started to decline; in 2010, 4,100 people retired due to depression, 
whereas in the top year 2007 there were 4,700 people who took early retirement due to 
depression. At the end of 2010, altogether 38,000 Finnish individuals were listed as retired 
due to depression (31). 
Public health relevancy of MDD is characterized by the increased risk of comorbid 
diseases and suicides. Depression increases the risk of common diseases, such as T2D, CVD 
and dementia (32-34), and substance-related disorders, panic disorder, eating disorders and 
personality disorders frequently co-occur with MDD (35). Altogether 7% of men and 4% of 
women with unipolar affective disorder, of which MDD is the most common, committed  
suicide after first psychiatric contact in Denmark (36). In Finland, depression causes about 
600 to 700 people to commit suicide each year (37). Suicides are the most common cause of 
death among young women, and the second most common cause of death among young 
men (38). Therefore, the relevance of depression to public health, economic burden and 
quality of life is extensive. 
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2.2 ASSESSMENT OF DEPRESSION STATUS AND DEPRESSIVE 
SYMPTOMS 
The definition and assessment of depression and depressive symptoms has been a 
challenge throughout the history of psychiatric medicine. Distinguishing clinically 
significant depressive symptoms that need treatment is demanding, because depressive 
feelings are universally experienced by everyone at some point of life as a natural reaction 
to stressful life events. Nevertheless, in MDD, sadness and depressed mood do not remit 
when the external cause of these emotions has vanished (39). In addition, classic severe 
depression often has no external expedite cause (39).  
MDD is characterized by depressed mood, change in sleeping patterns and weight, 
feelings of worthlessness or guilt, fatigue, a loss of interest in previously enjoyable activities 
and concentration and finally, ideation of death or suicide (40). Currently, diagnosis is 
based on the tenth version of the International Classification of Diseases (ICD) (41) and the 
new DSM-5 diagnostic classification, developed by the American Psychiatric Association 
(35). The ICD-10 criteria for clinical depression are presented in Table 1. Clinical depression 
is categorized into mild depression (F32.0), moderate depression (F32.1) and severe 
depression (F32.2 and F32.3) according to the number of symptoms present. The criteria can 
also be applied in recurrent depression (F33), in which a depressive episode has occurred at 
least once before. Mild depression involves subjective suffering but functioning usually 
remains good. Moderate depression, on the other hand, weakens the ability to function, 
while severe depression causes massive loss of functioning and need for everyday help 
(40).  
According to the DSM-5 criteria, MDD diagnosis is based on the presence of at least five 
of the following nine symptom categories: depressed mood, loss of interest or pleasure, 
significant weight loss (when not dieting) or weight gain or change in appetite, insomnia or 
hypersomnia, psychomotor agitation or retardation, fatigue or loss of energy, feelings of 
worthlessness or excessive or inappropriate guilt, cognitive abnormality, and recurrent 
thoughts of death or suicidal ideation (35). Symptoms should have been current for at least 
two weeks, most of the day, nearly every day, and represent a change compared to 
previous state. One of the symptoms should be depressed mood or the loss of pleasure or 
interest. In addition, symptoms should cause clinically significant distress or impairment in 
the areas of functioning, and the state should not be attributable to other medical conditions 
or substance abuse. Different subtypes of depression have also been defined. Atypical 
depression is characterized by mood reactivity, severe fatigue, and increase in appetite or 
sleepiness. In melancholic subtype of depression, loss of interest and decrease in appetite or 
sleepiness are commonly present (35).  
In addition to diagnostic instruments, depressive symptoms can be assessed using rating 
scales, which provide an assessment of symptom severity on an ordinal scale. Depression 
rating scales, like the Beck Depression Inventory (BDI) scale (42) (21-item version in Finnish 
is presented and explained in more detail in Appendix 1 and in chapter 9.2.4) and the 
Finnish Depression Screening tool (DEPS) (43) are valuable in the screening of depressive 
symptoms, estimating of symptom prevalence and in the follow-up of MDD patients. The 
Patient Health Questionnaire (PHQ-9) is a brief questionnaire based on the previous DSM-
IV criteria of MDD (44), and has also been shown to have diagnostic validity (45). Many 
depression rating scales are validated by a clinical interview, and for example the BDI has 
been found to be a valid instrument for the diagnosis of depression in adults (46). Some of 
the rating scales are self-administrated (BDI, DEPS, PHQ-9), while others are filled in by the 
interviewer, for example Montgomery-Åsberg Depression Rating Scale (47) and Hamilton 
Depression Rating Scale (HAM-D) (48). In addition, there is a group of other inventories 
that assess the depressive symptoms and are used especially for study purposes, like the 
Center for Epidemiological Studies Depression Scale (CES-D) or the Human Population 
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Laboratory (HPL) depression scale (49). The HPL depression scale is presented and 
explained in more detail in Appendix 2 and in chapter 9.1.5 of this thesis. 
2.3 DEVELOPMENT AND COURSE  
The first episode of MDD usually appears between puberty and 30 years of age, but it can 
appear at any age (35). However, although not common, a first episode is also possible in 
the elderly. Especially the first depression episode is usually triggered by negative life 
events. During the next six months after a negative life event, the risk of getting MDD is 
multiplied, and is often verified by acute or chronic psychosocial stress (50). The course of 
MDD is highly variable; some individuals stay in remission for years between the episodes, 
whereas others rarely or never achieve remission. Remission is usually defined as a period 
of two or more months without any symptoms or with only one or two mild symptoms. 
Two out of five individuals with MDD usually recover within three months, and four 
out of five, within one year. The risk of having multiple episodes of MDD is elevated in 
younger individuals, those having multiple episodes behind, and those with a severe 
preceding episode (35). It is possible that the risk factors and pathogenesis of acute 
depression are different from those of recurrent or chronic depression, although it is known 
that a single episode of depression increases the risk of developing a second or more 
episodes during the whole life-time (39). As the duration of remission increases, the 
possibility of recurrence of MDD decreases progressively (35). Life without any symptoms 
is an important goal, as even mild depressive symptoms during remission increase the risk 
of recurrence.  
2.4 RISK FACTORS AND PATHOGENESIS  
It is probable that a number of pathways lead to MDD and causation of depression is 
probabilistic, not deterministic (51). Since the 1950s, the risk factors and pathogenesis of 
depression have been studied from a neurochemical perspective. Both biological, 
psychological, sociological, genetic and environmental mechanisms are present in the 
pathogenesis of depression (39). 
Low socio-economic status (SES), short education, low income, disability, 
unemployment and marital status (being divorced or widowed) are associated with an 
elevated prevalence of MDD (2,29). Lifestyle factors, such as smoking, may independently 
increase the risk of MDD (52). Growing evidence indicates that physical inactivity is an 
independent risk factor for depression, and physical exercise may be protective for mental 
health (27). Childhood maltreatment and trauma in early life are also independent 
predictors of MDD. However, the influence of these risk factors is modulated by numerous 
other factors, such as genetic background, temperament, received care, age and 
reconstructive factors in later life (53). Interestingly, traumas and early experiences of 
heightened stress may cause long-term neuroendocrinological changes, which may 
represent adaptations (54). These neurobiological changes tend to increase the risk of 
depression in later life, especially during stressful life events (54,55). In addition to these 
functional changes, differences in brain structure have also been reported (54).   
  
6 
T
ab
le
 1
. 
Th
e 
IC
D
-1
0
 c
ri
te
ri
a 
fo
r 
di
ag
n
os
ti
c 
of
 c
lin
ic
al
 d
ep
re
ss
io
n
 (
F3
2
).
 (
4
1
) 
 C
ri
te
ri
a
 f
o
r 
d
e
p
re
ss
io
n
 
S
y
m
p
to
m
s 
 
S
ta
te
 o
f 
d
e
p
re
ss
io
n
 
N
u
m
b
e
r 
o
f 
sy
m
p
to
m
s 
A
. 
S
ym
p
to
m
s 
h
a
ve
 l
as
te
d
 a
t 
le
as
t 
fo
r 
tw
o
 w
e
e
ks
 
K
e
y 
sy
m
p
to
m
s:
 
P
e
rs
is
te
n
t 
sa
d
n
es
s 
o
r 
lo
w
 m
o
od
 
S
e
ve
re
 d
ep
re
ss
io
n
 
≥
7
, 
al
l 
3
 k
e
y 
sy
m
p
to
m
s 
B
. 
S
ym
p
to
m
s 
in
cl
u
d
e
 a
t 
le
as
t 
tw
o
 
ke
y 
sy
m
p
to
m
s 
 
Lo
ss
 o
f 
in
te
re
st
 o
r 
p
le
a
su
re
 
 
 
C
. 
A
lt
o
g
e
th
e
r 
at
 l
e
as
t 
fo
u
r 
sy
m
p
to
m
s 
(i
n
cl
. 
ke
y 
sy
m
p
to
m
s)
 i
s 
co
n
si
d
e
re
d
 
cl
in
ic
a
l 
d
ep
re
ss
io
n
 
 
Fa
ti
g
u
e 
o
r 
lo
w
 e
n
er
g
y 
M
o
de
ra
te
 d
ep
re
ss
io
n
 
5
-6
 
 
O
th
e
r 
sy
m
p
to
m
s:
 
D
is
tu
rb
ed
 s
le
ep
 
 
 
 
 
P
o
o
r 
o
r 
in
cr
e
as
ed
 a
p
p
et
it
e 
M
ild
 d
ep
re
ss
io
n
 
4
 
 
 
Lo
w
 s
e
lf
-c
on
fi
d
e
n
ce
 
 
 
 
 
P
o
o
r 
co
n
ce
n
tr
at
io
n
 o
r 
in
d
ec
is
iv
en
es
s 
 
N
o
t 
d
ep
re
ss
ed
 
<
4
 
 
 
A
g
it
at
io
n
 o
r 
sl
o
w
in
g
 o
f 
m
o
ve
m
en
ts
 
 
 
 
 
G
u
ilt
 o
r 
se
lf
-b
la
m
e 
 
 
 
 
S
u
ic
id
a
l 
th
o
ug
h
ts
 o
r 
ac
ts
 
 
 
A
b
b
re
vi
at
io
n
s:
 I
C
D
, 
In
te
rn
at
io
n
al
 C
la
ss
if
ic
at
io
n
 o
f 
D
is
e
as
es
7 
 
 
Susceptibility to depression is at least partly heritable, but the magnitude of genetic 
factors is still unknown. Approximations of heritability in MDD vary from 31% to 42%, 
which is substantially lower than in bipolar disorder or schizophrenia (39,51). Heritability 
may play a greater role when depression is severe, recurrent or has begun in early age (56). 
Susceptibility to depression is explained by multiple genes (39,51). There is also a gene-
environmental interaction in depression; for example, a polymorphism in the promoter 
region of the serotonin transporter gene moderates the influence of stressful life events on 
depression (57).  
There are several theories of the pathogenesis of depression, and these theories are not 
separate, but highly connected (58). The most common biological candidates of interest 
have been monoamines, adenoreceptors, the dopaminergic system, the function of the 
hypothalamus-pituitary-adrenal gland (HPA) axis, corticosteroids, neurotrophins and 
atrophy or resynthesization of neuronal cells (58,59). The following sections present the 
hypotheses of monoamines, inflammation, stress and neurogenesis, which are the most 
promising candidates to explain the association between diet and depression. 
2.4.1 Monoamine hypothesis  
The monoamine hypothesis, an earlier major theory of depression, is based on the 
presumption that abnormalities in the metabolism of the neurotransmitters serotonin and 
noradrenaline may cause depression (39). The serotonergic and noradrenergic systems are 
capable of modulating the brain areas involved in behavior, sleep, eating, feelings and 
thoughts. Especially the role of serotonin has been supposed to be central in the 
pathogenesis of depression. According to this theory, depression could be defeated by 
returning the serotonin levels in the central nervous system (CNS) back to normal (39). 
However, the monoamine hypothesis has been argued to be an insufficient approach to the 
etiology of depression, since typical monoamine-based antidepressant treatments have not 
been efficient enough, and the advantages of antidepressants to mood are seen only after 
several weeks of administration, not immediately (60).  
2.4.2 Inflammation hypothesis 
The first findings of the role of inflammation and cell-mediated immune activation in 
depression were reported already in the 1990s (61). Today, low-grade inflammation is 
believed to play an important role in the development of depression (62,63). Cytokines, 
secreted by macrophages as a result of the activation of sympathetic nervous system in 
stress, are proteins with either pro-inflammatory or anti-inflammatory effects (64). 
Depressed patients have been observed to have high blood C-reactive protein (CRP) levels, 
as well as elevated levels of plasma pro-inflammatory cytokines, like interleukin 1, 
interleukin-6, interleukin-2 and tumor necrosis factor-α (58,62,63). It has also been 
suggested that the serotonergic disturbances in depression could be a consequence of cell-
mediated immune activation (62), and pro-inflammatory cytokines reduce the functions of 
neurotransmitters in CNS (64). The inflammation theory supports the bi-directional 
relationships between depression and other non-communicable diseases, such as obesity, 
T2D and CVD (33,65).  
2.4.3 Stress hypothesis 
The stress hypothesis suggests that prolonged mental stress causes depression by 
hyperactivity of the HPA axis (66). Chronic mental stress disturbs the regulation of the 
HPA axis and causes chronic inflammation (67). Nevertheless, not all individuals who 
encounter acute or prolonged mental stress become depressed. Approximately half of the 
depressed patients have hyperactivity of the HPA axis (68) and elevated levels of cortisol 
are also common (39). It is possible that chronic mild elevations of cortisol levels have a 
pathogenic role in depression (39). In depressed patients, the ability of cortisol to restrict the 
activity of HPA axis is reduced, which further reinforces the hyperactivity of the HPA axis 
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(64). In addition, hypersecretion of corticotrophin-releasing hormone and impairment in 
responsiveness to glucocorticoids are typical in depression (58). Interestingly, the biological 
manifestations of mental stress are similar to depression at the biological level (69). 
Cytokine effects on behavior are believed to be related in part to their effects on 
neuropeptide and neurotransmitter functions, synaptic plasticity and neuroendocrine 
function (66). Specifically, cytokines accelerate the HPA axis and thus reinforce the 
secretion of cortisol (67,70).  
2.4.4 Neurogenesis and neural network hypothesis  
Depression has been linked to impaired neurogenesis and information-processing 
dysfunction within neural networks (71,72). Hypersecretion of cortisol elevates the 
activation of type II glucocorticoid receptors, which in turn increases the activity of the 
neurotransmitter glutamate in CNS and may lead to the loss of neurons in hippocampus, a 
center of mood and memory (64). The challenges in adaptation of neural networks to 
environmental conditions possibly predispose to MDD (71,72). Brain-derived neurotrophic 
factor (BDNF) is a critical mediator of activity-dependent neuronal plasticity in the cerebral 
cortex and deficit of neurotrophic factors have been suggested to cause mood disorders 
(71). Peripheral levels of BDNF have been found to be decreased in depressed patients 
(58,73). The network hypothesis suggests that it is not the level of neurotrophins including 
BDNF alone and directly, but together with environmental conditions that guides neuronal 
networks to adapt better to the environment (71). The network hypothesis is also related to 
other hypotheses of depression as low-grade inflammation status and endothelial 
dysfunction both prevent the expression of BDNF (74).  
 
In summary, the pathogenesis of depression is multifactorial and only partly understood. 
There are plenty of biological changes involved in depression. Nevertheless, regardless of 
several candidates, there is no certain positive biomarker of depression (75). The magnitude 
of multiple factors in the prevention and the therapeutic potential of other pathways are 
under investigation. 
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2.5 TREATMENT OF DEPRESSION 
The treatment strategies of depression in Finland are presented in Table 2. Depression is 
most often treated with antidepressant medication, but response to treatment is 
inconsistent, as approximately 50% to 60% of MDD patients do not receive adequate 
response (39,76). Ineffective antidepressant treatment usually leads to administration of a 
second drug, either simultaneously or separately. On average, patients with mild or 
moderate symptoms benefit from antidepressant treatment only slightly, whereas benefits 
increase with the severity of depression (77). In addition to neurotransmitter properties, 
antidepressant medication also induces changes in inflammatory factors, neuronal 
connectivity and improvements in neuronal plasticity (72,78,79).  
Psychotherapeutic treatments, such as cognitive-behavioral psychotherapy, 
psychodynamic psychotherapy or interpersonal psychotherapy, are effective in the 
treatment of depression (40). Psychotherapies have also been shown to be connected to the 
greater plasticity of the neural network in a few studies (80). To optimize the benefits, 
antidepressant and psychotherapy treatments should be given in combination (78). 
 
 
Table 2. Severity of depression and treatment strategies in acute phase. 
 
Treatment Mild Moderate Severe Psychotic 
Antidepressant treatment + + + + 
Psychotherapy + + (+) - 
Antipsychotic treatment - - - + 
Electrotherapy  - - + + 
Modified from Finnish Current Care Guidelines 2010 (40). 
2.6 DIET AND DEPRESSION 
Diet influences the biological and neurochemical actions in the body that may affect the 
development and progression of depression. Diet has been found to be involved in 
monoamine synthesis and inflammation, as well as to affect the HPA axis, neurogenesis 
and neural network functioning, for example by the effects on BDNF levels (58). Two most 
commonly studied nutrients possibly related to depression are folate (6,8) and n-3 PUFAs, 
especially EPA and DHA (6,17). In addition, several other nutrients, such as other group B 
vitamins, like vitamin B6 and B12 (10), vitamin D (81), and the amino acid trypthophan (82), 
and foods like fish (18), olive oil (6), fruits and vegetables (83), and healthy (26) and 
unhealthy (24) dietary patterns have been connected to the risk of depression. 
The association between folate deficiency and increased depression was already 
demonstrated in the 1960s. Victor Herbert showed that his self-induced elimination of 
folate from diet caused depressive symptoms, which disappeared when folate was 
reintroduced to the diet and folic acid supplementation was administrated (84). Since then, 
prospective studies have found an inverse association between folate intake (9) or serum 
concentrations of folate (7,8) and the risk of depression. Folate and vitamin B12 are involved 
in monoamine synthesis, and the potential effects of these vitamins on depression are 
probably mainly based on the monoamines (85). Based on the evidence from previous 
studies and the involvement in monoamine synthesis, folate and vitamin B12 were chosen to 
be studied in this thesis. 
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Interest in the relationship between n-3 PUFAs and depression was sparked based on 
ecological studies. Strong cross-national correlations between fish consumption and annual 
prevalence of MDD was demonstrated in the 1990s (86). From an ecological point of view, it 
could be hypothesized that the increasing incidence of MDD in many Western countries 
could be connected to the decline in n-3 PUFA intake from fish consumption (86). The 
neurobiological background, inflammatory effects and reciprocal associations between n-3 
PUFAs, depression and CVD have supported the hypothesis. However, the causation 
between the phenomena is impossible to verify based on ecological findings. Prospective 
studies on fish consumption or n-3 PUFA intake have been conducted since then, with 
partly inconsistent results (15,17-19,87-90). Especially the magnitude of gender has been 
argued, as n-3 PUFAs have been suggested to be protective especially in women (17,18). 
Therefore, as a part of this thesis, we decided to study the association between n-3 PUFAs 
and the risk of depression in male population.  
The prospective associations between coffee or tea consumption and depression are 
practically unstudied, with only a few cross-sectional studies published (91-93). Coffee 
consumption and caffeine intake have previously been found to associate with a decreased 
risk of chronic diseases including various cancers, T2D, Parkinsonism, and Alzheimer’s 
disease (23). Therefore, coffee, as well as tea and caffeine, and their associations with the 
risk of depression were chosen to be studied in this thesis.  
The most recent area of research on the subject has focused on the association between 
general, extensive dietary patterns and depression, and both protective and predisposing 
factors have been proposed (24,26,94). The dietary pattern area of research is fairly new, as 
all the largest studies have been published during the last five years (24-26,94-96). 
However, no previous studies on dietary patterns in Finnish population have been 
published. The work on dietary patterns and depression complemented well the coherent 
whole of this thesis. 
Finally, there is a lack of information of the effects of lifestyle-modified interventions on 
depressive symptoms. Therefore, we wanted to include a study on the effects of intensive 
three-year lifestyle intervention on the change in depressive symptoms in this thesis. 
The following sections describe in more detail the selected dietary factors suggested to 
be associated with the risk of depression. Studies on MDD or depressive symptoms were 
included, whereas studies on prenatal, postpartum and bipolar depression were excluded. 
Moreover, intervention studies demonstrating the effects of lifestyle factors on depressive 
symptoms are introduced. In addition, the potential mechanisms that may explain the 
associations are presented.  
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3 Folate and vitamin B12  
3.1 FOLATE AND VITAMIN B12 METABOLISM 
Folate and vitamin B12 (cobalamin) belong to the group B water-soluble vitamins. Folate 
presents in many forms, such as tetrahydrofolate and methylenetetrahydrofolate, or folic 
acid and folinic acid (the two synthesized forms of folate). Methyltetrahydrofolate (MTHF), 
also called L-methylfolate or levomefolic acid, is the bioavailable form of folate, and the 
only form that penetrates through the blood-brain barrier (13,97). Adequate intake of folate 
is important for the formation of the neural tube after conception of the fetus, development 
of the brain and nervous system, normal growth, nucleotide synthesis as well as 
programmed cell death (98,99). The metabolisms of folate and vitamin B12 are highly 
connected and both vitamins are essential in the remethylation processes of homocysteine 
(Figure 1).   
 
 
Abbreviations: BH2, quinonoid dihydrobiopterin; DHFR, dihydrofolate reductase; 5-MTHF, 5-
methyltetrahydrofolate; MTHFR, methylenetetrahydrofolate reductase; NADPH, reduced form of 
nicotinamide adenine dinucleotide phosphate; X-CH3, methyl group 
 
Figure 1. Overview of the one-carbon metabolism, methylation cycles and monoamine metabolism. 
Modified from Reynolds et al. 2002 and Freeman et al. 2010 (100,101). 
12 
 
 
3.2 RECOMMENDATIONS AND DIETARY INTAKE  
The recommendations for adequate daily folate intake suggest 300 μg for men and elderly 
women at population level (102). The recommendation for women of reproductive age is 
400 μg daily. Energy-adjusted folate intake is recommended to be 45 μg/MJ of energy in all 
age groups. Folate can be found in dark green vegetables like spinach and broccoli, lentils, 
fruits, especially oranges, berries, beans, nuts, whole-grain products and liver. In Finnish 
general population, folate has mainly been derived from grain products (24%), fruits and 
berries (10%), meat (10%), milk (10%) and vegetables (9%) (103). It is noteworthy that folate 
is easily destroyed due to heating or oxygen, and folate compounds are also dissolved into 
boiling water during food preparation.    
Folate is still one of the few vitamins Finnish people do not get enough of from their diet 
on population level (103). According to the National FINDIET 2007 survey, the mean daily 
folate intake in Finnish men and women was 270 μg and 226 μg, respectively. Also the 
elderly (65 to 74 years old) received less folate than recommended; men and women 
received 243 μg and 210 μg of folate daily, respectively.  In addition, the energy-adjusted 
daily intakes of folate were lower than recommended in both men and women in all age 
groups, varying from 30 μg/MJ in working-aged men to 36 μg/MJ in elderly women (103).  
The Finnish recommendation for daily vitamin B12 intake is 2.0 μg/day and 0.2 μg/MJ of 
energy (102). Vitamin B12 is mostly present in animal-based foods, and the most relevant 
sources of vitamin B12 in Finnish population are meat, fish, poultry, egg and dairy (103). The 
mean intake of vitamin B12 was 5.6/ μg/day and the energy-adjusted intake was 0.7 μg/MJ 
(103). On population level, vitamin B12 intake was sufficient in all age groups.   
3.3 DEFICIENCY  
Folate deficiency, which is one of the most common forms of vitamin deficiency in the 
world, is caused by low dietary intake, but also by improper absorption and decreased 
utilization (97). Certain gastro-intestinal diseases, alcohol consumption, smoking and 
several drugs, such as oral contraceptives, may predispose to deficiency (104). The 
symptoms of folate deficiency include nausea, irritability, insomnia, loss of appetite, 
diarrhea and muscular weakness. Macrocytic or megaloblastic anemia is caused by 
significant deficiency of folate for at least three months.  
Genetic polymorphisms, like polymorphism in methylenetetrahydrofolate reductase 
(MTHFR) gene, affect the ability to metabolize folate and cause the lack of functional form 
of folate, MTHF (97). Approximately 10% of the population carries the MTHFR C677T TT 
genotype (105) and MTHFR C677T TT genotype, and to a lesser extent the C677T CT 
genotype, associated with an increase in the circulating serum concentrations of 
homocysteine and a decrease in serum concentrations of folate (106). This may lead to a 
potential reduction in monoamine neurotransmitter function as there is a similar reduction 
in MTHF in the CNS (106).  
The reference range for serum concentrations of folate is 10.4-42.4 nmoles/L and for red-
cell folate 1187-2854 nmol/L (107). Circulating concentrations of folate in serum or plasma 
reflect dietary intake during several weeks, and for example at the onset of a folate-
deficient diet, it is seen that serum concentrations fall below normal in three to six weeks 
(108). However, red-cell concentrations reflect the intake and tissue stores of longer periods, 
at least months (109). In order to define folate deficiency, red-cell folate concentrations 
should be measured.  
Deficiency of vitamin B12 is present in approximately 3-6% of population in Western 
countries and the prevalence of deficiency increases substantially in the elderly (110). 
Approximately 20% of older adults have marginal depletion of vitamin B12 in the United 
States of America (U.S.) and in United Kingdom (110). The vitamin B12 deficiency is usually 
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caused by the loss of an intrinsic factor, synthesized by the gastric cells. This state, called 
pernicious anemia, is most often driven by autoimmune atrophic gastritis (111). Reference 
range for plasma vitamin B12 concentrations is 140-490 picomoles/L, and serum active 
vitamin B12 concentrations should be >35 picomoles/L (107). In vitamin B12 deficiency, serum 
folate concentrations are usually normal or increased, whereas red-cell folate 
concentrations are low.  
3.4 FOLATE, VITAMIN B12 AND DEPRESSION 
In psychiatric patients, deficiency of folate affects as many as one-third of the individuals 
(112), which may be explained by disturbed appetite, lowered intake, altered absorption or 
increased requirement (5,97). Two thirds of individuals with megaloblastic anemia have 
been documented to have neuropsychiatric problems, and depression is the most common 
neuropsychiatric manifestation of folate deficiency (100). Depressed individuals have been 
observed to have lower circulating concentrations of folate (113-115) and lower intake or 
concentrations of vitamin B12 (116,117) compared to non-depressed individuals. However, 
even though low folate status and depression are connected, there is limited evidence 
concerning the direction of the association. The following sections present the cross-
sectional studies and prospective studies clarifying the association. The most relevant 
studies for the assessment of the causality, intervention studies and clinical trials, are also 
presented. 
3.4.1 Cross-sectional studies  
The cross-sectional studies on the association between folate and depression are presented 
in Table 3. Most of the studies demonstrate an inverse association between folate intake or 
blood concentrations of folate and depression, and the majority of all studies were carried 
out in populations with elderly participants. However, energy intake may be a potential 
confounder of the association.  
 
Dietary intake of folate and vitamin B12 
An inverse association between intake of folate and the prevalence of depression was 
observed in some (118-120), but not in all studies (121,122). The details of the study 
populations are presented in more detail in Table 3. Depressive symptoms may affect 
appetite and cause decreased intake of folate as a natural cause of disease. Nevertheless, 
only in two studies with no association (121,122) total energy intake was regarded as a 
potential confounder in the statistical models, which may explain the inconsistent results. 
One of the two studies with no association (90), was the largest of these studies with more 
than 27,000 smoking Finnish men. In the second largest of the studies, a study from the 
Mediterranean area, folate intake was inversely associated with the prevalence of 
depression, but only in smoking men. In addition, as regards vitamin B12, high intake was 
related to lowered prevalence of depression in that study (123). However, in another 
Finnish study, a previous study based on the cohort studied in this thesis, an inverse 
association was shown even after adjustment for appetite, which is related to total energy 
intake (119). In that study, participants with elevated depressive symptoms had lower 
energy intake and poor appetite was more common compared to other participants. It has 
also been hypothesized that the association may differ according to the subtype of 
depression. Yet another study in Finnish adults showed that low dietary intake of folate 
associated with higher prevalence of melancholic depression, but no association with non-
melancholic, atypical depression was observed (124). This cross-sectional association may 
be a natural result from decreased appetite related especially to melancholic symptoms of 
depression. In this study, however, neither total energy intake nor appetite was taken into 
account as a potential confounder.  
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Circulating concentrations of folate and vitamin B12  
The majority of the cross-sectional studies on the association between blood concentrations 
of folate and prevalence of depression demonstrated an inverse association (8,114,125-129). 
However, there are also few studies with no association detected (116,130-132). There were 
no observed differences in the age of the participants between the studies with an inverse 
association or no association. None of these studies included total energy intake as a 
potential confounder. Circulating concentrations of folate were also inversely associated 
with severity of depression in clinical population (133). Depression may differ from other 
mental illnesses, as depressed patients have been reported to have lower blood 
concentrations of folate compared to other psychiatric illnesses, such as bipolar disorder or 
schizophrenia, and the concentrations were as low as in patients with alcoholism (133).  
Moreover, several studies have reported an inverse association between blood 
concentrations of vitamin B12 and depression. Deficiency of vitamin B12 was associated with 
an elevated prevalence of depression in Dutch middle-aged or older men and women (132), 
in Chinese elderly (114)  and in elderly North-American women (131). In contrast, another 
North-American study in younger participants from general population (127) and a 
Norwegian study in middle-aged or older adults (129) reported no association. However, it 
has been suggested that the risk of depression may be elevated especially in the elderly, 
and already at plasma vitamin B12 concentrations under 250 picomoles/L, which is in the 
reference range (>140 picomoles/L) (134). In addition, high serum concentrations of vitamin 
B12, but not red-cell concentrations of folate, have also been found to associate with 
improved recovery from MDD in Finnish 21- to 69-year-old outpatients (135).  
3.4.2 Prospective studies 
Only few prospective studies with inconsistent results have been published on the 
association between folate and depression (Table 4). Studies have mainly investigated the 
circulating concentrations of folate, whereas to date, only two studies have been published 
on dietary folate and depression in general population (9,10). The relation between folate 
and depression has been suggested to be shown especially in aging populations (100), but 
recent prospective studies do not support the hypothesis. Heterogeneity between the 
studies is large, which complicates the interpretation of the results. 
 
Dietary intake of folate and vitamin B12 
No association was detected between energy-adjusted intake of folate and the risk of 
depression in 3,503 North American elderly men and women (10). Dietary intake from long 
FFQs and total folate intake including supplementation were studied separately and 
summarized. Neither dietary intake nor total intake associated with the risk of depression. 
Separate analyses may be regarded as a strength of this study. However, total energy intake 
was not adjusted for in the statistical models. In the French Supplémentation en Vitamines 
et Minéraux Antioxydants Study (SU.VI.MAX) cohort with almost 2,000 middle-aged 
participants, an inverse association was found between the intake of folate and the risk of 
recurrent depression, but only in men (9). Furthermore, no associations were found for the 
risk of any depressive episode, or a single depressive episode. These results support the 
hypothesis that sufficient intake of folate would be beneficial especially in the prevention of 
recurrent depression episodes. Repeated measurements of food intake, six 24-hour diet 
records during the first two years of the study, were used to assess folate intake. Though 
the 24-hour diet record method as such is not valid for assessing individuals’ habitual diet 
due to large within-person variation in food intake, it has been stated that if collected over a 
long period, as in this study, it is a proper measurement of usual intake (136).
  
15 
T
ab
le
 3
. 
C
ro
ss
-s
ec
ti
on
al
 s
tu
di
es
 o
n
 t
h
e 
as
so
ci
at
io
n
 b
et
w
ee
n
 f
ol
at
e 
an
d 
d
ep
re
ss
io
n
. 
S
tu
d
ie
s 
ar
e 
m
ai
n
ly
 p
op
u
la
ti
on
 s
tu
di
es
. 
  S
tu
d
y
 b
y
 
S
tu
d
y
 p
o
p
u
la
ti
o
n
 
A
g
e
 
(y
e
a
rs
) 
N
u
m
b
e
r 
o
f 
d
e
p
re
ss
e
d
 
F
o
la
te
 
m
e
a
su
re
d
  
R
e
su
lt
s 
 
 
 
 
D
ie
t 
 
T
o
lm
u
n
e
n
 e
t 
a
l.
 2
0
0
3
 
(1
1
9
) 
2
4
4
3
 m
e
n
 f
ro
m
 E
a
st
e
rn
-
Fi
n
la
n
d
 
4
2
-6
0
 
2
2
8
 
4
-d
a
y 
fo
od
 
re
co
rd
 
Lo
w
 i
n
ta
ke
 o
f 
e
n
e
rg
y-
ad
ju
st
ed
 f
o
la
te
 w
as
 a
ss
oc
ia
te
d
 w
it
h
 
o
cc
u
rr
en
ce
 o
f 
el
ev
a
te
d
 d
ep
re
ss
iv
e
 s
ym
p
to
m
s.
 
 
 
 
 
 
 
H
a
kk
a
ra
in
en
 e
t 
a
l.
 
2
0
0
4
 (
1
2
1
) 
2
7
,1
1
1
 s
m
o
ki
n
g
 F
in
n
is
h
 m
e
n
  
5
0
-6
9
 
4
3
1
6
 
2
7
6
-i
te
m
 F
FQ
 
E
n
e
rg
y-
ad
ju
st
ed
 f
o
la
te
 i
n
ta
ke
 w
a
s 
n
o
t 
as
so
ci
at
e
d
 w
it
h
 t
h
e
 s
e
lf
-
re
p
o
rt
ed
 d
ep
re
ss
ed
 m
oo
d
. 
 
 
 
 
 
 
 
M
u
ra
ka
m
i 
e
t 
a
l.
 2
0
0
8
 
(1
1
8
) 
5
1
7
 J
a
p
a
n
e
se
 w
or
ke
rs
 (
3
0
9
 
m
e
n
, 
2
0
8
 w
o
m
e
n
) 
2
1
-6
7
 
1
8
8
 
5
6
-i
te
m
 F
FQ
 
H
ig
h
er
 e
n
er
g
y-
ad
ju
st
ed
 i
n
ta
ke
 o
f 
fo
la
te
 w
a
s 
a
ss
o
ci
at
ed
 w
it
h
 a
 
lo
w
e
r 
p
re
va
le
n
ce
 o
f 
d
ep
re
ss
iv
e
 s
ym
p
to
m
s 
in
 m
e
n
, 
b
u
t 
n
o
t 
in
 
w
o
m
e
n
. 
K
a
m
p
h
u
is
 e
t 
a
l.
 2
0
0
8
 
(1
2
2
) 
 
3
3
2
 D
u
tc
h
 m
e
n
  
7
0
-9
0
 
7
2
 
Lo
n
g
 F
FQ
 
N
o
 a
ss
o
ci
at
io
n
 b
e
tw
ee
n
 e
n
er
g
y-
ad
ju
st
ed
 i
n
ta
ke
 o
f 
fo
la
te
 a
n
d
 
p
re
va
le
n
ce
 o
f 
d
ep
re
ss
iv
e
 s
ym
p
to
m
s.
  
 
 
 
 
 
 
S
a
n
ch
e
z-
V
ill
eg
as
 e
t 
a
l.
 
2
0
0
9
 (
1
2
0
) 
 
9
6
7
0
 S
p
a
n
is
h
 u
n
iv
e
rs
it
y 
g
ra
d
u
a
te
s 
(4
2
1
1
 m
en
, 
5
4
5
9
 
w
o
m
e
n
) 
1
8
-7
0
 
3
6
3
 
1
3
6
-i
te
m
 F
FQ
 
In
ta
ke
 o
f 
fo
la
te
 w
as
 i
n
ve
rs
e
ly
 a
ss
o
ci
at
e
d
 w
it
h
 t
h
e
 p
re
va
le
n
ce
 o
f 
d
ep
re
ss
io
n
 o
n
ly
 i
n
 s
m
o
ki
n
g
 m
e
n
 a
n
d
 m
en
 w
it
h
 l
o
w
 a
n
xi
e
ty
 
le
ve
ls
. 
 
 
 
 
 
 
 
S
ep
p
ä
lä
 e
t 
a
l.
 2
0
1
2
 
(1
2
4
) 
2
8
0
6
 F
in
n
is
h
 i
n
d
iv
id
u
a
ls
 
(1
3
2
8
 m
e
n
, 
1
4
7
8
 w
om
en
) 
4
5
-7
4
 
4
2
9
 
1
3
2
-i
te
m
 F
FQ
 
Lo
w
 e
n
er
g
y-
ad
ju
st
ed
 f
o
la
te
 i
n
ta
ke
 w
a
s 
as
so
ci
a
te
d
 w
it
h
 
m
e
la
n
ch
o
lic
 d
e
p
re
ss
io
n
, 
b
u
t 
n
o
t 
w
it
h
 n
o
n
-m
e
la
n
ch
o
lic
 
d
ep
re
ss
io
n
. 
 
 
 
 
B
lo
o
d
 
 
E
b
ly
 e
t 
a
l.
 1
9
9
8
 (
1
2
5
) 
1
7
7
1
 C
a
n
a
d
ia
n
 m
e
n
 a
n
d
 
w
o
m
e
n
  
≥
6
5
 
1
9
9
 
S
e
ru
m
 
Lo
w
 s
e
ru
m
 f
o
la
te
 w
as
 a
ss
o
ci
at
e
d
 w
it
h
 d
e
p
re
ss
io
n
. 
 
 
 
 
 
 
Li
n
d
em
an
 e
t 
a
l.
 2
0
0
0
 
(1
3
0
) 
1
1
3
0
 N
o
rt
h
-A
m
e
ri
ca
n
 m
e
n
 
an
d
 w
om
e
n
 
≥
6
5
 
n
/a
 
S
e
ru
m
 
Lo
w
 s
e
ru
m
 f
o
la
te
 w
as
 a
ss
o
ci
at
e
d
 w
it
h
 im
p
a
ir
ed
 c
og
n
it
iv
e
 
fu
n
ct
io
n
, 
b
u
t 
n
o
t 
w
it
h
 d
e
p
re
ss
io
n
. 
 
 
 
 
 
 
Pe
n
n
in
x 
e
t 
a
l.
 2
0
0
0
 
(1
3
1
) 
7
0
0
 N
o
rt
h
-A
m
e
ri
ca
n
 
d
is
ab
le
d
, 
n
o
n
-d
em
en
te
d
 
w
o
m
e
n
  
>
6
5
 
2
2
2
 
S
e
ru
m
 
S
e
ru
m
 f
o
la
te
 o
r 
fo
la
te
 d
e
fi
ci
en
cy
 w
e
re
 n
o
t 
as
so
ci
at
ed
 w
it
h
 
d
ep
re
ss
io
n
. 
 
 
 
 
 
 
T
ie
m
e
ie
r 
et
 a
l.
 2
0
0
2
 
(1
3
2
) 
3
8
8
4
 D
u
tc
h
 m
e
n
 a
n
d
 w
o
m
e
n
, 
a
m
on
g
 w
h
o
m
 c
h
os
en
 2
7
8
 
d
ep
re
ss
ed
 s
u
b
je
ct
s 
an
d
 4
1
6
 
ra
n
d
o
m
ly
 s
e
le
ct
ed
 c
o
n
tr
o
ls
  
 
>
5
5
 
2
7
8
 
S
e
ru
m
 
N
o
 a
ss
o
ci
at
io
n
s 
b
et
w
e
en
 s
e
ru
m
 f
o
la
te
 a
n
d
 d
e
p
re
ss
io
n
. 
 
 
 
 
 
 
 
S
a
ch
d
e
v 
e
t 
a
l.
 2
0
0
5
 
(1
2
6
) 
4
1
2
 c
om
m
u
n
it
y-
d
w
e
lli
n
g
 
A
u
st
ra
lia
n
 m
e
n
 a
n
d
 w
o
m
e
n
 
6
0
-6
4
 
5
8
 
S
e
ru
m
 
Lo
w
 s
e
ru
m
 f
o
la
te
 w
as
 a
ss
o
ci
at
e
d
 w
it
h
 i
n
cr
ea
se
d
 d
e
p
re
ss
iv
e
 
sy
m
p
to
m
s.
 
 
 
 
 
 
T
a
b
le
 3
 t
o
 b
e
 c
on
ti
n
u
ed
 
 
 
 
 
 
 
  
16 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
T
a
b
le
 3
 c
o
n
ti
n
u
es
 
 
 
 
 
 
S
tu
d
y
 b
y
 
S
tu
d
y
 p
o
p
u
la
ti
o
n
 
A
g
e
 
(y
e
a
rs
) 
 
F
o
la
te
 
m
e
a
su
re
d
 
R
e
su
lt
s 
 
 
 
 
B
lo
o
d
 
 
N
g
 e
t 
a
l.
 2
0
0
9
 (
1
1
4
) 
6
6
9
 c
om
m
u
n
it
y-
liv
in
g
 
C
h
in
e
se
 (
2
5
5
 m
e
n
, 
4
1
4
 
w
o
m
e
n
) 
6
5
 
(m
ea
n
) 
1
7
8
 
S
e
ru
m
 
Lo
w
 s
e
ru
m
 f
o
la
te
 w
as
 a
ss
o
ci
at
e
d
 w
it
h
 g
re
a
te
r 
p
re
va
le
n
ce
 o
f 
d
ep
re
ss
iv
e
 s
ym
p
to
m
s.
  
 
 
 
 
 
 
R
o
b
in
so
n
 e
t 
a
l.
 2
0
1
1
 
(1
1
6
) 
 
2
4
4
 h
ea
lt
h
y 
co
m
m
u
n
it
y-
d
w
e
lli
n
g
 I
ri
sh
 e
ld
e
rl
y 
(1
0
9
 
m
e
n
, 
1
3
5
 w
o
m
e
n
) 
7
8
 
(m
ea
n
) 
3
5
 
S
e
ru
m
 
N
o
 a
ss
o
ci
at
io
n
 b
e
tw
ee
n
 s
e
ru
m
 f
o
la
te
 a
n
d
 d
ep
re
ss
iv
e
 
sy
m
p
to
m
s.
 
 
 
 
 
 
 
N
a
n
ri
 e
t 
a
l.
 2
0
1
2
 (
8
) 
5
4
5
 J
a
p
a
n
e
se
 e
m
p
lo
ye
e
s 
(3
1
9
 m
en
, 
2
2
6
 w
o
m
e
n
) 
2
1
-6
7
 
1
5
9
 
S
e
ru
m
 
S
e
ru
m
 f
o
la
te
 w
as
 i
n
ve
rs
e
ly
 a
ss
oc
ia
te
d
 w
it
h
 t
h
e
 p
re
va
le
n
ce
 o
f 
d
ep
re
ss
iv
e
 s
ym
p
to
m
s 
 
 
 
 
 
 
M
or
ri
s 
et
 a
l.
 2
0
0
3
 
(1
2
7
) 
2
9
4
8
 N
o
rt
h
-A
m
e
ri
ca
n
 m
e
n
 
an
d
 w
om
e
n
 
1
5
-3
9
 
3
0
1
 
S
e
ru
m
  
R
e
d
-c
e
ll 
 
Lo
w
 r
ed
-c
e
ll 
o
r 
se
ru
m
 f
o
la
te
 w
a
s 
as
so
ci
at
ed
 w
it
h
 l
if
e
-t
im
e
 
d
ep
re
ss
io
n
 d
ia
g
n
o
se
s.
  
 
 
 
 
 
 
R
a
m
os
 e
t 
a
l.
 2
0
0
4
 
(1
2
8
) 
1
5
1
0
 m
a
in
ly
 L
at
in
-A
m
e
ri
ca
n
s 
(6
2
7
 m
en
, 
8
8
3
 w
o
m
e
n
) 
>
6
0
 
3
7
8
 
P
la
sm
a 
Lo
w
 p
la
sm
a
 f
o
la
te
 w
as
 a
ss
oc
ia
te
d
 w
it
h
 d
ep
re
ss
io
n
 i
n
 w
o
m
e
n
 
b
u
t 
n
ot
 i
n
 m
e
n
. 
 
 
 
 
 
 
B
je
lla
n
d
 e
t 
a
l.
 2
0
0
3
 
(1
2
9
) 
5
9
4
8
 N
o
rw
e
g
ia
n
 m
e
n
 a
n
d
 
w
om
e
n
 
4
6
–
4
9
 
or
 7
0
–
7
4
 
2
4
3
 
P
la
sm
a 
H
ig
h
 f
o
la
te
 c
o
n
ce
n
tr
at
io
n
s 
d
ec
re
a
se
d
 t
h
e
 l
ik
e
lih
o
o
d
 o
f 
d
ep
re
ss
io
n
 o
n
ly
 i
n
 a
 s
u
b
-g
ro
u
p
 o
f 
m
id
d
le
-a
g
ed
 w
om
en
. 
 
A
b
b
re
vi
at
io
n
s:
 F
FQ
, 
fo
od
 f
re
q
u
en
cy
 q
u
es
ti
o
n
n
ai
re
 
    
17 
 
 
In addition, the use of total energy intake as a potential confounder in the statistical models 
may be regarded as a strength. Both studies had long duration of follow-up, seven and 
eight years, respectively. There were no large differences between the mean intake of folate 
between the study populations: the range of the second folate tertile was 263 to 397 μg/day 
in the North American study (10) and the mean in the second folate tertile was 336 μg/day 
in the French study (9). 
The North American study described above was the only prospective work to 
demonstrate an association between vitamin B12 and the risk of depression; high total intake 
of vitamin B12 (summarized from both diet and supplements) was shown to be inversely 
associated with depressive symptoms, whereas pure dietary intake of vitamin B12 was not 
(10). More specifically, each additional 10 μg of vitamin B12 derived from foods and 
supplements associated with a 2% lower likelihood of developing depressive symptoms 
(10). The result was explained by the impaired bioavailability and absorption of vitamin B12 
from dietary intake, as these are suggested to be diminished in the elderly. 
 
Circulating concentrations of folate and vitamin B12 
An inverse association between serum concentrations of folate and the risk of depression 
was demonstrated in elderly Korean men and women (7) and in Japanese employees (8). In 
contrast, the largest of these studies, a study in young women in the United Kingdom 
measuring red-cell folate concentrations (11) and other in elderly European men and 
women measuring plasma folate concentrations (12) found no associations. In the Korean 
study with an inverse association (7), the mean serum concentration of folate was 24.2 
nmol/L for the whole study population, which is high, whereas in the Japanese study with 
an inverse association, mean serum concentrations of folate were lower, 3.9 nmol/L in the 
lowest tertile and 9.7 nmol/L in the highest tertile of folate concentrations (8). In a 
multinational European study with no association, the mean plasma concentrations of 
folate varied between study centers from 12.0 nmol/L to 18.4 nmol/L (12). Unfortunately, 
there is no information available of the mean concentrations or the range of red-cell 
concentrations of folate in another study with no association (11). Red-cells reflect the 
intake over a longer period, even months of folate intake compared to plasma or serum 
concentrations, but the blood measurement, as well as other characteristics, such as age or 
gender, hardly explained the inconsistency in the results. In addition, energy intake was not 
taken into account as a potential confounder in these studies. 
A meta-analysis based on observational studies (three case-control studies, seven 
population surveys and one cohort study) concluded that there is a statistically significant 
association between folate status and depression (85). However, this meta-analysis was 
published already in 2007, and the majority of the prospective studies have been published 
since then. Unfortunately, recent meta-analyses are lacking. 
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3.4.3 Intervention studies  
 
Prevention trials 
To date, there are only three double-blind randomized controlled trials (RCTs) published to 
demonstrate the effects of group B vitamin supplementations, including folate and vitamin 
B12, on the prevention of depression in non-depressed individuals. In a recent trial, daily 
supplementation with MTHF (560 μg), vitamin B12 (20 μg) and vitamin B6 (3 mg) for almost 
five years showed no beneficial effect on depressive symptoms (adjusted odds ratio (OR): 
0.91, 95% CI: 0.75 to 1.11) in 2,000 men and women who were CVD survivors (137). In a trial 
with 299 elderly men free from clinically significant depressive symptoms, daily 
supplementation of folic acid (2 mg), vitamin B12 (400 μg), and vitamin B6 (25 mg) for two 
years did not show benefits in either reducing the severity of depressive symptoms or in 
reducing the incidence of depression compared to placebo (138). However, it was found 
that participants treated with vitamins were 24% more likely to remain free of depression 
during the trial, although the difference between the groups was not statistically significant 
(95% CI: 0.68 to 2.28). The third trial in 273 non-depressed men who were stroke survivors 
observed that daily supplementation of folic acid (2 mg), vitamin B12 (500 μg) and vitamin 
B6 (25 mg) for approximately seven years decreased the risk of MDD with 52% (95% CI: 0.31 
to 0.76) compared to placebo, which supports the evidence of the benefits (139). Such 
inconsistencies in the results could have occurred because of differences in dosage (in 
vitamin B12 the range was from 20 to 500 μg/daily between the trials), duration (two to 
seven years), or study population (high-risk individuals vs. others) between the trials.  
There are also few short RCTs to demonstrate the effects of multivitamin and mineral 
supplementations, including folic acid and vitamin B12, on depressive symptoms in healthy 
adults (140,141). Recently, a meta-analysis based on these RCTs and one unpublished trial 
(142), all conducted in male populations with supplementation durations of a maximum of 
eight weeks, showed no benefits on depressive symptoms (143). However, in addition to 
folic acid and vitamin B12, which were delivered at doses above the recommended daily 
intakes, these supplementations included various other vitamins, as well as minerals, such 
as zinc, calcium and magnesium (141), herbal extracts and antioxidants (140) and DHA 
(142).  
 
Treatment trials 
Several trials (presented in Table 5) have demonstrated that antidepressant treatment 
augmentation with MTHF, folic acid or folinic acid (leucovorin) has improved the recovery 
from depression (13,14,144-148). However, one of these studies was not randomized (146). 
Based on the trials, MTHF is suggested to be the most effective form of folate 
supplementation compared to others, probably because it is able to pierce the blood-brain 
barrier. However, the study with the longest duration, two years, suggested no statistically 
significant benefit of supplementation with a combination of folic acid and vitamin B12 in 
participants with elevated psychological distress in non-clinical population, in which only 
one fifth of the participants used antidepressant medication (149). The duration of the other 
trials has been short, mainly weeks, apart from one study with a duration of six months 
(144). Remission in depression may occur gradually after weeks of treatment, which is why 
adequate duration of augmentation is necessary. It is also unknown whether the 
effectiveness of augmentation is antidepressant-specific, and; the benefits of folate 
augmentation on for example serotonin selective reuptake inhibitors (SSRIs) may therefore 
not necessarily be applicable to other types of antidepressants (13). Interestingly, MTHF or 
folic acid supplementation may benefit not only those who have low concentrations of 
folate, but also those whose concentrations of folate are at reference level (150).  
A Cochrane analysis based on three RCTs (14,144,145) concluded that MTHF or folic acid 
supplementation as an augmentation treatment may be beneficial for depressed individuals 
20 
 
 
(151). Supplementation decreased depression scores on average by a further 2.65 points 
(95% CI: -0.38 to -4.93). In two of the trials (14,144) supplementation was added to 
antidepressant treatment, whereas in one (145) MTHF was delivered as an exclusive 
treatment and compared to trazodone. However, no evidence for efficacy as monotherapy 
was demonstrated (151). The meta-analysis was published already in 2003, which is why 
the most recent studies were not included.  
 
In summary, the limited number of trials to study prevention of depression with 
supplementations including folate and vitamin B12, have reported inconsistent results. In 
prevention trials, supplementation studies with long duration included altogether 2,572 
participants, and short multivitamin and mineral supplementation RCTs only 303 
participants. In treatment trials, evidence shows a slight benefit of augmentation of 
antidepressant treatment with MTHF or folic acid in depressed patients, but the limited 
number of studies constricts the precision of the results. Altogether 1,417 participants have 
been involved in treatment trials, 900 out of them taking part in trials concerning non-
clinical population (149). Additional investigations are needed also to characterize those 
individuals who are the most responsive to augmentation.  
3.4.4 Potential mechanisms  
The potential protective effects of folate and vitamin B12 on depression are mainly based on 
the monoamine hypothesis. Deficiency of folate can cause irregularities in methylation and 
synthesis of monoamine neurotransmitters (152). Monoamine synthesis is presented in 
Figure 1. Folate forms share an interconversion potential and are present in the pathways of 
one-carbon cycles impacting the synthesis of norepinephrine, dopamine and serotonin 
(13,85,152). In detail, MTHF regulates the formation of tetrahydrobiopterin, which is a 
critical cofactor essential in the synthesis of neurotransmitters (13). MTHF indirectly 
regulates the levels of monoamines in CNS as deficiency of folate impairs the synthesis of 
tetrahydrobiopterin (114). However, these reactions in CNS are also dependent on the 
availability of B12 and homocysteine.  
Folate in MTHF form is needed in the methylation reactions to reverse homocysteine, a 
sulphurated amino acid, back to methionine (Figure 1) (152). Homocysteine is derived from 
dietary methionine, which is present in meat, fish, cheese, eggs and poultry (153). Elevated 
blood homocysteine is a functional marker of both folate and vitamin B12 deficiency (154). 
Homocysteine concentrations are usually higher among elderly people and in men 
compared to women (153). In addition to the influence on the monoamine metabolism, 
homocysteine is suggested to have  neurotoxic effects (152). High blood concentrations of 
homocysteine have been associated with elevated prevalence of depression (129,154,155). 
Nevertheless, as low blood concentrations of folate, vitamin B12 and high blood 
concentrations of homocysteine are highly connected, it is difficult to distinguish which of 
them is more important in terms of depression (129).  
MTHF is also required in the synthesis of S-adenosyl-methionine (SAMe), the vital 
methyl donor in several methylation reactions (Figure 1) (152,154). SAMe has been 
suggested to have independent antidepressant properties and to be more effective than 
placebo and equally effective with tricyclic antidepressants with fewer side effects in the 
treatment of depression (101,152,156,157). The dose-response rate and mechanisms behind 
SAMe’s possible effects on depressive symptoms are still partly unrecognized, and hence 
SAMe is regarded with caution.  
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3.4.5 Dietary therapy with folate or vitamin B12 in depression  
Based on treatment RCTs, evidence suggests potential benefits of antidepressant 
augmentation with MTHF or folic acid, and several treatment strategies have been 
suggested (104,134,154,158). These strategies may be utilized, as more than half of the 
depressed patients treated with antidepressant monotherapy will fail to experience 
remission (39), and dietary supplementation is considered safe and well-tolerated. 
The first screening and treatment strategy is to measure the blood concentrations of 
folate and vitamin B12 of all depressed patients with treatment resistance (158). 
Augmentation is given to those whose concentrations are below the reference values or 
close to the reference border (158). However, in populations with normal concentrations of 
folate, routine screening of folate concentrations is hardly to be indicated (109). The second 
approach is to measure blood folate and vitamin B12 concentrations of all depressed 
individuals, and supplementation is recommended for those whose concentrations of 
vitamins are decreased or close to the borderline (134). It is also recommended for 
psychiatric patients to assess vitamin status every three to five years because changes in 
diet or drug treatments may lead to deficiencies. The third strategy is to examine 
concentrations of folate in patients with severe or chronic depression, patients with 
treatment resistance, as well as in the individuals at elevated risk for folate deficiency (104). 
The fourth treatment approach is to give supplementation (folic acid 800 μg/day and 
vitamin B12 1 mg/day) to all depressed patients as an adjunctive treatment, as in part of the 
augmentation studies treatment effect has increased regardless of the vitamin levels (154). It 
has been observed that especially those who have recently recovered from depression may 
have a deficiency of folate (127), and folate intake has been inversely associated especially 
with the risk of recurrent depression (9). Consequently, folic acid supplementation has been 
recommended for as long as a year following a depressive episode (127). 
There are no general recommendations of the dosage of supplementation presented. 
However, it is assumed that smaller doses of folic acid from 800 μg up to two milligrams 
are preferable to bigger doses, as the blood-brain barrier limits the entry of folate to the 
CNS and large doses would go to waste (104,154). Large doses may also lead to 
neurological problems, such as hyperactivity and insomnia among individuals who are 
predisposed. In addition, large doses may conceal a potential deficiency of vitamin B12 (104). 
 
In summary of the association between folate and depression: there are several cross-
sectional, but only few prospective studies published. The majority of the cross-sectional 
studies were conducted in the elderly, and the magnitude of energy intake as a confounder 
was shown to be significant. Two out of six prospective studies showed an inverse 
association between folate and the risk of depression, three studies showed no association, 
and one study showed an inverse association only with recurrent depression only in men. 
Only two of the previous prospective studies investigated the association between dietary 
folate and the risk of depression, one of them with models adjusted for energy intake. 
Results from the prevention trials suggest no benefits, but treatment trials indicate that 
MTHF or folic acid augmentation of antidepressant medication may benefit depressed 
patients. However, the number of the studies is limited. 
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4 N-3 polyunsaturated fatty acids 
4.1 N-3 POLYUNSATURATED FATTY ACID METABOLISM 
PUFAs are typically classified into n-3 (or omega-3) and n-6 (or omega-6) fatty acids.  N-3 
PUFAs are a family of PUFAs, named due to the positioning of the first double carbon bond 
on the third atom from the methyl end of the acyl chain (159). The role of the n-3 PUFAs is 
important in the development of the nervous system, blood vessels and skin (160). 
Moreover, n-3 PUFAs are present in the synthesis of eicosanoids and needed in the 
aggregation of thrombocytes, regulation of blood pressure and inflammation, and defense 
reactions of the body (159,160). In addition, long-chain PUFAs are needed in the cell 
membranes of CNS and retina of the eyes (160). 
The long-chain n-3 PUFAs, EPA and DHA, are the major bioactive components of n-3 
PUFAs, but also docosapentaenoic acid (DPA), which is in a minor role, is included in the 
long-chain n-3 PUFAs (161). The conversion of the long-chain PUFAs is presented in Figure 
2. Alpha-linolenic acid (ALA) can be endogenously converted to 20-carbon EPA and further 
to 22-carbon DHA. However, current evidence suggests that this synthesis is not that 
effective and the rate of conversion in human is very low. Conversion of ALA to EPA is 
considered to be more effective compared to conversion of ALA to DHA, and it is estimated 
that approximately 4% to 15% of ALA from plant sources is converted to EPA or DHA (162-
164). This conversion is suggested to be more efficient in women compared to men and in 
younger compared to elderly people (165,166). In addition, the intake of n-6 fatty acid 
arachidonic acid (AA) affects the production of EPA and DHA, as it competes for the same 
metabolizing enzymes (161).  
4.2 RECOMMENDATIONS AND DIETARY INTAKE  
The Finnish dietary recommendations suggest that at least one percent of total energy 
intake should be accounted for by n-3 PUFAs at population level (102). According to the 
National FINDIET 2007 survey Finnish people in general reach the recommended level of 
intake; the mean daily intake of n-3 PUFAs was 1.2% of energy for both women and men 
(103). Among the elderly, n-3 PUFA intake was even higher, 1.3% of total energy intake. 
However, the greatest proportion of the mean n-3 PUFA intake was from ALA intake (1.0% 
of total energy intake) (103).  
Dietary sources of EPA and DHA include fatty fish like salmon, mackerel, herring, Baltic 
herring or vendace and other seafood, and certain eggs and animal products depending on 
the animals’ diet (159). Fish oil supplements are also a good source of long-chain n-3 
PUFAs. Plant-based n-3 PUFAs, especially in flaxseed, hempseed, walnuts and rapeseed 
oil, are usually in the form of ALA. ALA and linoleic acid (LA), which is an n-6 fatty acid, 
and mainly derived from plant and vegetable seeds and oils, are termed essential fatty 
acids, because human cells are unable to synthesize them.   
The biomarkers of fatty fish consumption and intake of n-3 PUFAs include serum, 
plasma, red-cell or adipose tissue fatty acid concentrations. Fatty acid concentrations in 
triglycerides and free fatty acids are the most rapid to reflect the intake, showing 
concentration changes just hours after fatty acid intake (136). Plasma or serum cholesterol-
esters reflect quite recent intake of fatty acids, usually one to two weeks of intake, while 
phospholipids reflect few weeks’ longer intake before blood sampling. Fatty acid 
biomarkers from red-cell membranes reflect the intake over the past months while adipose 
tissue reflects longer-term intakes, even over years (19,136).  
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Abbreviations: AA, arachidonic acid; ALA, alpha-linolenic acid; EPA, eicosapentaenoic acid; LA, linoleic 
acid; DHA, docosahexaenoic acid; DPA, docosapentaenoic acid  
 
Figure 2. Desaturation, elongation and retroconversion of polyunsaturated fatty acids. Modified from Holub 
et al. 2002 (162).  
 
4.3 N-3 FATTY ACIDS AND DEPRESSION  
Increasing evidence suggests that depletion of n-3 PUFAs may play an etiological role in 
several inflammatory and neuropsychiatric disorders including depression (167). 
Depressed individuals have been shown to have lower intake or concentrations of n-3 
PUFAs compared to non-depressed individuals in some (168-171), but not in all studies 
(89,121). To clarify if n-3 PUFAs are potential protective nutrients against depression, 
following sections review the studies of the association between fish consumption or n-3 
PUFAs and depression, concentrating on the long-chain n-3 PUFAs, EPA and DHA. 
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4.3.1 Cross-sectional studies 
 
Consumption of fish and dietary intake of n-3 PUFAs 
Fish consumption has been associated with lower prevalence of depression or 
psychological distress in several (16,172-176), but not in all studies (177,178). In most of 
these studies, fish consumption has been assessed by validated, long FFQs. In cross-
sectional studies, however, the presence of depressive symptoms may affect appetite and 
food consumption, and hence, cause lower intake of n-3 PUFAs, which may in turn cause 
reverse causality. Therefore, cross-sectional studies alone are not good enough for assessing 
the risk. The greatest difference between the studies with observed association and studies 
with no association was that total energy intake was not taken into account as a potential 
confounder in the studies with observed association, except for a small study in 332 Dutch 
elderly men (174). In contrast, in both of the studies with no association (177,178) energy 
intake was adjusted for in the statistical models.  
The largest of these studies with more than 10,000 middle-aged men from Northern 
Ireland and France showed that depressed mood was associated with a lower fish intake, 
but as fish intake increased, the incremental decrease in depressed mood was reduced (16). 
Studies in Finnish adults showed that regular (at least once a week) fish consumption 
associated with lower prevalence of depressive symptoms especially (172) or only (173) in 
women. The number of study participants was almost 3,000 and over 6,000, respectively. 
However, there is great heterogeneity in the frequency or amount of fish consumption in 
which the benefits have been observed. Consumption of ≥20 grams of fish daily was 
associated with a 37% lower likelihood of depressive symptoms compared to no fish 
consumption in Dutch elderly men (174), whereas in over 4,600 adults from New Zealand 
(175), fish consumption was examined as a dichotomous variable (yes/no), and an inverse 
association was found. One portion increase in fish consumption per week associated with 
42% lower likelihood of having clinically relevant depressive symptoms in 1,200 elderly 
men and women from the Mediterranean area (176). In contrast, the large North American 
National Health and Nutrition Examination Survey (NHANES) with more than 10,000 
participants demonstrated that all fish and non-breaded fish consumption, measured by 30-
day FFQs, was not associated with symptom severity, while consumption of breaded fish 
showed an elevated risk of symptom severity (177). Similarly, a Finnish study with 5,840 
men and women from general population and 308 high-fish-consumers demonstrated no 
associations between fish consumption and psychological distress (178). However, as 
previously stated, total energy was taken into account as a potential confounder in both of 
these studies with no associations.  
Cross-sectional studies have also shown an association between a low intake of n-3 
PUFAs and increased prevalence of depression in over 10,000 participants from the 
NHANES population (177), in almost 3,000 participants from the SU.VI.MAX cohort (87), 
and in 332 Dutch elderly men (174). However, in the NHANES study, intake of long-chain 
n-3 PUFAs was assessed by only two 24-h diet recalls (DR), which may not represent a 
valid method for the assessment of usual fatty acid intake. In contrast, a population study 
in almost 10,000 individuals from the Mediterranean area showed no association between 
n-3 PUFA intake and the likelihood of depression in men, although a protective trend was 
observed in women (179). The differences between these studies include that energy intake 
was taken into account as a potential confounder in three (174,177,179), but not in one study 
(87). However, there were no large differences in the intake level of n-3 PUFAs between the 
study populations that would explain the inconsistency. Nevertheless, in the SU.VI.MAX 
cohort, the intakes of n-3 PUFAs were relatively high (mean in the lowest quartile 0.9 g/day 
vs. mean in the highest quartile 1.8 g/day), and in the study from the Mediterranean area, 
the variation between n-3 PUFA intake was large (mean in the lowest quintile 0.4 g/day vs. 
mean in the highest quintile 1.9 g/day) (179).  
 
27 
 
 
Circulating and adipose tissue concentrations of n-3 PUFAs 
Depressed individuals have been reported to have lower circulating concentrations of n-3 
PUFAs (169,180-184) and reduced adipose tissue levels of DHA (185) compared to non-
depressed individuals. Lower n-3 PUFA concentrations resulted from significantly lower 
DHA concentrations (169,180,181,185), from lower EPA concentrations (183,184) or from 
both EPA and DHA concentrations (182). In the Finnish Fishermen Study with over 1,200 
high fish consumers, higher serum DHA concentrations associated with higher scores of 
psychological distress (178). However, no associations between phospholipid or adipose 
tissue concentrations of n-3 PUFAs and depressive symptoms were observed in almost 400 
Cretan adults (186). Some studies have also reported an inverse relationship between 
circulating concentrations of n-3 PUFAs and severity of depression (170,183,187). Severity 
of depression has been inversely associated with the concentrations of EPA, DHA, ALA 
and total n-3 PUFAs in two studies (183,187) and only with the circulating concentration of 
EPA in one study (170).  
 
Ratio of n-6 to n-3 PUFAs 
The potential association between depression and n-3 fatty acids might be explained by an 
unfavorable ratio of n-6 to n-3 PUFAs (161,187). During the last centuries in Western 
populations, n-3 fatty acids from fish, wild game and plants have been replaced by 
saturated fatty acids (SFAs) from domestic animals (20). In addition, intake of n-6 fatty 
acids, especially LA, has increased significantly because of increased consumption of 
vegetable oils. By a rough estimate, the ratio of n-6 to n-3 fatty acids has increased from 1:1 
to even more than 10:1 in Western countries (162). This change may have caused an 
increase of an n-6 fatty acid, AA, a pro-inflammatory n-6 PUFA, in cell membranes 
replacing EPA, which may in turn have increased the proportion of inflammatory 
eicosainoids (188). Overlapping, the prevalence rates of depression have been rising, which 
has given  reason to assume that the ratio of n-6 to n-3 PUFAs could play a role in the 
pathophysiology of depression (86). Nevertheless, recent evidence does not support this 
theory. Blood ratio of n-6 to n-3 PUFAs or concentrations of AA have been higher in 
depressed individuals compared to controls in some (169,180,181,187,189), but not in all 
studies (184,190). In addition, a study in the SU.VI.MAX cohort demonstrated that the ratio 
of n-6 to n-3 PUFAs was not associated with depressive symptoms after adjustments for 
several potential confounders, including total energy intake (87). Moreover, concentrations 
of AA are under close homeostatic regulation and changes in dietary LA intake do not 
appreciably affect the concentrations of AA (163). Further, not only n-3 PUFAs, but also n-6 
PUFAs, especially LA, are involved in inhibition of the production of inflammatory factors 
(191). It is possible that the intake of n-6 PUFAs even in large amounts does not accelerate 
inflammation, as no elevations in plasma CRP or interleukin-6 were found in a RCT 
comparing 4% to 10% of energy intake from LA (192). 
4.3.2 Prospective studies 
Only few large prospective studies have been published on the relationship between n-3 
PUFAs and depression, and the results are partly contradictory (Table 6). The studies were 
conducted in all age groups and almost all studies investigated either fish consumption or 
dietary intake of n-3 PUFAs; only one study with nested case-control design investigated 
circulating fatty acid concentrations (19). The analyses were mainly adjusted for total 
energy intake, except for two studies (17,89) and stratified analyses revealed that smoking 
and gender may be modifying the association.  
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Consumption of fish and dietary intake of n-3 PUFAs 
An inverse association between fish consumption or intake of total or long-chain n-3 
PUFAs and the risk of depression was reported in some prospective studies (15,17,18), 
whereas others have reported no association (87,88,90). The North American Nurses’ 
Health Study (NHS) with more than 50,000 female participants demonstrated no 
association between EPA+DHA from fish and the risk of depression after ten years of 
follow-up (the adjusted hazard ratio (HR) for 0.3-g/d increment: 0.99; 95% CI: 0.88 to 1.10) 
(88). In that study, depression cases were defined as presence of both self-reported 
physician-diagnosed depression and antidepressant use, which increases the specificity. 
The cumulating average of four dietary assessments was used to measure long-term dietary 
exposure of fish consumption. The comparisons were made between women who ate fish 
<once a month, 1-3 times/month, once a week, 2-4 times/week or ≥5 times a week, which is 
quite a large range, and might be suitable for detecting differences. However, no 
differences in the risk of depression were found. In addition, separate analyses according to 
the fattiness of fish revealed that neither lean nor fatty fish consumption associated with the 
risk of depression, while intake of ALA had an inverse association (HR for 0.5 g/d 
increment: 0.82, 95% CI: 0.71 to 0.94), especially in women whose intake of LA was low, 
indicating that long-term dietary ALA intake may play an independent physiological role 
in depression. 
The second largest of the prospective studies, a previous Finnish study with almost 
30,000 smoking men followed up for nine years, demonstrated no association between fish 
consumption or total n-3 PUFA intake and severe depression (highest total n-3 PUFA 
intake tertile vs. lowest tertile HR: 0.96; 95% CI: 0.70 to 1.30) (90). However, men in the 
highest tertile of fish consumption had a marginally elevated risk of self-reported 
depressed mood compared to men in the lowest tertile (HR: 1.06; 95% CI: 1.00 to 1.12). The 
mean intake of total n-3 PUFAs at baseline was quite high, 2.2 g/day, for individuals who 
received depression during the follow-up, and 2.1 g/day for the rest of the population. 
In a Spanish study with almost 8,000 men and women, a non-linear, inverse association 
was found, as moderate consumption of n-3 PUFAs (the median consumption of fish in this 
group was 112 g/day) associated with a 35% decreased HR reduction of depression (95% CI: 
0.45 to 0.90) compared to the lowest consumption of n-3 PUFAs (the mean consumption of 
fish 36 g/day) (18). Separate analyses showed that the association was statistically 
significant in women only. Similarly, in over 3,000 young adults from the U.S., EPA+DHA 
intake (≥0.08% of energy) was inversely associated with the risk of depressive symptoms 
(highest quintile vs. lowest HR: 0.71; 95% CI: 0.52 to 0.95), after three years of follow-up, but 
only in women (17). However, depression scores were measured approximately 13 years 
after diet assessment, without taking the baseline depression scores into consideration, 
which is a limitation of the study. 
In almost 2,000 middle-aged subjects from the French SU.VI.MAX cohort with eight 
years of follow-up, intake of long-chain n-3 PUFAs (higher than 0.1% of energy) was 
associated with 47% lower risk of having recurrent depression (P for trend=0.09), in men 
only (15). Nevertheless, in that study, there were no associations with long-chain PUFA 
intake and single episode of depression. In addition, high fatty fish consumption was 
associated with a decreased risk of recurrent depression in current non-smokers, whereas 
in smokers, fatty fish consumption associated with an elevated risk of recurrent depression 
(15). However, later in the sub-sample of the SU.VI.MAX cohort after 13 years of follow-up, 
prospective analyses showed no associations between n-3 PUFA intake and incidence of 
depressive symptoms (87). In addition, that was the only prospective study on the 
association between the ratio of n-6 to n-3 PUFAs and the risk of depression, reporting no 
association in either non-adjusted or adjusted (total energy intake included) models. 
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Circulating concentrations of n-3 PUFAs 
To date, there is only one prospective study on the association between serum 
concentrations of n-3 PUFAs and depression published. A nested case-control study based 
on the French SU.VI.MAX cohort reported no associations between serum phospholipid 
concentrations of any n-3 PUFAs and the risk of depression (19). Surprisingly, as described 
above, in the same cohort, dietary long-chain n-3 PUFA intake had previously been 
associated with the risk of recurrent depression (15). The inconsistency in the results may 
be explained by the finding that dietary intakes of fatty acids were correlated with plasma 
fatty acid concentrations only weakly (r<0.3), regardless of the precision in the food intake 
assessment (six repeated 24-h diet records per year) (19). Plasma phospholipids reflect 
mainly recent, a couple of weeks’ intake of fatty acids (136). However, it was suggested that 
especially the long-chain n-3 PUFA status at a determined time could predict the risk of 
depression even more precisely than the biomarkers of the long-term intake (19).  
A recent systematic review based on the six cohort studies of n-3 PUFAs suggested 
potential benefits of intakes of total n-3 PUFAs and consumption of fish, but firm 
conclusions cannot be drawn based on the current evidence (6). Results from the 
observational studies may be biased, mainly by weaknesses in the assessment of exposure 
and outcomes, as well as by selection and publication bias. 
4.3.3 Intervention studies 
 
Prevention trials 
To date, only two RCTs have investigated the effects of n-3 PUFA supplementation on 
mental health in non-depressed individuals. In the other trial with over 2,500 men and 
women who were CVD survivors, daily supplementation of EPA and DHA, 600 mg at a 2:1 
ratio, showed no effect on depressive symptoms (adjusted OR: 1.16; 95% CI: 0.95 to 1.41) 
(137). However, in gender-specific analyses, a positive association was found in men 
(adjusted OR: 1.28; 95% CI: 1.03 to 1.61), but not in women (adjusted OR: 0.78; 95% CI: 0.51 
to 1.20). This trial had a long duration, almost five years, and the participants were 45 to 80 
years old. In the other study, daily supplementation of either 1.8 g of EPA+DHA or 0.4 g of 
EPA+DHA for 26 weeks did not statistically significantly improve mental well-being 
compared to placebo in independently living 302 elderly men and women from general 
population (193). After 26 weeks,  mean changes in CES-D scores in the high-dose fish oil, 
low-dose fish oil and placebo groups were -0.2, 0.2, and -0.4; P=0.87, respectively (193).  
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Treatment trials 
The effects of the n-3 PUFAs on the treatment of depression have been more extensively 
studied compared to prevention (Table 7). Several studies have demonstrated the beneficial 
effect of supplementation with n-3 PUFAs on depressive symptoms (194-201), but not all 
(202-208). The most effective n-3 PUFA supplementation, as well as the optimal dosage of 
supplementation, has been argued. EPA may be more beneficial than DHA in the 
alleviation of depressive symptoms (21,209,210). However, the number of trials with pure 
DHA or mainly DHA supplementation is low (197,206,210) and patients might have had 
too minor depressive symptoms (202,204). As regards the dosage of supplementation, in a 
trial with patients with treatment resistance, 1 g/day, but not 2 or 4 g/day of ethyl-EPA (E-
EPA) improved symptoms more likely than placebo (200). In addition, in almost all RCTs, 
participants were on antidepressant treatment, but in two trials with no benefits (202,203), 
n-3 PUFA supplementation was used as a monotherapy. Similarly, in a trial with the largest 
study population (201), 40% of the 432 participants were having antidepressant treatment at 
baseline, and the beneficial effect was on the borderline of statistical significance (P for the 
difference=0.053), and statistically significant only when patients with comorbid anxiety 
disorders were excluded. In addition, there were two trials in which the antidepressant 
treatment started simultaneously with the -3 PUFA administration (196,205). In the one, 
EPA and fluoxetine medication were reported to have similar efficacy, but the combination 
was superior to either of these alone (196). In the other, augmentation of sertraline 
treatment with EPA and DHA provided no extra benefits (205). 
Meta-analyses propose that n-3 PUFA supplementation is more effective than placebo in 
the treatment of depression (21,210-212). The latest meta-analysis with 16 RCTs in adult 
MDD patients only, showed the greatest treatment effect for the supplementation of EPA 
being dominant (≥60%) compared to DHA (standardized mean difference: 0.62; 95% CI: 0.33 
to 0.91). Similarly, a recent meta-analysis of EPA only showed that supplementation with 
EPA≥60% benefitted most vs. supplements with EPA<60% (effect size: 0.53; 95% CI: 0.28 to 
0.73) (213).  
 
In summary of the trials, only two prevention trials have been conducted with altogether 
2,803 participants, with results that do not support the beneficial effects of n-3 PUFA 
supplementation. In treatment trials, individuals with more severe depressive symptoms 
have achieved the greatest benefit from n-3 PUFA, especially EPA, administration 
(21,210,212), but there is not enough evidence of the benefits for individuals without a 
diagnosis of MDD (21,212). During the trials, the participants’ fish consumption was not 
taken into account, only the supplementation with n-3 PUFAs was, which is a limitation. It 
is still difficult to summarize the effects due to considerable heterogeneity between the 
trials (212). However, the RCTs published by now have included altogether 1,452 
participants, which is a relatively low number of participants to form valid conclusions.  
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4.3.4 Potential mechanisms 
The physiological functions of n-3 PUFAs in the brain include regulation of cell membrane 
fluidity, membrane-bound enzymes, dopaminergic and serotoninergic transmission, and 
cellular signal transduction; n-3 PUFAs also participate in brain eicosanoid synthesis, which 
is connected to depression (161,167). High concentrations of n-3 PUFAs in neuronal 
membranes are hypothesized to play a role in synaptic neurotransmission including 
metabolism, release, uptake, and receptor functioning of neurotransmitters (209,215). N-3 
PUFAs are involved in, or modulate, the mechanism by which brain neurons communicate 
(209). DHA is the predominant fatty acid in the brain (approximately 15% of fatty acids), 
whereas EPA exists in the brain to a lesser extent (approximately 0.2% of fatty acids) 
(216,217). Therefore, DHA concentration especially affects the permeability of membrane 
cells in CNS (218) and deficiency of DHA has been found to relate to dysfunctions and 
impaired transmission of serotonin, norepinephrine and dopamine (217). Phospholipids of 
neural cell membrane consist especially of PUFAs (200). Long-term supplementation with 
EPA may raise the stimulated release of AA from membrane phospholipids, whereas DHA 
has no such effect (219). Interestingly, the traditional view of the effects of n-3 PUFAs as 
antagonists of AA might become more complicated, since n-3 PUFAs have also been 
suggested to increase the abundance of AA in membrane phospholipids (220). In animal 
models, it was shown that a diet containing 0.01% or 0.1% of EPA increased the 
concentrations of EPA, DHA and also AA, but with higher intakes, a diet containing 1% of 
EPA increased EPA and DHA, but decreased AA concentrations (220). A similar 
phenomenon was also observed  in humans: after receiving one gram or two grams of EPA 
daily, AA concentrations in red-cells increased, whereas with four grams daily AA 
concentrations decreased (200). This supports the hypothesis that there is a significant 
endogenous regulation of the metabolism of these fatty acids.   
N-3 PUFAs and fish consumption have been connected to the inflammation theory 
(17,221). Traditionally, a high ratio of n-6 to n-3 has been thought to enhance pro-
inflammatory cytokine production, whereas n-3 PUFAs as such have anti-inflammatory 
properties (221). Fish intake >150 grams/week has been linked to decreased levels of pro-
inflammatory markers, such as CRP and cytokines, like interleukin-6 (176,222), which 
supports the hypothesis that eating more fish could lead to altered depressive symptoms 
through the modification of inflammation process (176). This theory has also been 
reinforced in the current Kuopio Ischaemic Heart Disease Risk Factor (KIHD) Study 
population, as serum n-3 PUFA and especially long-chain n-3 PUFA concentrations were 
found to be inversely associated with CRP levels (223).  
Different PUFAs may have different effects on eicosanoid production (161). The details 
of this process have been presented in more detail elsewhere (224). In summary, AA, an n-6 
fatty acid, can be metabolized to proinflammatory eicosanoids, whereas ALA, an n-3 fatty 
acid, can be converted to EPA, which can be further converted to anti-inflammatory 
eicosanoids (17). Higher dietary intake of ALA has been found to associate with lower 
plasma levels of inflammatory biomarkers (225). EPA and DHA reduce inflammation by 
decreasing the effect on the synthesis of eicosanoids by competing with AA (185).  
N-3 PUFAs may also affect the HPA axis. In MDD patients, serum cortisol levels 
decreased with both EPA administration (one gram daily) alone and EPA (one gram daily) 
in combination with fluoxetine treatment (20 mg/day) groups in an eight-week trial (226). 
However, serum levels of cytokines, interleukin-1 and interleukin-6, did not change 
statistically significantly in the intervention. 
N-3 PUFAs may also play a role in the neuroprogression, as n-3 PUFA supplementation 
(EPA 0.15 g/day and DHA 1.5 g/day) increased the concentrations of serum BDNF in an 
open-label trial for 12 weeks (227). However, the effects of n-3 PUFAs on BDNF levels may 
not be evident, as in a RCT in diabetic patients with MDD, E-EPA supplementation (one 
gram daily) for 12 weeks did not seem to increase the levels of BDNF (208). The differences 
may be explained by the varying dosage and fatty acids used in the supplementation. 
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However, it should also be taken into account that an increase in the consumption of one 
food group usually leads to a decrease in another. Increasing fish consumption, and thus 
increasing long-chain n-3 PUFA intake, is prone to decrease the consumption of other food 
groups that may have an independent connection to depression. Previously, fish 
consumption was shown to have a negative association with the consumption of 
unhealthy-considered foods like meat and sausages, and a positive linear association with 
other healthy-considered foods like vegetables, fruit and berries (228). Therefore, these 
potential confounders need to be considered.  
4.3.5 Dietary therapy with n-3 PUFAs in depression 
In 2006, the American Psychiatric Association’s Omega-3 Fatty Acid Subcommittee 
published clinical recommendations for the n-3 PUFA intake and supplementation to 
prevent and treat depression (229). Firstly, all adults were recommended to eat fish 
according to present dietary recommendations, at least twice a week. Patients with mood 
disorders were recommended to take a supplementation of one to nine grams of EPA and 
DHA daily. Supplementation of more than three grams should, however, be monitored by 
a physician. Evidence did not support supplementation with essential fatty acids, ALA or 
LA. It is noteworthy, however, that increased fish consumption above at least two times a 
week was not recommended, only supplementation was recommended. In Finland, we 
have no recommendations for treatment augmentation for depression with fish 
consumption or n-3 PUFA supplementations. 
 
In summary of the association between n-3 PUFAs and depression: there are several cross-
sectional, but only few prospective studies published, and the results are partly 
inconsistent. Five out of eight prospective studies showed no association. One study 
showed an inverse association, one study a non-linear association, whereas one study 
showed an inverse association with recurrent depression in men. Only one of the previous 
prospective works examined the association between serum n-3 PUFAs and the risk of 
depression. However, the validity of the findings is limited by several methodological 
issues and gender may be a confounding factor. There is a lack of prevention trials 
concerning n-3 PUFAs and depression. However, treatment trials suggest that 
augmentation of antidepressant treatment with EPA and DHA may have a slight benefit in 
clinically depressed individuals, but the results are still partly inconsistent. 
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5 Coffee, tea and caffeine  
5.1 COFFEE AND TEA CONSUMPTION 
Coffee is one of the most popular beverages in the world. Finnish people rank first in coffee 
consumption (230). In 2011, Finnish people consumed coffee approximately 12.2 
kg/person/year. According to the National FINDIET 2007 survey, 88% of Finnish working-
aged men and 87% of women drank coffee daily (103). The mean daily coffee consumption 
for men and women was 553 mL and 429 mL, respectively. Among the elderly, coffee 
drinking was even more common: 93% of men and 92% of women aged 65 to 75 years 
drank coffee (103). Today, people in Finland usually drink filtered coffee while 
consumption of boiled, unfiltered coffee has decreased dramatically since the 1970s. 
Drinking instant coffee has never been popular in Finland and was practically non-existent 
still in the 1990s. Nevertheless, interest in special coffee types, such as espresso, cappuccino, 
café latte and café mocha, has probably increased during the latest decade. However, there 
are no statistics available of the consumption of these special types of coffees.  
Coffee drinking is a life-style habit, usually enforced for hedonistic or psychosimulant 
purposes, sometimes also to complement meals, but not as nourishment (231). There are 
two species of coffee trees that are in commercial use, Caffea arabica and Caffea robusta. 
Globally, 80% of coffee consists of arabica with a more desirable flavor. Robusta, instead, 
contains more caffeine as well as polyphenols, including chlorogenic acid, and fewer lipids 
(232). The coffee consumed in Finland is usually Caffea arabica. Coffee contains thousands of 
different chemical compounds, many formed during the roasting process (23,233). 
However, it is suggested that there are only three groups of compounds that may be 
physiologically relevant with a sufficient concentration in coffee drink: caffeine, diterpene 
alcohols cafestol and kahweol, and polyphenols including chlorogenic acid (234). 
Tea drinking is popular especially in Asian countries and in a few countries in North 
Africa and the Middle East, where green tea is commonly used. In Nordic countries, tea 
drinking is less popular, and the type of tea consumed is different; in Western countries 
black tea accounts for approximately 78% of tea consumption (235). However, the 
popularity of green tea is increasing also in Western populations (236). According to the 
National FINDIET 2007 survey, altogether 28% of Finnish working-aged men and 44% of 
women drank tea daily, the mean daily consumption being 94 mL for men and 154 mL for 
women (103). Tea contains plenty of bioactive substances, such as polyphenols, especially 
flavonoids (236). Especially green tea has been suggested to possess clinically significant 
health-promoting effects (237). 
5.2 CAFFEINE METABOLISM 
Caffeine, 1,3,7-trimethyl xanthine, is the most well-known and pharmacologically studied 
substance in coffee. Coffee and tea are the most important sources of caffeine consumed. 
Coffee consumption accounts for approximately 71% of the intake of caffeine in the U.S. 
(238). A cup of coffee (~110 mL) contains about 100 mg of caffeine, although caffeine 
content varies greatly depending on the composition of the blend, the method of brewing 
and the strength of the brew, and variation is large even when the same machines and 
processes are repeatedly used (239). Tea is also a source of caffeine even though the 
amounts are much smaller than in coffee; tea contains about half as much caffeine as coffee. 
Caffeine containing energy drinks have become popular since the 1990s especially among 
adolescents, and caffeine is also available, in addition to supplement form, in smaller 
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amounts in cola drinks, cocoa, hot chocolate and chocolate (240). Caffeine doses up to 450 
mg/day for adults, 300 mg/day for pregnant women and 45 mg/day for children are 
regarded as safe (241). However, the Finnish recommendations for beverage consumption 
suggest caffeine intake of maximum of 2.5 mg/kg for children (242). 
Caffeine is metabolized in the liver by an enzyme known as cytochrome P450 1A2. 
Caffeine typically increases mental alertness, speeds up information processing, promotes 
wakefulness, reduces fatigue, causes restlessness and delays the need for sleep (243). Thus, 
caffeine intake is suggested to lead to better cognitive performance (22). At daily levels 
above 500 mg of caffeine, dependency and withdrawal symptoms become evident (244).  
5.3 COFFEE CONSUMPTION, CAFFEINE INTAKE AND DEPRESSION 
The short-term effects of caffeine on mood are fairly well known, but the long-term effects 
are still mostly unknown. In theory, caffeine may contribute to many psychiatric disorders, 
such as depression, anxiety and psychosis (244). The psychiatric symptoms caused by 
caffeine consumption have been demonstrated to lead to a state called “caffeinism”, which 
is usually related to daily intakes of 1000 to 1500 mg of caffeine (22). Similarly, a review of 
the caffeine effects reported that high single doses of caffeine (300 mg or higher), usually 
rarely ingested by the majority of people, may increase mental symptoms (22). In contrast, 
at lower doses, mood-state remains quite stable or even reduces self-rated depression or 
anxiety. Approximately 10% of regular caffeine consumers suffer from increased depressive 
symptoms when caffeine is withdrawn (245). Therefore, regular caffeine consumption is 
likely to substantially benefit drinkers, but mainly due to the “withdrawal relief” (246). 
However, this theory of the alleviation of caffeine withdrawal responsible for improved 
mood has been argued, as behavioral effects of withdrawal have also been observed in 
animals and caffeine non-consumers (247,248).  
The following sections clarify the association between coffee or caffeine consumption 
and depression, based on cross-sectional and prospective studies. Studies demonstrating 
the association are presented in Table 8. Almost all of the previous studies assessed coffee 
consumption or caffeine intake with semi-quantitative FFQs, except for one with no 
quantitative analyses (249). In only one of these studies (250), total energy intake was taken 
into account as a potential confounder.  
5.3.1 Cross-sectional studies 
In general population, life-time caffeine intake was associated with a higher prevalence of 
many psychiatric disorders, including MDD, especially in heavy-consumers (≥625 mg of 
caffeine daily) (91). However, opposite findings have also been presented, as coffee and 
caffeine intake were inversely associated with depression in a British non-working sample 
(92) and in Japanese workers (251). A study with Eastern Finnish men and women from 
general population showed no association between daily coffee consumption and the 
prevalence of depressive symptoms (93). The review of the general effects of caffeine 
concluded that moderate caffeine intake (<six cups of coffee per day) was associated with 
less depressive symptoms compared to no caffeine consumption, due to caffeine’s mood-
elevating effect (252). Nevertheless, coffee drinking may be a common habit among 
depressed individuals and for example, partly replace eating meals. As these studies 
reviewed were cross-sectional, it is impossible to determine the causality, i.e., whether 
coffee or caffeine consumption affects depression or vice versa.  
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5.3.2 Prospective studies 
To date, there is only one prospective study published on the association between coffee 
consumption and the risk of depression. The large North American NHS, with over 50,000 
female participants followed up for ten years, reported an inverse, dose-dependent 
relationship between caffeinated coffee consumption and the risk of depression (250). 
Consumption of three or more cups of coffee was associated with a 20% reduced risk of 
depression compared to those who consumed less than a cup of coffee daily (95% CI: 0.64 to 
0.99). In addition, an inverse dose-response association was observed between total caffeine 
intake and the risk of depression, whereas decaffeinated coffee consumption showed no 
such association. Moreover, no association between caffeine from non-coffee sources and 
the risk of depression was found, which suggests that the combination of coffee and 
caffeine accounts for the association. The strengths of the study include that in order to 
reduce random measurement error, analyses were conducted using the cumulative average 
of caffeine consumption and a two-year latency period in exposure before depression. In 
addition, total energy intake and several other relevant potential confounders were taken 
into account. However, the NHS included women only. 
Another prospective study examined the association between caffeine consumption and 
depression in more than 500 Australian middle-aged or older women and showed that 
baseline caffeine consumers had lower scores of mental well-being measured five years 
later, as compared to baseline non-caffeine consumers (249). However, caffeine 
consumption was not associated with mental well-being in cross-sectional analyses. The 
limitations include that there was a lack of quantitative information, as regular caffeine 
consumption was coded as a dichotomous variable (yes/no) and the amount of caffeine 
consumed was not assessed.  
Depression is an important predictor of suicides (253). Supporting an inverse association, 
coffee consumption has been connected to a decreased risk of suicides in three cohort 
studies. In a Finnish study (254), a J-shaped association was found, whereas in an North 
American study (255), women who drank two or more cups of coffee per day had a 70% 
lower risk of suicide compared to never-drinkers. Another North American study reported 
a strong inverse association between coffee consumption and the risk of suicide, but also 
tea was found to decrease the risk of suicides (256). 
There are no intervention studies or RCTs published on the effects of coffee consumption 
on depressive symptoms.  
5.3.3 Potential mechanisms 
The potential mechanisms of the effects of coffee or caffeine on depression are mainly based 
on monoamine metabolism and neurotransmission, but also on inflammation. In theory, 
caffeine could mediate the protective effect of coffee or tea for example by stimulating the 
CNS (257) and enhancing dopaminergic neurotransmission (258). Caffeine targets 
especially adenosine A1 and A2A receptors. Adenosine functions as a neuromodulator and 
caffeine assists the activity of dopamine, an important neurotransmitter (252).  
Coffee contains plenty of substances with potential to affect both inflammation and 
oxidation. (23,259). Chlorogenic acid has anti-inflammatory effects in vivo (260) and 
therefore, it may slow down the process of inflammation. Oxidation may also play a role in 
depression (261), and the phenolic acids of coffee, especially chlorogenic acid and caffeic 
acid, have in some studies been found to have also antioxidant effects both in vitro (262) 
and in vivo (259). Antioxidants present in coffee may improve the overall antioxidant 
capacity and contribute to ameliorating oxidative stress (23). Previously, a positive 
association has been found between the potency of oxidative stress and severity of 
depression (263).  
  
39 
T
ab
le
 8
. 
C
ro
ss
-s
ec
ti
on
al
 a
n
d
 p
ro
sp
ec
ti
ve
 s
tu
di
es
 o
n
 t
h
e 
as
so
ci
at
io
n
 b
et
w
ee
n
 c
of
fe
e,
 t
ea
 o
r 
ca
ff
ei
n
e 
in
ta
ke
 a
n
d 
d
ep
re
ss
io
n
. 
S
tu
d
y
 b
y
 
S
tu
d
y
 
p
o
p
u
la
ti
o
n
 
S
tu
d
y
 
d
e
s
ig
n
  
(f
o
ll
o
w
- u
p
 
y
e
a
rs
) 
N
o
 o
f 
s
u
b
-
je
ct
s  
D
e
p
re
ss
io
n
 
m
e
a
su
re
d
 
b
y
 
N
o
 o
f 
ca
se
s 
E
x
p
o
su
re
 
m
e
a
su
re
m
e
n
t 
 
C
o
m
p
a
ri
so
n
 
R
e
su
lt
s 
 
A
d
ju
st
e
d
 H
R
/
O
R
  
( 9
5
%
 C
I)
  
H
in
ti
kk
a
 e
t 
al
. 
2
0
0
5
 (
9
3
) 
Fi
n
n
is
h
 g
en
er
a
l 
p
op
u
la
ti
o
n
 
C
ro
ss
-
se
ct
io
n
a
l 
2
0
1
1
 
B
D
I 
2
1
0
 
C
o
ff
ee
 c
o
n
su
m
p
ti
o
n
  
 T
e
a
 c
o
n
su
m
p
ti
o
n
  
D
a
ily
 v
s.
 n
o
 d
a
ily
 d
ri
n
ki
n
g
 
 D
a
ily
 v
s.
 n
o
 d
a
ily
 d
ri
n
ki
n
g
 
0
.9
2
 (
0
.6
4
, 
1
.3
2
) 
 0
.4
7
 (
0
.2
7
, 
0
.8
3
) 
 
K
e
n
d
le
r 
et
 a
l.
 
2
0
0
6
 (
9
1
) 
V
ir
g
in
ia
 T
w
in
 
R
e
g
is
tr
y,
 U
.S
. 
C
ro
ss
-
se
ct
io
n
a
l 
3
7
0
6
 
C
lin
ic
a
l 
in
te
rv
ie
w
 
n
/a
  
Li
fe
-t
im
e
 c
a
ff
e
in
e
 
in
ta
ke
  
 Li
fe
-t
im
e
 h
ea
vy
 
ca
ff
e
in
e
 i
n
ta
ke
  
In
ta
ke
: 
ye
s 
vs
. 
n
o
  
  H
ig
h
 i
n
ta
ke
 (
≥
6
2
4
 m
g
/d
a
y)
: 
 
ye
s 
vs
. 
n
o
  
1
.0
6
 (
1
.0
4
, 
1
.0
8
) 
  1
.7
9
 (
1
.4
7
, 
2
.1
7
) 
S
m
it
h
 2
0
0
9
 
(9
2
) 
N
o
n
-w
or
ki
n
g
 
B
ri
ti
sh
 p
op
u
la
ti
o
n
  
C
ro
ss
-
se
ct
io
n
a
l 
3
2
2
3
 
H
A
D
S
 
n
/a
 
C
a
ff
e
in
e 
in
ta
ke
  
>
2
6
0
 m
g
/d
 v
s.
 n
o
 i
n
ta
ke
 
0
.1
2
 (
0
.1
0
, 
0
.2
0
) 
X
u
 e
t 
a
l.
 2
0
1
0
 
(2
4
9
) 
H
ea
lt
h
y 
A
g
in
g
 o
f 
W
om
en
 S
tu
d
y,
 
A
u
st
ra
lia
 
Pr
o
sp
ec
ti
ve
 
(5
 y
e
a
rs
) 
5
6
4
 
G
C
S
 
n
/a
 
C
a
ff
e
in
e 
in
ta
ke
  
C
o
rr
el
a
ti
o
n
 b
et
w
ee
n
 c
a
ff
ei
n
e 
in
ta
ke
 (
ye
s)
 a
n
d
 m
e
n
ta
l 
w
e
ll-
b
e
in
g
 s
co
re
s 
 r
=
-0
.4
9
6
 (
P=
0
.0
3
7
) 
 
Lu
ca
s 
et
 a
l.
 
2
0
1
1
 (
2
5
0
) 
T
h
e 
N
H
S
, 
U
.S
. 
Pr
o
sp
ec
ti
ve
 
(1
0
 y
e
a
rs
) 
 
5
0
7
3
9
 
A
D
 +
 
p
h
ys
ic
ia
n
 
d
ia
g
n
o
si
s 
2
6
0
7
 
C
o
ff
ee
 c
o
n
su
m
p
ti
o
n
 
 C
a
ff
e
in
e 
in
ta
ke
 
2
-3
 v
s.
 <
1
 c
u
p
/d
 
≥
4
 v
s.
 <
1
 c
u
p
/d
 
≥
5
5
0
 v
s.
 <
1
0
0
 m
g
/d
 
0
.8
5
 (
0
.7
5
, 
0
.9
5
) 
0
.8
0
 (
0
.6
4
, 
0
.9
9
) 
0
.8
0
 (
0
.6
8
, 
0
.9
5
) 
P
h
am
 e
t 
al
. 
2
0
1
3
 (
2
5
1
) 
E
m
p
lo
ye
e
s 
in
 
Ja
p
a
n
 
C
ro
ss
-
se
ct
io
n
a
l 
5
3
7
 
C
E
S
-D
 
1
5
7
 
C
o
ff
ee
 c
o
n
su
m
p
ti
o
n
 
≥
2
 v
s.
 <
1
 c
u
p
/d
 
0
.6
1
 (
0
.3
8
, 
0
.9
8
) 
 
 
 
 
 
 
G
re
en
 t
ea
 
co
n
su
m
p
ti
o
n
 
≥
4
 v
s.
 ≤
1
 c
u
p
/d
 
 
0
.4
9
 (
0
.2
7
, 
0
.9
0
) 
H
o
za
w
a
 e
t 
a
l.
 
2
0
0
9
 (
2
6
4
) 
1  
O
h
sa
ki
 C
o
h
o
rt
 
2
0
0
6
 S
tu
d
y,
 J
ap
a
n
 
C
ro
ss
-
se
ct
io
n
a
l 
4
2
0
9
3
 
K
e
ss
le
r 
6
-
p
sy
ch
o
lo
g
i-
ca
l 
d
is
tr
es
s 
sc
a
le
 
2
7
7
4
 
G
re
en
 t
ea
 
co
n
su
m
p
ti
o
n
 
≥
5
 v
s.
 <
1
 c
u
p
/d
 
0
.8
0
 (
0
.7
0
, 
0
.9
1
) 
N
iu
 e
t 
a
l.
 2
0
0
9
 
(2
6
5
) 
C
om
m
u
n
it
y-
d
w
e
lli
n
g
 e
ld
e
rl
y 
in
 
Ja
p
a
n
 
C
ro
ss
-
se
ct
io
n
a
l 
1
0
5
8
 
G
D
S
 
3
6
1
 
G
re
en
 t
ea
 
co
n
su
m
p
ti
o
n
  
≥
4
 v
s.
 ≤
1
 c
u
p
/d
 
0
.5
6
 (
0
.3
9
, 
0
.8
1
) 
 
 
 
 
 
 
B
la
ck
 o
r 
o
o
lo
n
g
 t
e
a 
≥
1
 c
u
p
/d
a
y 
vs
. 
al
m
o
st
 n
e
ve
r 
0
.7
1
 (
0
.4
9
, 
1
.0
2
) 
C
h
en
 e
t 
a
l.
 
2
0
1
0
 (
2
6
6
) 
B
re
as
t 
ca
n
ce
r 
su
rv
iv
o
rs
, 
C
h
in
a 
Pr
o
sp
ec
ti
ve
 
(1
8
 m
o
n
th
s)
 
1
3
9
9
 
C
E
S
-D
 
1
8
2
 
G
re
en
 t
ea
 
co
n
su
m
p
ti
o
n
 
>
1
0
0
 g
 d
ri
ed
 t
ea
 l
ea
ve
s/
m
on
th
s 
vs
. 
n
o
 c
o
n
su
m
p
ti
o
n
 
0
.3
9
 (
0
.1
9
, 
0
.8
4
) 
A
b
b
re
vi
at
io
n
s:
 A
D
, 
an
ti
d
e
p
re
ss
an
t 
u
se
; 
B
D
I,
 B
e
ck
 D
ep
re
ss
io
n
 I
n
ve
n
to
ry
 d
ep
re
ss
io
n
 s
ca
le
; 
C
E
S
-D
, 
C
e
n
te
r 
fo
r 
E
p
id
em
io
lo
g
ic
 S
tu
d
ie
s 
D
ep
re
ss
io
n
 S
ca
le
; 
 C
I,
 c
o
n
fi
d
en
ce
 
in
te
rv
al
; 
FF
Q
, 
fo
o
d
 f
re
q
u
e
n
cy
 q
u
e
st
io
n
n
a
ir
e
; 
G
C
S
, 
G
re
en
e 
C
lim
ac
te
ri
c 
S
ca
le
; 
G
D
S
, 
G
e
ri
at
ri
c 
D
e
p
re
ss
io
n
 S
ca
le
; 
H
A
D
S
, 
H
o
sp
it
al
 A
n
xi
et
y 
a
n
d
 D
ep
re
ss
io
n
 S
ca
le
; 
H
R
, 
h
az
ar
d
 r
at
io
; 
N
H
S
, 
N
u
rs
es
’ 
H
e
al
th
 S
tu
d
y;
 O
R
, 
od
d
s 
ra
ti
o
; 
U
.S
.,
 U
n
it
ed
 S
ta
te
s 
o
f 
A
m
e
ri
ca
  
1
S
tu
d
y 
o
n
 p
sy
ch
o
lo
g
ic
a
l 
d
is
tr
e
ss
 
 
40 
 
 
5.4 TEA CONSUMPTION AND DEPRESSION 
Studies demonstrating the association between tea consumption and depression are also 
presented in Table 8. Almost all of the studies are cross-sectional and no adjustment for 
energy intake was done. Moreover, almost all of the studies clarify the association between 
green tea consumption and depression, while information concerning black tea 
consumption is lacking.  
5.4.1 Cross-sectional studies 
A Japanese study in more than 40,000 participants reported an inverse relation between the 
frequency of green tea consumption and psychological distress (264). Those who consumed 
five or more cups of green tea daily had 20% lower risk of being depressed than those who 
drank less than one cup daily, after adjustments for a large number of confounders. 
Similarly, more frequent consumption of green tea was associated with a lower prevalence 
of depressive symptoms in more than 1,000 elderly Japanese (265). The prevalence of 
depressive symptoms was 44% lower for those who drank four or more cups of green tea 
daily compared to those who drank one cup or less daily. In addition, a weak but not 
statistically significant association was found between consumption of black tea and the 
prevalence of depressive symptoms (265). In a study of general population sample of 
Eastern Finnish men and women, it was observed that after adjustments for various 
confounders, those who drank tea daily had a 53% reduced risk of being depressed 
compared to tea non-drinkers (93). Tea drinking in that study, as generally in Finland, 
focused on black tea.  
5.4.2 Prospective studies 
There is only one prospective study published on tea consumption and the risk of 
depression with 18 months of follow-up (266). Participants with high green tea 
consumption (consumption of >100 g of dried tea leaves per month) had a 61% decreased 
risk of depression compared to those with no green tea consumption. However, that study 
was conducted in breast cancer survivors, and there are no prospective studies concerning 
men or general population. Therefore, further prospective studies should be conducted.  
No intervention studies or RCTs have been published on the subject. 
5.4.3 Potential mechanisms 
The association between tea consumption and depression may be explained by the 
potential effects of caffeine on mood described earlier in this thesis. Moreover, tea contains 
catechin polyphenols, which have demonstrated anti-inflammatory and antioxidant 
properties in several studies (236). Tea extract has been shown antidepressive effects in 
animal studies, and antidepressant activity may be explained for example by the inhibition 
of monoamine oxidase enzymes (267). Green tea is rich in theanine, an amino acid, which 
has been shown to elevate brain concentrations of dopamine and serotonin in animal 
studies (268). In addition, green tea contains folate, but studies adjusting for folate 
concentrations have reported that the association between green tea and depression 
attenuated the shown association only slightly (251). 
 
In summary, the evidence suggests that coffee and green tea consumption may be 
beneficial for mental health, though there is a lack of studies. Only one prospective study 
has been published on the association between coffee consumption and depression, 
showing an inverse association in female population. No prospective studies in the general 
population have been published on either green or black tea. In addition, there are no 
published RCTs focusing on the effects of coffee, tea or caffeine consumption on the 
prevention or treatment of depression.  
41 
 
 
6 Dietary patterns 
6.1 RECOMMENDATIONS AND DIETARY INTAKE 
The Finnish Dietary Recommendations have given recommendations for overall dietary 
patterns and food consumption (102). The recommendations suggest consumption of at 
least five portions of vegetables, fruits and berries daily, which is about 400 grams/day 
(102). It is also recommended to consume whole-grain products rich in fiber as  part of all 
daily meals in order to achieve a total intake of 25 to 35 grams of fiber. Fish should be eaten 
at least twice a week. In addition, low-fat (≤7%) poultry, meat, meat products and sausages 
are recommended to replace high-fat products to avoid excess intake of SFAs. Low-fat 
(≤1%) milk and dairy is recommended to be consumed at least 500 mL/day, and two to 
three daily slices of low-fat and low-salt cheese is also recommended. Vegetable oils and 
margarines should be in every-day use. Furthermore, consumption of sucrose should be 
limited to 10% of energy intake and daily consumption of salt to seven grams in men and 
six grams in women. The daily alcohol consumption is suggested to be moderate, 
maximum of two alcohol units in men and one alcohol unit in women. In addition, regular 
frequency of meals is recommended. 
The food consumption in Finnish general population mainly meets the recommended 
levels or is close to the borderline, but there are also intakes that do not meet the 
recommendations. According to the National FINDIET 2007 survey, the mean daily 
consumption of vegetables, fruits and berries in Finnish men and women was 339 g and 408 
g, respectively (103). The mean consumption of fiber in men and women was 24 and 21 
grams/day, respectively. The mean daily fish consumption was 28 g in men and 24 g in 
women, and the mean dairy consumption, including all milk and sour milk products, was 
505 mL/day in men and 476 mL/day in women. The mean cheese consumption was 40 
g/day in men and 34 grams/day in women. Finnish men ate meat (pork, poultry, beef, 
sausages and cold cuts summarized) approximately 167 grams/day and women 98 
grams/day. In addition, the mean salt intake was approximately eight grams per day in 
men and six grams per day in women. The mean daily intake of sucrose was 9.7% of energy 
intake in men and 10.5% of energy intake in women. Finally, the mean daily alcohol 
consumption in men and women was 224 mL and 58 mL, respectively.  
6.2 THE WHOLE-DIET APPROACH 
The majority of the previous studies of the association between diet and diseases have 
focused on single food items or nutrients. Nevertheless, instead of isolated nutrients, 
people eat meals with mixed food groups, which are sources of several nutrients that may 
interact. Therefore, dietary patterns reflecting a combination of foods may be more useful in 
assessing the risk of diseases (269). The influence of overall diet can be studied using a 
whole-diet approach with dietary pattern analyses (270). Two main approaches, both data-
driven methods, are factor analysis and cluster analysis. Factor analysis identifies the 
patterns of correlation between foods, while cluster analysis reduces data into patterns 
based upon individual differences in mean intakes (269). These analyses are not defined a 
priori, but a posteriori, and do not depend on the researcher’s wish to define a healthy 
dietary pattern, for example by comparing the quality of the diet to dietary 
recommendations (269). However, researchers’ decisions and definitions are prone to affect 
the interpretation of the patterns also in dietary pattern analysis conducted with factor 
analysis.  
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The third method for assessing diet quality involves using diet quality indices, which 
have been developed upon current knowledge of nutrition. Diet quality indices reflect the 
general quality of the diet and include variables thought to be healthy, and often determine 
the ideal diet for disease prevention based on recent evidence a priori (269). Higher diet 
quality scores usually indicate healthier dietary patterns. There is no certain golden 
standard regarding diet quality indices. The most well-known diet quality index 
instruments are the Healthy Eating Index (HEI), which is based on the U.S. Dietary 
Guidelines, and the latest modified version of the preceding, Alternative Healthy Eating 
Index (AHEI-10) (271). AHEI-10 delivers scores based on the number of portions for certain 
food items (e.g. fruit portions), but also for absolute intake (e.g. whole-grain products 
grams/day) and percentages of intakes (e.g. % of energy from trans-fatty acids out of total 
energy intake). AHEI-10 correlates well with the validated HEI, and both indices have been 
found to strongly predict the risk of chronic diseases (271). The commonly used 
Mediterranean Diet Score (MDS) was developed to assess the effect of Mediterranean diet 
on chronic diseases (272). High scores in MDS reflect high consumption of vegetables, 
fruits, nuts, cereal, legumes, fish, and also a high ratio of monounsaturated fatty acids 
(MUFAs) to SFAs. MDS has been found to assess adherence to the Mediterranean diet fairly 
well (273). In addition, there are diet quality indices developed in the Nordic countries, for 
example the Baltic Sea Diet Score, developed in Finland (274). The Baltic Sea Diet Score is 
based on the Nordic Dietary Recommendations and takes into account the consumption of 
foods regarded as traditional in the Baltic Sea area. 
6.3 DIETARY PATTERNS, DIET QUALITY AND DEPRESSION 
6.3.1 Dietary patterns in depressed individuals 
Depressed individuals often have poor eating habits and unfavorable food choices, and the 
severity of depression predicts poorer overall diet quality (115,171,275). Depressed 
individuals have been reported to consume fewer servings of vegetables, fruits and grains 
both compared to controls and compared to the recommendations, both in the U.S. (171) 
and in Finland (276,277). In practice, it has been estimated that in order to meet the 
recommended standard, at least 45% of the patients with mood disorders should add two 
to three more servings of vegetables and fruits, and about 15% should add two extra daily 
servings of grains to their diet (171). In contrast, individuals suffering from mood disorders 
have been demonstrated to consume more unhealthy foods, such as processed meats and 
sugary, fatty and salty foods compared to others (171). In addition, depressed individuals 
have been documented to eat less foods containing protein, such as meat, fish, eggs and 
beans compared to others (115,278), although the consumption of processed meats has been 
higher among depressed individuals (171). Depressed individuals, especially those with 
atypical depression, have increased consumption of carbohydrates, mostly sucrose 
(278,279) and lower consumption of high-fiber grain products compared to non-depressed 
individuals (171). 
Depressed individuals have more irregular frequency of meals, are more prone to eat an 
inadequate amount of meals, and the diversity of their meals is poorer compared to non-
depressed controls (115). In addition, patients with mood disorders have been found to eat 
even two fifths of their meals outside the home, at least in Canada (171). Emotional eating is 
highly connected to both depressive symptoms and unhealthy food choices (276). However, 
emotional eating does not explain the association between depressive symptoms and food 
choices in general, but it may be one explaining factor behind the association between 
intake of particularly sweet foods and depressive symptoms (276). 
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6.3.2 Cross-sectional studies 
Several studies have applied whole-diet approaches to examine the associations between 
dietary patterns and depression (Table 9). The majority of the studies were from Australia, 
Europe (France, United Kingdom, Spain, Norway) or Asia (Japan, China) and dietary 
pattern analyses were usually based on long FFQs. However, statistical models were 
adjusted for total energy intake only in about a half of the studies (24,25,95,280-285), which 
is regarded as a limitation. In addition, gender may affect the observed association, as 
healthy dietary patterns or diet quality indices have been observed to be protective 
especially or only in women (25,95,283,285,286). Depression was usually measured by self-
reported questionnaires, such as BDI or CES-D, whereas clinical interview was used to 
define depression in only one study (285). The following sections present in more detail the 
cross-sectional and prospective studies on healthy or unhealthy dietary patterns or diet 
quality indices and depression.  
 
Healthy dietary patterns 
Associations between dietary patterns and depression have been demonstrated by using a 
posteriori methods. Studies in adults in Australia (285), Norway (95), France (283) and Japan 
(281) as well as in adolescents in China (287) reported an inverse association between 
healthier dietary patterns and depression. However, the traditional Norwegian dietary 
pattern, which also included milk products and butter, was associated with a decreased 
prevalence of depressive symptoms only in men (95). In contrast, studies in Japanese 
community-dwelling adults (282) and in Australian adolescents (280) reported no 
associations between healthy dietary patterns and depressive symptoms. A healthy cluster 
characterized by high fish consumption in French men (283) and healthy dietary pattern in 
Norwegian men (95) showed no association, either. However, three out of four of the 
studies with no association (95,280,283) were energy-adjusted.  
There are some differences between dietary patterns defined as “healthy”, except for the 
presence of vegetables and fruits, which are usually included in the healthy patterns. In an 
Australian study (285), healthy diet was characterized by eating lots of vegetables, lean 
meat, fish and whole-grains, whereas in a Japanese study (281) it was characterized by high 
consumption of vegetables, fruits, mushrooms and soy products. A study conducted in 
China (287) demonstrated a traditional dietary pattern with gruel, oatmeal, whole-grains, 
vegetables, fruits and soya milk. In a Norwegian study, the healthy dietary pattern, 
protective in women, had high loadings for vegetables, fruits, rice, cereals and non-
processed meat, whereas a traditional Norwegian dietary pattern, protective in men, was 
characterized by high consumption of fish, shellfish, potatoes, fruits, vegetables, butter, 
margarine and milk products (95). In a French study, a healthy cluster that associated with 
fewer depressive symptoms in women was characterized by high consumption of fruits 
and vegetables (283).  
 
Unhealthy dietary patterns 
Dietary patterns characterized by unhealthy Western-type food consumption were found to 
associate with prevalence of depression in Australian (280) and Chinese (287) adolescents. 
In Australian women, the positive association was diminished after adjustment for energy 
intake (285). In Australian adolescents, the unhealthy dietary pattern associated with 
elevated depression was characterized by high consumption of take-away foods, 
confectionery and red meat (280), whereas in Chinese adolescents, snack dietary pattern 
was rich in fruits, a sweet course, frozen confections, yoghurt, chocolate, candies and 
carbonated drinks (287). In Australian women, Western dietary pattern was based on 
processed or fried foods, refined grains, sugary products and beer (285). A dietary pattern 
based on animal foods was associated with higher likelihood of co-existing depression in 
Chinese adolescents (287). Nevertheless, in Norwegian adults (95), higher intake of 
processed and unhealthy foods and, in Japanese adults, Western, bread and confectionery, 
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or alcohol and accompanying patterns were not related to depression (282). The differences 
in the results may be explained by the age of the participants, as  the association was shown 
especially studies in adolescents (280,287). However, adjustment for energy intake was 
done in almost all of these studies, except for the Japanese study with no association (282) 
and the Chinese study with a positive association (287).  
 
Diet quality indices 
Lower adherence to dietary guidelines has been demonstrated to have a cross-sectional 
association with elevated prevalence of depression in North American adults (288) and in 
Norwegian women, and after adjustments, also in men (95). Unhealthy diet quality scores 
associated with elevated mental health problems also in British (96) and in Australian (289) 
adolescents. 
6.3.3 Prospective studies 
 
Healthy dietary patterns  
The protective relation between healthy dietary patterns and the risk of depression has 
been demonstrated in four large prospective studies in adults. The largest study showed 
that a healthy dietary pattern reflecting high consumption of vegetables, fruits and oils was 
protective in a study with over 12,000 middle-aged French working men and women 
(highest vs. lowest tertile, in men OR: 0.72; 95% CI: 0.63 to 0.83 and in women OR: 0.75; 95% 
CI: 0.61 to 0.93) (26). This was the first study on the subject to use repeated depression 
measurements (CES-D) over ten years. However, the dietary patterns were assessed by 
short FFQs and models were not adjusted for total energy intake. Adherence to a traditional 
Australian dietary pattern predicted lower scores in psychological distress scale (highest vs. 
lowest quartile OR: 0.61; 95% CI: 0.40 to 0.91) in a study with 8,660 participants and the 
longest follow-up on the subject, 12 years (94). The traditional Australian dietary pattern 
consisted of not only healthy-considered whole-grains, fruits, vegetables and margarine, 
but also sweet snacks and lack of olive oil (94). However, in that study, the Mediterranean 
dietary pattern was not associated with psychological distress (highest vs. lowest quartile 
OR: 0.94; 95% CI: 0.87 to 1.01). Nevertheless, the greatest limitation in that study was that 
psychological distress was not assessed at baseline, but only at the end of the study; thus it 
is possible that the dietary patterns were affected by the presence of symptoms. In contrast, 
in 7,588 Australian women, a strong protective association was demonstrated between 
adherence to Mediterranean dietary pattern and depression (OR: 0.84; 95% CI: 0.78 to 0.90) 
(25), also when energy intake was taken into account as a potential confounder. The pattern 
was characterized by high intake of garlic, peppers, mushrooms, salad greens, pasta and 
red wine. Nevertheless, in the same study, cooked vegetable pattern or fruit pattern did not 
show an association with depression risk, neither did high-fat and sugar or processed meat 
patterns. Similarly, in almost 3,500 middle-aged British men and women (24), adherence to 
a healthy dietary pattern, called whole-food pattern, characterized by high consumption of 
vegetables, fruits and fish, was associated with a 30% lower risk of depression in energy-
adjusted model (second vs. lowest tertile OR: 0.70; 95% CI: 0.50 to 0.96).  
 
Unhealthy dietary patterns  
In the above-described British study, dietary pattern rich in processed foods, such as 
sweetened desserts, processed meats, fried foods, refined grains and high-fat dairy 
products associated with a 76% higher risk of depression (highest vs. lowest tertile OR: 1.76; 
95% CI: 1.14 to 2.70) also in energy-adjusted models (24). Similarly, in the above-described 
French cohort, Western (OR: 1.36; 95% CI: 1.19 to 1.54), fat-sweet (OR: 1.49; 95% CI: 1.30 to 
1.71) and snacking (OR: 1.50; 95% CI: 1.32 to 1.71) dietary patterns associated with an 
elevated risk of depression in men and snacking (OR: 1.43; 95% CI: 1.16 to 1.76) and low-fat 
patterns (OR: 1.39; 95% CI: 1.22 to 1.73) in women (comparisons were made for the highest 
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vs. lowest tertiles) (26). Nevertheless, in that study, energy intake was not taken into 
account as a potential confounder. 
  
Diet quality indices 
Adherence to dietary guidelines has been related to the reduced risk of depression in 
prospective studies. In the Spanish Seguimiento Universidad de Navarra (SUN) cohort 
with more than 10,000 adults, higher MDS showed to predict decreased depression (HR: 
0.58; 95% CI: 0.44 to 0.77) (284). In addition, an inverse dose-dependent association was 
found between consumption of fruits, nuts, ratio of MUFAs to SFAs and the risk of 
depression (284). Similarly, MDS had an inverse association with the risk of psychological 
distress in over 8,500 Australian adults (OR: 0.71; 95% CI: 0.54 to 0.95) (94) and MDS was 
also associated with a reduced number of newly occurring depressive symptoms in over 
3,500 North American elderly (290). In over 4,000 British participants, AHEI scores were 
inversely and dose-dependently associated with recurrent depressive symptoms, but only 
in women (286). Women who maintained high AHEI scores had a 65% (95% CI: 0.19 to 0.64) 
and women who improved their scores a 68% (95% CI: 0.13 to 0.78) lower risk of recurrent 
depression compared to women who maintained lower AHEI scores during the ten years of 
follow-up. Among AHEI components, especially vegetables, fruits ant the ratio of PUFA to 
SFA were associated with the reduced risk of recurrent depression.   
Prospective studies in adolescents have also shown that healthy diet quality scores were 
inversely associated with depression in almost 3,000 British (96) and in almost 3,000 
Australian adolescents (289). Moreover, in Australian adolescents, higher unhealthy diet 
scores predicted higher depression scores at follow-up (289), whereas in British adolescents, 
unhealthy diet quality scores associated with elevated mental problems only before 
adjustments (96). However, no adjustments for energy intakes were done. 
6.3.4 Intervention studies 
There are no large-scale or long-lasting RCTs conducted on the effects of dietary patterns 
on depression. However, in a recent pilot RCT, healthy participants were assigned to eat 
fish three to four times a week and to avoid meat and poultry, to favor a vegetable-oriented 
diet and to avoid fish, meat and poultry, or to eat meat, fish and poultry (291). The study 
demonstrated that those in the vegetable group had greater improvements in mood 
compared to the fish or meat+fish group after two weeks of trial. However, there were only 
39 participants in this short trial, but the results support the beneficial effects of a vegetable-
oriented diet on mood.  
6.3.5 Potential mechanisms 
As presented earlier in this thesis, several nutrients, such as long-chain n-3 PUFAs, folate 
and vitamin B12 may be related to the risk of depression (10,21,132), but also foods or food 
groups, such as high consumption of vegetables and fruits (281,285) and fish (15,172,173) 
have been associated with a reduced risk of depression. Individuals’ diets consist of mixed 
food groups instead of isolated nutrients, and different nutrients interact and modulate 
each other’s effects. Thus, dietary patterns reflect more than just the effect of individual 
factors summarized. 
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Among the indicators of diet quality, consumption of fruits and vegetables has especially 
been found to properly assess the quality of diet (292). Fruit and vegetable intakes have 
been the primary components of a healthy diet also in studies demonstrating the 
association between diet and depression (95,281,283-285). Interestingly, dietary antioxidants 
from fruits and vegetables were found to be protective against depression, whereas 
antioxidants from dietary supplements did not associate with depression (83), which 
indicates the benefits of elevated consumption of fruits and vegetables instead of 
supplementation. Recently, a short-term positive effect of fruit and vegetable consumption 
on mood was shown, as daily consumption of approximately seven to eight servings of 
fruits and vegetables predicted a greater positive affect the following day (293). Diet was 
assessed with 21-day food records and the association was stronger in men than women. 
However, positive affects, especially followed by the fruit and vegetable consumption only 
in days, may not be based on real physiological effects, but result from the perceived 
healthiness of fruits and vegetables. However, positive affects did not predict changes in 
next-day fruit and vegetable consumption. 
In theory, a healthy, vegetable-oriented diet rich in vitamins, minerals, antioxidants, and 
n-3 PUFAs modulates several physiological systems, such as inflammatory and oxidative 
processes, brain plasticity, synthesis of monoaminergic neurotransmitters, brain cell 
membrane functions and the stress-response system (95,217,294). Hence, in theory, a 
healthy diet is likely to play a role in the genesis and course of depression (295). Adherence 
to a dietary pattern closer to the Mediterranean diet was shown to be associated with 
decreased levels of HPA axis disturbances (296). In addition, depressed patients who were 
assigned to the Mediterranean diet were found to have elevated plasma BDNF levels 
compared to patients assigned to a control diet (297).  
Several mechanisms are suggested to explain the harmful effects of unhealthy dietary 
patterns. It is possible that not only do these unhealthy food items replace more nutritious 
foods causing a lack of protective nutrients, but an unhealthy diet may also contain 
potential harmful substances. Previously, a dietary pattern associated with lower mental 
health status was loaded with high refined sugar intake and red meat intake in adolescents 
(280). In theory, high consumption of sugar-containing products may affect for example 
inflammatory factors (298), and high intake of processed red meat may also be harmful to 
general health and increase the risk of non-communicable diseases (299). In addition, a 
high-fat, refined sugar diet decreased the levels of BDNF in hippocampus and decreased 
neuronal plasticity (300). Unhealthy dietary patterns may lead to chronic inflammation by 
elevating the levels of pro-inflammatory cytokines, which may in turn elevate the risk of 
MDD (301). It has also been suggested that rather than the proportion of unhealthy foods in 
the overall diet, it is the absolute amount of unhealthy foods consumed that is the most 
relevant for health (95).  
 
In summary, several cross-sectional and prospective studies have shown an inverse 
association between healthy dietary patterns and depression in studies mainly from 
Australia, Europe or Asia. This association has been found especially in women. In some 
studies, unhealthy dietary patterns have been shown to predict elevated depressive 
symptoms, especially in studies conducted in adolescents, but most of the studies showed 
no associations. However, adjustment for total energy intake has not been done in about 
half of the studies, which may affect the results. A recent review reported that even if there 
is evidence of potential benefits for certain dietary patterns, due to large heterogeneity, a 
meta-analysis is still impossible to conduct (302). The review pointed out an urgent need 
for further studies. Moreover, there are no large-scale intervention studies published on the 
dietary modifications and the effects on depression status. 
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7 Lifestyle interventions  
7.1 LIFESTYLE INTERVENTIONS IN NON-CLINICAL POPULATIONS 
Lifestyle intervention studies are usually conducted to improve lifestyle habits, such as 
eating habits, to lose weight in overweight individuals, to increase physical activity, or to 
enhance sleep length or quality. In lifestyle interventions, these improvements are usually 
driven in combination, and social support is often given as a control treatment. Table 10 
presents the intervention studies aimed at improvements in lifestyle factors that have 
reported the effects on depressive symptoms in non-clinical individuals. Studies have 
mainly been conducted in high-risk populations for depression, such as stroke survivors, 
overweight and pregnant individuals or individuals with IGT or T2D. 
In the Diabetes Prevention Program (DPP), participation in the intensive lifestyle 
modification group for three years was not associated with changes in depressive 
symptoms in over 3,000 overweight or obese subjects with IGT (303). The intervention 
group aimed at a mean loss of at least 7% of initial weight through a healthy low-fat diet 
and an increase of moderately intense physical activity to at least 150 minutes/week. 
Several individual and group sessions were included. There were also two control groups, 
a metformin and a placebo group (303). Similar results were achieved in elderly stroke 
survivors; improvements in mental health were seen in both groups, but the difference 
between intervention and control groups did not reach a statistically significant level (304). 
However, in that study the intervention group received 36 group sessions on lifestyle 
factors and 36 physical activity sessions while the control group received 36 exercise group 
sessions, so a “null-exposed” control group was lacking. In addition, an intervention study 
among nearly one hundred elderly stroke survivors compared the effects of a lifestyle 
course with physical activity intervention (intervention group) to a physical exercise alone 
group (control group) (304). Similarly, mental health improvements were seen in both 
groups, with no specific group effect. Additionally, an intervention among elderly 
individuals demonstrated that physical activity intervention showed no benefit over 
successful ageing counseling sessions as a control (305). In that study the intervention 
group received intensive exercise intervention including at least three 40- to 60-minute 
sessions per week, while a series of sessions on health topics were given to the control 
group. Finally, similar results were achieved in an intervention in obese pregnant women; 
an intensive, tailored dietary intervention based on Belgian National Dietary 
Recommendations had no difference in the effect on depressive symptoms compared to 
either brochure-delivered or normal care control groups (306). In overweight and obese 
women, dietary restrictions (~6000 kJ/day energy restricted high-protein meal plan) both 
alone and combined with physical exercise decreased depressive symptoms. The results 
suggest that exercise provided no additional benefit to the effect of diet alone (307). There 
was, however, no null-control group in that study. 
In contrast, in over 4,000 participants from the 12-month Look AHEAD trial, aimed at 
weight reduction in overweight adults with T2D, BDI scores decreased more in the 
intensive lifestyle intervention group compared to diabetes support and education group as 
a control group (308). The intervention was aimed at reducing weight (≥7% of initial 
weight) and increasing moderately intense physical activity to at least 175 minutes per 
week. The weight control intervention was adapted from the DPP (303), in which 
participants had several group meetings as well as individual tailored counseling sessions. 
The control group received three one-hour group meetings that addressed diet, physical 
activity and social support. The mean reduction in weight was 8.8 kg in the intervention 
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and 0.9 kg in the control group, and weight change was regarded as a mediator on the 
effect of intervention on BDI reduction. Recently, also another study was published based 
on The Look AHEAD Trial (309) and this is the largest conducted trial on the subject with 
almost 5,000 participants. That study aimed at comparing the effects of intervention on 
incidence of symptoms of depression. The results showed that the incidence of potentially 
clinically significant symptoms of depression was statistically significantly lower in the 
intervention group compared to the control group (309).   
 An intervention among pregnant Latino women also demonstrated similar findings: 
women in IG had a statistically significant decrease in depression scores during the 
intervention compared to the control group (310). The intervention included a 14-session 
weekly curriculum and aimed at empowering women to develop knowledge and skills to 
promote healthy eating, regular exercise and social support. The intervention was rigorous 
and group meetings included healthy eating and exercise activities, such as healthy 
cooking, walking and dancing. The control group had only group meetings relating to 
general health in pregnancy and was given standard pregnancy education materials about 
eating and exercise (310).  
Recently, the first trial comparing the effects of a combination of diet and physical 
exercise on the effects of diet and exercise separately was published (311). The results 
showed that although both diet and diet plus exercise improved mental health, the 
combination of diet and exercise showed greater improvements in mental health than diet 
alone. In addition, participation in the diet plus exercise group associated with a decrease in 
depression scores. There was also a statistically significant correlation between weight loss 
and reduced depressive symptoms. In that study, the participants were overweight or 
obese women without major medical conditions. The diet group received individualized 
counseling based on a reduced calorie weight loss intervention, which was a modification 
of the DPP lifestyle trial (303) and the Look AHEAD trial (309). The diet group was advised 
to restrict their total calorie intake to 1200-2000 kcal/day based on baseline weight, eat ≤30% 
of calories from fat, and achieve 10% weight loss within the intervention period. The 
exercise intervention was based on 45 minutes of moderate-to-vigorous intensity aerobic 
exercise daily five days per week including three supervised exercise sessions per week. 
The combined group received both diet and exercise intervention while controls were not 
given the intervention.  
 
  
52 
T
ab
le
 1
0
. 
In
te
rv
en
ti
on
 s
tu
di
es
 o
n
 li
fe
st
yl
e 
fa
ct
or
s 
an
d 
d
ep
re
ss
iv
e 
sy
m
p
to
m
s.
 
S
tu
d
y
 b
y
 
P
a
rt
ic
ip
a
n
ts
 (
a
g
e
, 
y
e
a
rs
) 
D
u
ra
ti
o
n
  
S
p
e
ci
fi
c 
in
te
rv
e
n
ti
o
n
 s
tr
a
te
g
y
/
 
a
d
v
ic
e
 t
o
 c
o
n
tr
o
l 
g
ro
u
p
 
R
e
s
u
lt
s
  
R
u
b
in
 e
t 
a
l.
 
2
0
0
5
 (
3
0
3
) 
3
1
8
7
 o
ve
rw
ei
g
h
t/
ob
e
se
 
su
b
je
ct
s 
 w
it
h
 I
G
T
  
in
 D
PP
 
tr
ia
l 
(≥
2
5
 y
) 
3
.2
 y
e
a
rs
 
IG
: 
1
) 
A
 m
ea
n
 l
o
ss
 o
f 
at
 l
ea
st
 7
%
 o
f 
in
it
ia
l 
w
ei
g
h
t 
th
ro
u
g
h
 a
 h
e
al
th
y 
lo
w
-f
at
 d
ie
t 
2
) 
to
 i
n
cr
ea
se
 m
o
d
e
ra
te
ly
 i
n
te
n
se
 p
h
ys
ic
al
 
a
ct
iv
it
y 
to
 a
t 
le
a
st
 1
5
0
 m
in
/w
ee
k 
C
G
1
: 
M
e
tf
o
rm
in
 t
re
a
tm
e
n
t 
C
G
2
: 
P
la
ce
b
o
 t
re
at
m
e
n
t 
D
PP
 p
a
rt
ic
ip
at
io
n
 w
as
 n
o
t 
as
so
ci
at
ed
 w
it
h
 c
h
an
g
e
s 
in
 
le
ve
ls
 o
f 
d
ep
re
ss
io
n
. 
W
e
ig
h
t 
lo
ss
 a
ss
oc
ia
te
d
 w
it
h
 
re
d
u
ct
io
n
 o
f 
in
 t
h
e
 r
is
k 
o
f 
el
ev
a
te
d
 d
ep
re
ss
io
n
. 
 
 
 
 
 
W
ill
ia
m
so
n
 e
t 
a
l.
 2
0
0
9
 (
3
0
8
) 
4
2
2
3
 o
ve
rw
ei
g
h
t/
ob
e
se
 
ad
u
lt
s 
w
it
h
 T
2
D
 i
n
 L
o
o
k 
A
H
E
A
D
 T
ri
a
l 
(4
5
-7
6
 y
) 
1
2
 m
o
n
th
s 
IG
: 
1
) 
A
 m
ea
n
 l
o
ss
 o
f 
at
 l
ea
st
 7
%
 o
f 
in
it
ia
l 
w
ei
g
h
t,
 2
) 
to
 i
n
cr
ea
se
 m
o
d
e
ra
te
ly
 i
n
te
n
se
 
p
h
ys
ic
a
l 
a
ct
iv
it
y 
to
 a
t 
le
as
t 
1
7
5
 m
in
/w
e
e
k 
C
G
: 
 E
d
u
ca
ti
o
n
a
l 
in
fo
rm
a
ti
o
n
, 
3
 g
ro
u
p
 
m
ee
ti
n
g
s 
T
h
e 
B
D
I 
sc
o
re
s 
re
d
u
ce
d
 i
n
 b
o
th
 I
G
 (
-0
.8
3
, 
P
<
0.
0
0
1
) 
a
n
d
 i
n
 C
G
 (
-0
.2
3
, 
P
<
0.
0
0
1
) 
(P
 f
o
r 
th
e 
d
if
fe
re
n
ce
 
<
0
.0
0
1
) 
 
 
 
 
 
T
h
o
m
so
n
 e
t 
a
l.
 2
0
1
0
 (
3
0
7
) 
9
4
 o
ve
rw
e
ig
h
t/
ob
es
e 
w
o
m
e
n
 w
it
h
 p
o
ly
cy
st
ic
 
o
va
ry
 s
yn
d
ro
m
e
  
(m
ea
n
 a
g
e
 2
9
 y
) 
2
0
 w
ee
ks
 
IG
1
: 
Im
p
ro
vi
n
g
 d
ie
t 
on
ly
 
IG
2
: 
Im
p
ro
vi
n
g
 d
ie
t 
a
n
d
 a
er
o
b
ic
 e
xe
rc
is
e 
IG
3
: 
Im
p
ro
vi
n
g
 b
o
th
 a
e
ro
b
ic
 a
n
d
 r
es
is
ta
n
ce
 
ex
er
ci
se
 
IG
1
 a
n
d
 I
G
2
 h
ad
 s
im
ila
r 
b
en
ef
it
s 
in
 i
m
p
ro
vi
n
g
 
d
ep
re
ss
io
n
, 
n
o
 s
ta
ti
st
ic
a
lly
 s
ig
n
if
ic
an
t 
d
if
fe
re
n
ce
s 
b
et
w
e
e
n
 t
h
e
 g
ro
u
p
s.
  
 
 
 
 
 
Lu
n
d
 e
t 
a
l.
 
2
0
1
1
 (
3
0
4
) 
8
6
 s
tr
o
ke
 s
u
rv
iv
o
rs
  
(≥
6
5
 y
) 
9
 m
o
n
th
s 
IG
: 
Im
p
ro
vi
n
g
 p
h
ys
ic
al
 a
ct
iv
it
y 
+
 o
th
e
r 
lif
e
st
yl
e
-r
e
la
ti
n
g
 f
a
ct
o
rs
 
C
G
: 
Im
p
ro
vi
n
g
 p
h
ys
ic
al
 a
ct
iv
it
y 
N
o
 s
ta
ti
st
ic
al
ly
 s
ig
n
if
ic
an
t 
d
if
fe
re
n
ce
s:
 m
en
ta
l 
re
d
u
ct
io
n
 i
n
 d
ep
re
ss
io
n
 s
co
re
s:
 I
G
 (
-0
.8
; 
9
5
%
 C
I:
 
 -
1
.7
 t
o 
0
.2
),
 C
G
 (
-1
.1
; 
9
5
%
 C
I:
 -
2
.0
 t
o 
0
.2
) 
(P
 f
o
r 
th
e
 d
if
fe
re
n
ce
=
0.
6
6
) 
M
at
h
e
w
s 
et
 a
l.
 
2
0
1
1
 (
3
0
5
) 
4
2
4
 s
ed
e
n
ta
ry
, 
n
on
-
in
st
it
u
ti
o
n
al
iz
ed
 a
d
u
lt
s 
e
ld
e
rl
y 
in
d
iv
id
u
al
s 
 
(7
0
-8
9
 y
) 
1
2
 m
o
n
th
s 
IG
: 
Im
p
ro
vi
n
g
 p
h
ys
ic
al
 a
ct
iv
it
y 
C
G
: 
S
u
cc
e
ss
fu
l 
a
g
e
in
g
: 
se
ss
io
n
s 
in
 h
e
a
lt
h
 
to
p
ic
s 
 
N
o
 s
ta
ti
st
ic
al
ly
 s
ig
n
if
ic
an
t 
d
if
fe
re
n
ce
s 
b
et
w
e
en
 t
h
e
 
g
ro
u
p
s 
(P
=
0
.8
5
).
 
 
 
 
 
 
Im
ay
a
m
a
 e
t 
a
l.
 2
0
1
1
 (
3
1
1
) 
4
3
9
 o
ve
rw
e
ig
h
t/
ob
es
e
 
p
o
st
m
e
n
op
au
sa
l 
w
o
m
e
n
 in
 
th
e
 N
u
tr
it
io
n
 a
n
d
 E
xe
rc
is
e
 
T
ri
a
l 
(5
0
-7
5
 y
) 
1
2
 m
o
n
th
s 
IG
1
: 
D
ie
ta
ry
 w
e
ig
h
t 
lo
ss
 o
f 
1
0
%
 
IG
2
: 
M
o
de
ra
te
-t
o
-v
ig
o
ro
u
s 
a
er
ob
ic
 e
xe
rc
is
e
 
(2
2
5
 m
in
/w
e
e
k)
  
IG
3
: 
C
om
b
in
ed
 d
ie
t 
a
n
d
 e
xe
rc
is
e
  
C
G
: 
N
o
 i
n
te
rv
e
n
ti
on
  
IG
1
 a
n
d
 I
G
3
 i
m
p
ro
ve
d
 m
e
n
ta
l 
h
ea
lt
h
 s
ta
ti
st
ic
al
ly
 
si
g
n
if
ic
an
tl
y 
m
o
re
 c
om
p
ar
ed
 t
o
 C
G
 (
P
=
0
.0
5
 a
n
d
 
P
=
0
.0
1
, 
re
sp
ec
ti
ve
ly
),
 I
G
2
 h
a
d
 n
o
 e
ff
ec
t 
(P
=
0
.2
9
).
 
E
ff
e
ct
 o
f 
IG
3
 w
a
s 
g
re
a
te
r 
th
an
 I
G
1
 o
r 
IG
2
 a
lo
n
e
 
(P
=
0
.0
4
).
  
 
 
 
 
T
a
b
le
 1
0
 t
o
 b
e
 c
on
ti
n
u
ed
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
53 
A
b
b
re
vi
at
io
n
s:
 B
D
I,
 B
e
ck
 D
e
p
re
ss
io
n
 I
n
ve
n
to
ry
; 
C
G
, 
co
n
tr
o
l g
ro
u
p
; 
C
I,
 c
on
fi
d
e
n
ce
 i
n
te
rv
al
; 
D
PP
, 
T
h
e 
D
ia
b
e
te
s 
P
re
ve
n
ti
o
n
 P
ro
g
ra
m
; 
H
R
, 
h
a
za
rd
 r
at
io
; 
IG
, 
in
te
rv
en
ti
o
n
 g
ro
u
p
; 
T
2
D
, 
ty
p
e
 2
 d
ia
b
e
te
s 
m
e
lli
tu
s
T
a
b
le
 1
0
 
co
n
ti
n
u
es
 
 
 
 
 
S
tu
d
y
 b
y
 
P
a
rt
ic
ip
a
n
ts
 (
a
g
e
, 
y
e
a
rs
) 
D
u
ra
ti
o
n
  
S
p
e
ci
fi
c 
in
te
rv
e
n
ti
o
n
 s
tr
a
te
g
y
/
 
a
d
v
ic
e
 t
o
 c
o
n
tr
o
l 
g
ro
u
p
 
R
e
s
u
lt
s
  
Fa
u
lc
o
n
b
ri
d
g
e 
e
t 
a
l.
 2
0
1
2
 
(3
0
9
) 
4
8
0
2
 o
ve
rw
ei
g
h
t/
ob
e
se
 
ad
u
lt
s 
w
it
h
 T
2
D
 i
n
 L
o
o
k 
A
H
E
A
D
 T
ri
a
l 
(4
5
-7
6
 y
) 
1
2
 m
o
n
th
s 
IG
: 
1
) 
A
 m
ea
n
 w
e
ig
h
t 
lo
ss
 o
f 
≥
7
%
 o
f 
in
it
ia
l 
2
) 
in
cr
ea
se
 p
h
ys
ic
al
 a
ct
iv
it
y 
≥
1
7
5
 m
in
/w
ee
k 
C
G
: 
E
d
u
ca
ti
o
n
a
l 
in
fo
rm
at
io
n
, 
th
re
e
 g
ro
u
p
 
m
ee
ti
n
g
s 
T
h
e 
in
ci
d
e
n
ce
 o
f 
d
e
p
re
ss
io
n
 l
o
w
e
r 
in
 I
G
 c
om
p
ar
ed
 t
o
 
C
G
 (
6
.3
%
 a
n
d
 9
.6
%
, 
re
sp
e
ct
iv
e
ly
; 
IG
 H
R
: 
0
.6
6
; 
P
 f
o
r 
th
e
 d
if
fe
re
n
ce
 <
0
.0
0
1
).
 M
ea
n
 r
ed
u
ct
io
n
 i
n
 t
h
e
 B
D
I 
sc
o
re
s:
 1
.4
±
4.
7
 i
n
 I
G
 a
n
d
 0
.4
±
4
.5
 i
n
 C
G
 (
P
 f
o
r 
th
e
 
d
if
fe
re
n
ce
 <
0
.0
0
1
).
  
B
o
g
a
e
rt
s 
et
 a
l.
 
2
0
1
2
 (
3
0
6
) 
2
0
5
 o
b
e
se
 p
re
g
n
a
n
t 
w
om
e
n
 
1
-3
 
tr
im
es
te
rs
 
IG
: 
D
ie
ta
ry
 g
o
al
s 
b
as
ed
 o
n
 t
h
e 
N
a
ti
o
n
al
 
D
ie
ta
ry
 R
ec
om
m
e
n
d
a
ti
on
s 
+
 i
n
cr
ea
si
n
g
 
ex
er
ci
se
  
C
G
1
: 
B
ro
ch
u
re
 g
ro
u
p
 
C
G
2
: 
N
o
rm
a
l 
ca
re
 
N
o
 d
if
fe
re
n
ce
s 
in
 d
ep
re
ss
iv
e
 s
ym
p
to
m
s 
w
e
re
 f
o
u
n
d
 
b
et
w
e
e
n
 t
h
e
 g
ro
u
p
s 
(P
=
0.
7
6
).
 
K
ie
ff
e
r 
et
 a
l.
 
2
0
1
3
 (
3
1
0
) 
2
4
9
 p
re
g
n
an
t 
La
ti
n
o
 w
o
m
e
n
 
in
 H
ea
lt
h
y 
M
om
s 
Li
fe
st
yl
e
 
in
te
rv
en
ti
o
n
 
2
-3
 
tr
im
es
te
rs
 
IG
: 
 I
n
cr
ea
si
n
g
 h
e
al
th
y 
e
a
ti
n
g
, 
e
xe
rc
is
e
 
ac
ti
vi
ti
e
s 
+
 s
oc
ia
l 
su
p
p
o
rt
: 
g
ro
u
p
 m
ee
ti
n
g
s 
an
d
 h
o
m
e
 v
is
it
s 
C
G
: 
G
e
n
e
ra
l 
a
d
vi
ce
 
IG
 h
ad
 a
 s
ta
ti
st
ic
a
lly
 s
ig
n
if
ic
an
tl
y 
g
re
a
te
r 
d
e
cr
ea
se
 i
n
 
d
ep
re
ss
io
n
 s
co
re
s 
fr
o
m
 b
as
e
lin
e
 t
o
 f
o
llo
w
-u
p
 
co
m
p
a
re
d
 t
o
 C
G
. 
M
e
an
 d
if
fe
re
n
ce
 b
et
w
ee
n
 t
h
e 
g
ro
u
p
s:
 -
1
.8
3
 p
o
in
ts
; 
9
5
%
 C
I 
-3
.5
9
, 
-0
.0
7
; 
P
=
0.
0
4
. 
 
 
 
 
 
54 
 
 
7.2 LIFESTYLE INTERVENTIONS IN DEPRESSED INDIVIDUALS 
There is a lack of large-scale dietary or lifestyle interventions among depressed patients. 
Based on the information of the impaired quality of diet and decreased dietary intakes of 
essential nutrients, it is evident that depressed individuals would benefit from dietary 
improvements that are possible to achieve in dietary or lifestyle specific interventions (171). 
Positive effects have been shown in interventions (312), but the effects of improved lifestyle 
factors on depression course are still partly unclear. 
The beneficial effect of physical exercise is suggested to be considerable in the treatment 
of depression. A recent Cochrane review concluded that exercise seems to improve 
depressive symptoms (27). The results indicated a moderate clinical effect in people with a 
diagnosis of depression when compared with no treatment or control intervention. Physical 
exercise is effective especially in the prevention of recurrent depression (101). However, 12 
months of pure exercise intervention reported no statistically significant effect on 
depressive symptoms in elderly depressed individuals (305). In contrast, a psycho-
educational group program aimed at healthier lifestyle in patients with depression showed 
benefits compared to usual care as a control (313). 
A recent RCT clarified the effects of four lifestyle recommendations on the treatment of 
depression (314). The study consisted of 80 depressive out-patients on antidepressant 
treatment. The intervention aimed at four goals: improving sleep (detailed instructions, for 
example go to bed before 11 pm), walking at least one hour a day, being exposed to 
sunlight at least two hours per day and finally, eating a healthy and balanced diet and 
regular meals. Specific dietary aims were to eat fish at least three times per week, consume 
vegetables, fruits, cereals and nuts daily and avoid sugary drinks. The control group 
received only general advice, for example “try to eat a healthy and balanced diet”. After six 
months of intervention, all scales indicated better recovery in the intervention group (mean 
decrease of the BDI scores in intervention and control group was 9.3 and 5.3, respectively). 
In addition, the number of psychopharmacological treatment prescriptions was reduced 
more in the intervention compared to the control group. The study suggested that lifestyle 
recommendations may be used as an effective antidepressant complementary treatment in 
clinical practice.  
Recently, a study protocol was published for the “Supporting the Modification of 
Lifestyle In Lowered Emotional States” study, an RCT investigating the effects of dietary 
intervention for adults with MDD (315). This is the first diet-only based trial with 12 weeks 
of intervention focusing on advocating a healthy diet based on the Australian Dietary 
Guidelines and the Dietary Guidelines for Adults in Greece, started at the end of 2012. 
After completion of this trial, there will be more evidence of the effects of dietary 
intervention in depressed individuals. 
It has been assumed that current depression may affect adherence to intervention 
instructions, achieving goals and the possibility of dropping out during the intervention. In 
the elderly, intervention participants with high depressive symptoms did not benefit from 
physical exercise intervention as much as healthy controls (305). However, in that study 
adherence rates to the exercise sessions did not differ between depressed individuals and 
others. In a recent Finnish study, a diagnosis of MDD, chronic depression or specific 
symptoms of depression did not predict quitting a weight loss intervention (316). It was 
observed that only anhedonia predicted drop-outs. 
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7.3 POTENTIAL MECHANISMS 
Lifestyle factors are interrelated, and when one of these habits is modified it usually 
facilitates change in others (16). Therefore, the mechanism that may explain why these 
lifestyle habits can prevent or improve depression is probably complex (312). The possible 
effects of dietary factors on depression have been presented in detail earlier in this thesis. 
On biological level, it is likely that exercise improves the balance of serotonergic, 
dopaminergic and noradrenergic systems in contrast to stress, which impairs the systems 
(317). In addition, the magnitude of social support and regular meetings may affect 
depressive symptoms. 
In summary, results from the lifestyle intervention studies aimed at improving diet 
and/or increasing physical activity in non-clinical high-risk populations, as well as in 
depressed individuals, are inconsistent. There is great heterogeneity between the studies. It 
seems that increasing physical exercise alone does not benefit participants as much as the 
combination of lifestyle factors. In addition, the effect of comprehensive lifestyle 
intervention aimed at healthy diet, increased physical activity and weight reduction has 
been less studied compared to intervention studies with only one aim, usually increasing 
the amount of exercise or losing weight.  
 
In summary of the review of the literature section of this thesis, the evidence suggests that 
diet may have a role in the prevention and treatment of depression although heterogeneity 
between the studies is large. The inconsistency in the results may partly be explained by 
potential confounders, such as total energy intake, gender, age or smoking. Further 
prospective studies and intervention studies are especially needed.  
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8 Aims of the study 
The general aim of this study was to examine the associations between diet and depression.  
 
The specific aims for each sub-study were: 
 
I To examine whether dietary folate and vitamin B12 are associated with the risk of 
depression in a prospective setting in middle-aged men (work I)  
 
II To study if serum concentrations of total long-chain n-3 PUFAs (sum of 
EPA+DPA+DHA), individual PUFAs, or the ratio of n-6 to n-3 PUFAs are 
associated with the risk of depression in a prospective setting in middle-aged 
men (work II).  
III To study if coffee or tea consumption or intake of caffeine are associated with the 
risk of depression in a prospective setting in middle-aged men (work III). 
 
IV To examine if dietary patterns are associated with a prevalence of depressive 
symptoms or the risk of clinical depression in middle-aged men. Both cross-
sectional and prospective settings where used to clarify the associations (work 
IV).  
 
V To investigate how lifestyle intervention affects the depressive symptoms 
assessed by BDI score in middle-aged men and women, and to ascertain the 
determinants of this effect (work V). 
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9 Subjects and methods 
The data used in this thesis were from two separate studies, the Kuopio Ischaemic Heart 
Disease Risk Factor (KIHD) Study and the Finnish Diabetes Prevention Study (DPS) (Table 
11).  
 
9.1 THE KUOPIO ISCHAEMIC HEART DISEASE RISK FACTOR (KIHD) 
STUDY (I-IV) 
9.1.1 Study population and participants 
The KIHD study is an ongoing population-based cohort study designed to investigate the 
risk factors for CVD and other chronic diseases in middle-aged men in Eastern Finland 
(318). The study population consists of a stratified balanced one third random sample of 
men aged 42, 48, 54 or 60 years living in the city of Kuopio or one of the six neighboring 
rural communities. Baseline characteristics of the KIHD study population are presented in 
Table 12. Baseline examinations occurred between March 1984 and December 1989. The 
study population is based on two cohorts: the first cohort consisted of men aged 54 years 
enrolled in 1984 to 1986, while the second cohort included men aged 42, 48, 54 and 60 years 
enrolled in 1986 to 1989. Of 3,235 eligible men, a total of 2,682 (83%) participated in the 
study at baseline, 1,166 in the first and 1,516 in the second cohort. The subjects gave written 
informed consent.  
Those men in the second KIHD cohort who had been studied between January 1987 and 
December 1989 and who had undergone ultrasound examination of the right and left 
carotid arteries at baseline, a total of 1,229 men eligible, were asked to participate in the 
four-year re-examination. Out of them, 52 could not participate because of death, severe 
illness or relocation, and 139 could not be contacted or refused to participate. Thus, 1,038 
men (88% of those eligible) were examined between March 1991 and December 1993. Study 
participants were 46 to 65 years old at the four-year re-examinations.  
Altogether 1,007 men from the four-year re-examinations were invited to participate in 
the 11-year examinations of the KIHD study. In addition, 1,714 women were invited to 
participate. Altogether 854 men and 921 women participated in the 11-year re-examinations 
between March 1998 and February 2000. The KIHD study protocol was approved by the 
Research Ethics Committee of the University of Kuopio. 
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9.1.2 Assessment of diet  
Food records 
The dietary intake of foods and beverages was quantitatively assessed by a four-day food 
recording at the KIHD study baseline. The food records were instructed and delivered at 
study visits, and participants filled them in by household measures. Four days were 
supposed to be consecutive, three work days and one weekend day. Food records were 
returned and interview-checked at the next study visit. In the case of atypical day, food 
records were approved if they were otherwise properly filled; in the case of clear scarcity, 
the food records were rejected.  
Nutrient intakes were calculated using the Finnish Nutrica® software, which is mainly 
compiled using Finnish values for the nutrient composition of foods. The calculations also 
take into account the loss of vitamins during food preparation. The software has been 
developed at the Research Center of the Social Insurance Institution of Finland. The 
nutrient compositions of foods in the Nutrica® software version 2.5 were mainly obtained 
from analyses carried out in the 1990s. Nutrica® software contained the latest data on the 
vitamin contents of fruits and vegetables. It includes a comprehensive database comprising 
over 1,300 food items and dishes and 30 nutrients. 
Intake of dietary folate was obtained from the four-day food records (work I). Folate 
intake was adjusted for total energy intake using the regression residual method (136). 
Energy-adjustment is based on the assumption that a larger, more physically active person 
requires greater energy intake, which is also associated with a greater absolute intake of all 
nutrients. Energy-adjustment takes into account the differences in energy requirements 
among individuals. The residuals were standardized by the mean nutrient intake of a 
participant consuming 10 MJ/d, the approximate average total energy intake in the KIHD 
study population.  
Information on coffee and tea consumption was obtained from the four-day food records 
(work III). In addition, we calculated the caffeine intake of the participants. As mentioned 
previously, caffeine content varies greatly depending on the composition of the blend, 
brewing method etc. (239) and for these calculations, we assumed that 100 mL of coffee and 
tea contain 100 mg and 40 mg of caffeine, respectively. The brewing method (boiling vs. 
filtering) was not taken into account, as the information on the usual method of brewing 
coffee at home was available only for a sub-sample of 1,002 men in the KIHD cohort. In the 
1980s, it was very uncommon for middle-aged men to consume any other caffeine-
containing drinks or foods, thus they were not added on total caffeine amount. In addition, 
in the KIHD cohort, there was no information on the use of decaffeinated coffee, since it 
was almost non-existent during the baseline analyses in the early 1980s. The food record 
data from the 11-year examinations was used in assessing the consistency of dietary intakes 
and food consumption during the follow-up period. The information on dietary covariants 
used in multi-adjusted models (works I-III); total energy intake, daily energy-adjusted 
intakes of vitamin C, folate, fiber, EPA and DHA, PUFAs, MUFAs, SFAs, total fat, and use 
of dairy products, were also obtained from four-day food records.  
 
Food frequency questionnaire 
At four-year examinations, the consumption of food items was assessed with an instructed 
unvalidated FFQ, developed especially for this cohort. Responders were asked about their 
frequency of consumption of 38 food and beverage items during the previous 12 months. 
There were six possible frequency categories: never or more seldom than once a month,  
once or twice a month, once a week, a couple of times a week, almost every day, once a day 
or more often. In addition, some items, such as coffee, tea and egg consumption were 
assessed quantitatively. Altogether 11 participants had missing information on food 
consumption. All the completed FFQs (n=1,003) were checked by a nutritionist and unclear 
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or missing responses were clarified. The information based on the FFQs was used to 
determine the dietary patterns in the KIHD study population (work IV). 
9.1.3 Identification of dietary patterns  
Dietary patterns were identified using a posteriori method, factor analysis. Principal 
components analysis with promax rotation was used, and 25 food and drink frequency 
groups with 38 food and beverage items (presented in work IV) were entered into the 
factor analysis. Eigenvalues greater than 1.5 were retained. The scree plot of eigenvalues 
indicated that there were three main dietary patterns. The three patterns were chosen and 
named based on the rationality in the co-operation with statistician. Factors were retained 
as variables in the data set, labeled on the basis of the behavioral concept and named as: 
“prudent”, “Western” and “mixed” dietary pattern. The higher the pattern score for the 
subjects was, the more the diet reflected the particular dietary pattern. For each pattern, a 
label was proposed based on food groups displaying factor loading >0.20. These three 
dietary patterns accounted for 11.5%, 9.1% and 6.9%, respectively, of the variance in food 
consumption and explained altogether 27.5% of the variance distribution. The patterns are 
described in more detail in the Results section of work IV. 
9.1.4 Ascertainment of follow-up events  
In the prospective works, we used depression diagnosis set by a physician as the outcome 
(works I-IV). Data included participants who received a hospital discharge diagnosis of 
depressive disorder during the follow-up period. The information was obtained by 
computer linkage to the national hospital discharge register. Diagnoses were made 
according to the ICD criteria: ICD-8 for the years 1985-1986, ICD-9 for the years 1987-1995 
and ICD-10 for the years 1996-2011. The category of depressive disorders included 
diagnoses of major depression (ICD-9: 2961-, ICD-10: F32.1-3, F33.1-3), a depressive, 
otherwise unspecified disorder (ICD-9: 2968A, ICD-10: F32.9, F33.9), chronic depression 
(ICD-8: 300.41, ICD-9: 3004A, ICD-10: F34.1) and adjustment disorder with depressive 
symptoms (ICD-9: 3090A). After an average 20.4 years of follow-up at the end of 2011, 
altogether 82 men had received a hospital discharge diagnosis of depressive disorder in the 
KIHD cohort.  
9.1.5 Assessment of depressive symptoms  
Depressive symptoms were assessed by the 18-item HPL depression scale at the baseline 
and at the four-year examinations (49). HPL depression score was used in assessing the 
depressive symptoms in work IV. The scale consists of items dealing with mood 
disturbance, negative self-concept, loss of energy, problems with eating and sleeping, 
trouble with concentration, and psychomotor retardation or agitation (Appendix 2). The 
HPL depression score is generated by defining one point for each true or false answer that 
is indicative of depression. For some items, the response “often” or “never”, whichever is 
appropriate, was assigned one point. The range of the HPL scale is 0-18 points. Appetite 
was attained from the HPL depression score statement “I have a good appetite”. The cut-off 
score of five or more has been used to define depression (49,119,319). The HPL depression 
scale was developed especially for screening general population samples (49) and it also 
conceptually resembles other brief symptom checklists such as CES-D (319,320). The HPL 
depression scale is highly correlated with the 21-item BDI (42,49). The Cronbach’s alpha for 
the HPL depression scale was 0.60 at the baseline after exclusion of the participants with a 
previous psychiatric disorder, and 0.71 at the four-year examination. 
9.1.6 Exclusion criteria 
In the prospective works I-III, those whose HPL depression scores were five or more at 
baseline were considered to have elevated depressive symptoms. To prevent reverse 
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causation, these subjects were excluded, thus eliminating a group of men at higher risk of 
severe depression.  
In the prospective work concerning the association between the dietary folate and 
vitamin B12 intake and the risk of receiving a hospital discharge diagnosis of depression 
(work I), the information of dietary intakes was missing in 82 participants. After exclusion 
of men having depressive symptoms at baseline (n=287), a total of 2,313 participants were 
included.  
In the prospective work focusing on the association between serum concentrations of n-3 
fatty acids and depression (work II), after exclusions of men with current depressive 
symptoms and previously diagnosed psychiatric disorder (n=409) and missing data on 
serum fatty acids (n=196), 2,077 participants were left to be analyzed.  
In the prospective work of the association between coffee, tea and caffeine consumption 
and depression (work III), complete data were available for 2,232 men. Exclusions included 
previous psychiatric disorders (n=153) and current depressive symptoms (n=271). In 
addition, 26 participants were excluded due to missing data on coffee, tea or caffeine 
consumption.  
In the cross-sectional and prospective work concerning dietary patterns and elevated 
depressive symptoms or depression (work IV), data from the KIHD study four-year re-
examination was utilized. Altogether 1,038 men participated in the four-year examination, 
but 35 participants had missing data on food consumption frequency (n=11) or depressive 
symptoms (n=32). Thus, 1,003 men were included in the analyses.  
9.1.7 Biochemical measurements  
Serum esterified and non-esterified fatty acids (work II) were determined in one gas 
chromatographic run without pre-separation (321). Fatty acids (s-EPA, s-DHA, s-DPA, s-
ALA, s-LA, s-AA) were chromatographed in an NB-351 capillary column (HNU-Nordion, 
Helsinki, Finland) by a Hewlett-Packard 5890 Series II gas chromatograph (Hewlett-
Packard, Avondale, Pennsylvania, U.S.) with a flame ionization detector. The coefficient of 
variation for repeated measurements of major esterified fatty acids was about 5%. Because 
the relative degree of fatty acid saturation varies among the various types of esterified fatty 
acids (i.e., cholesterol esters, phospholipids, and triglycerides), the concentration of 
esterified fatty acids was adjusted for serum low-density lipoprotein cholesterol, high-
density lipoprotein cholesterol, and triglyceride concentrations. The coefficient of variation 
for major non-esterified fatty acids was about 15%. For non-esterified fatty acids no 
adjustment was necessary. Based on serum fatty acid concentrations, we calculated the 
concentrations of total long-chain n-3 PUFAs (EPA+DPA+DHA), total n-6 PUFAs (LA+AA) 
and ratio of n-6 to n-3 PUFAs.  
Serum folate was used as a potential confounder in work IV. Serum concentrations of 
folate were measured by radioimmunoassay (Quantaphase II, Bio-Rad, Hercules, 
California, U.S.). These measurements were carried out in 1998 from serum samples 
collected during 1991–1993 and kept frozen at −80°C.  
9.1.8 Assessment of other variables 
At the baseline and the four-year examinations, the KIHD participants completed 
questionnaires on their background, marital status (married or living as a couple, not 
married, separated or divorced, widowed), history of morbidity (hypertension, diabetes) 
and education (years of education, educational level) (321,322). A trained nurse checked 
and completed the questionnaires during an interview. Smoking habits were also reported, 
including ever-smoking, current smoking, cigarettes, cigars and pipefuls per day and 
duration of regular smoking.  The number of years smoked was defined as the sum of 
smoking years, whether the smoking had occurred continuously or during several periods. 
The lifetime exposure to smoking (pack years) was estimated as a product of years smoked 
and the number of tobacco products smoked daily at the time of the examination, or for ex-
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smokers, at the time when they had last smoked. The variable of adulthood SES was 
compiled from current income, current and previous occupations, the highest level of 
education, the perception of financial security, and housing tenure. In addition, an index of 
material living conditions was created by summing the number of material possessions 
(e.g., dishwasher, car, summer cottage) from a list of 12 items. The variable “adulthood 
SES” was formed from these indicators (323).  
Alcohol consumption (grams/week) was assessed with a structured quantity-frequency 
method using the Nordic Alcohol Consumption Inventory for drinking behavior over the 
previous 12 months (324). Physical activity was assessed using the 12-month Leisure-time 
Physical Activity Questionnaire (325). The questionnaire included the most common 
leisure-time physical activities of middle-aged Finnish men, selected based on a previous 
population study in Finland, and is described in more detail elsewhere (326). The 
participants were asked to record the frequency, average duration and intensity of each 
activity. The energy expenditure from physical activity was expressed as kcal per day. 
Description of the determination of maximal oxygen uptake has been published previously 
(321). The criteria for the history of CVD included a diagnosis of at least one coronary 
condition and have been presented earlier in more detail (327). The weight and height of 
the participants was measured by a study nurse, and the BMI was calculated as the ratio of 
weight in kilograms to the square of height in meters.  
9.1.9 Statistical methods  
In works I-IV, the heterogeneity of means of the baseline variables was tested by using the 
analysis of variance (ANOVA), Student’s t-test, Mann-Whitney U-test, chi-squared test and 
Fisher's Exact test. The normal distributions were tested with the Kolmogorov-Smirnov 
(Lilliefors) test. The non-parametric Mann-Whitney U-test was utilized when the 
distribution of the values was skewed. Correlations were examined using Pearson's 
correlation coefficient or Spearman’s correlation coefficient. Potential confounders in 
multivariate models were selected based on the literature and the characteristics of the 
study population. For entry, backward stepwise method was used, and those confounders 
with the strongest association with depression were chosen. Potential confounders were 
discarded from the models if they did not change the associations (HR change <5%). 
In work I, the participants were classified into two categories according to the median 
energy-adjusted intake of folate:  ≤248 μg/day and >248 μg/day. We also divided the study 
population into two groups according to the median daily intake of vitamin B12: ≤7.09 
μg/day and >7.09 μg/day. The HR for depression was examined using the Cox proportional 
hazard’s model adjusted for age and examination year (Model 1) and further, for adulthood 
SES, baseline HPL depression score, energy-adjusted intake of vitamin C and fiber, and 
total fat intake (Model 2), and further, for total energy intake, marital status, education, 
current smoking habits and alcohol consumption. 
In work II, to study the differences between serum fatty acid groups, we divided the 
study population into three groups according to the tertile values: n-3 PUFA 
(EPA+DPA+DHA: <3.85%, 3.85% to 4.92% and >4.92% of all serum fatty acids), EPA 
(<1.21%, 1.21% to 1.76% and >1.76%), DPA (<0.50%, 0.50% to 0.58% and >0.58%), DHA 
(<2.09%, 2.09% to 2.63% and >2.63%), LA (<24.6%, 24.6% to 28.3% and >28.3%), ALA 
(<0.62%, 0.62% to 0.80% and >0.80%), AA (<4.3%, 4.3% to 5.2% and >5.2%), ratio of n-6 to n-3 
PUFAs (<5.3:1, 5.3:1 to 6.8:1, >6.8:1) and total n-6 PUFA (<29.6%, 29.6% to 33.6% and 
>33.6%). Because of the modest number of cases, in the stratified analyses dichotomous 
variables were used instead of tertiles; median values were used as the cut-off point: n-3 
PUFAs (<4.36% and ≥4.36%) and n-6 PUFAs (<31.7% and ≥31.7%). Tests of linear trend were 
conducted by assessing the median values for each category of exposure variable and 
treating those as a single continuous variable. For the tests of non-linear trend, the linear 
trend variable was squared after centering it at median serum fatty acid value. The HR for 
depression was examined using the Cox proportional hazard’s model adjusted for age and 
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examination year (Model 1) and further, for adulthood SES, maximal oxygen uptake, 
smoking (lifetime exposure), alcohol consumption and BMI (Model 2), and further, for total 
energy intake, appetite, energy-adjusted intake of folate, education, and baseline HPL 
depression score. 
In work III, the participants were divided into four groups according to coffee drinking: 
non-drinkers, light drinkers (<375 mL/day), moderate drinkers (375 to 813 mL/day) and 
heavy drinkers (>813 mL/day). These coffee drinking categories have been used earlier in 
the KIHD cohort (328). Because of the low amount of tea consumed by the tea drinkers 
(mean intake 105 mL/day), subjects were categorized into tea drinkers and non-drinkers. 
The cohort was also divided into quartiles based on caffeine intake: <425 mg/day, 425 to 594 
mg/day, 595 to 781 mg/day and >781 mg/day. The HR for depression was examined using 
the Cox proportional hazard’s model adjusted for age and examination year (Model 1) and 
further, for adulthood SES, smoking (lifetime exposure), alcohol consumption, maximal 
oxygen uptake, BMI and daily intakes of folate and PUFAs (Model 2). Model 3 included 
Model 2 covariates plus baseline HPL depression score. In addition, total energy intake, the 
energy-adjusted intakes of EPA and DHA, use of dairy products, marital status, medical co-
morbidity (hypertension, diabetes and CVD) and leisure-time physical activity, as well as 
substituting the intake of PUFAs with MUFAs and SFAs, were tested as potential 
confounders. 
In work IV, the associations between dietary patterns and elevated depressive 
symptoms were examined using logistic regression models. Depressive symptoms (HPL>5) 
were treated as a binary dependent variable, and each dietary pattern score as a continuous 
variable. In cross-sectional analyses, the ORs were calculated in multivariate models, 
adjusted for age and examination year (Model 1), and further, for alcohol consumption, 
current smoking, marital status, education, leisure-time physical activity and history of 
CVD and mental illnesses (Model 2). The HR for getting a hospital discharge diagnosis of 
depression during the follow-up was examined using the Cox proportional hazard’s model 
adjusted for age and examination year (Model 1), and further, for HPL depression score in 
four-year examination, history of mental illnesses and education (Model 2). Leisure-time 
physical activity, marital status, BMI, history of CVD, alcohol consumption and current 
smoking were tested for entry, but did not change the associations (HR change <5%) and 
were thus excluded from the models.  
The 95% confidence intervals (CI) were estimated based on the assumption of asymptotic 
normality of estimates. P-value <0.05 was considered statistically significant. All statistical 
analyses were conducted using the Statistical Package for the Social Sciences software 
(SPSS) 14.0 for Windows or a newer version (SPSS Inc., Chicago, Illinois, U.S.).  
9.2 THE FINNISH DIABETES PREVENTION STUDY (DPS) (V) 
9.2.1 Study population  
The DPS is a randomized, controlled, multicenter lifestyle intervention study conducted in 
Finland. The DPS included five study centers in Helsinki, Kuopio, Turku, Tampere, and 
Oulu. The main aim of the DPS was to assess the efficacy of lifestyle modification on 
preventing or delaying the onset of T2D in people with IGT. Study participants were 
recruited mainly by screening of high-risk individuals, such as first-degree relatives of T2D 
patients, who voluntarily responded to local advertisements, or were identified in earlier 
epidemiological surveys. The main inclusion criteria were BMI over 25 kg/m2, age 40–64 
years, and IGT on the basis of the mean values of two oral glucose tolerance tests. 
Randomization of the study participants started in November 1993, the recruitment period 
lasted until June 1998 and the intervention period lasted until the end of 2001. The data 
used in this work was based on the information of the study baseline and three-year 
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examinations. The study design and the methodology are described in more detail 
elsewhere (329-331). 
The characteristics for the DPS population are presented in Table 13. Altogether 522 
overweight individuals, 172 men and 350 women with IGT participated, and were 
randomly allocated to an intensive, individualized diet and exercise intervention or a 
control group. Randomization was done by the study physician, with the use of a 
randomization list, with stratification according to center, gender, and the mean plasma 
glucose concentration two hours after oral glucose challenge (331). Study design was 
single-blinded, as the staff members involved in the intervention had to be aware of the 
group assignment. Criteria for exclusion included the presence of chronic disease rendering 
survival for six years unlikely, and other characteristics (psychological or physical 
disabilities) deemed likely to interfere with participation in the study. The participants gave 
written informed consent. The study protocol was approved by the Ethics Committee of the 
National Public Health Institute in Helsinki, Finland. 
9.2.2 Advice for the lifestyle intervention group 
The main goals of the lifestyle intervention were based upon available evidence on risk 
factors of diabetes. The participants in the intervention group (n=265) were given detailed 
advice to achieve the goals: 1) weight reduction of ≥5%, 2) fat intake <30% of the total 
energy intake, 3) SFAs <10% of total energy intake, 4) dietary fiber intake to ≥15 g per 1000 
kcal, and  5) moderate exercise for ≥30 minutes per day.  
The intensive intervention consisted of seven face-to-face counseling sessions with the 
study nutritionist during the first year of the study, and one session every three months 
thereafter for three years. The first-year sessions were tailored based on the food records, 
focusing on specific individual problems. However, each session had a preplanned topic, 
for example regular meal patterns and substituting energy-dense foods containing SFAs, 
sugar, or alcohol with lower-energy items. Consumption of whole-grains instead of refined 
grains, abundant daily consumption of vegetables and fruits, consumption of low-fat milk 
and meat products, soft margarines and vegetable oils rich in unsaturated fatty acids were 
also recommended. The plate model was used to estimate portion sizes. Additionally, there 
were voluntary group sessions, expert lectures, low-fat cooking lessons, visits to local 
supermarkets, and possibility to have between-visit phone calls and discussions by letters. 
The goal was to equip the participants with the necessary knowledge and skills and to 
achieve gradual, permanent behavioral changes (330). Very-low-calorie diet was considered 
to be used for two to five weeks, if preferred by the subject, to boost weight loss. 
The exercise intervention was individualized and aimed at increasing all physical 
activity. It was based on daily physical activities, endurance exercise (such as walking, 
jogging, swimming, aerobic ball games, or skiing) and muscle strengthening. Progressive, 
individually tailored, supervised circuit-type resistance training sessions to improve the 
functional capacity and strength of the large muscle groups of the upper and lower body 
were also offered. Training sessions began four to six months after randomization. The 
exercise intervention has been described in more detail elsewhere (330,331).  
9.2.3 Advice for the control group  
At baseline, the participants in the control group (n=257) were given general verbal and 
written information, a two-page leaflet, on diet and exercise. This was done either 
individually or in one group session. The principles of the message for the control group 
were the same as for the intervention group participants: to reduce weight, increase 
physical activity, and to make qualitative changes in diet. The advice the control group 
received concerning healthy lifestyle could be regarded “a mini-intervention”. The control 
group visited the research centers once a year for three years and all the measurements 
were similar in both groups.  
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9.2.4 Assessment of depressive symptoms 
Depressive symptoms were assessed with the Finnish version of the self-administered 21-
item BDI, which is one of the most commonly used instruments for measuring the severity 
of depression (42). The BDI is a well-known and well-validated self-report measurement 
method of depressive symptoms (332). Also the Finnish version of the 21-BDI has been 
validated (333). The version used in the DPS, BDI Ia (Appendix 1), is a modestly modified 
version of the original version, as for example the alternative “a” and “b” statements have 
been removed to ease the use, and symptoms are asked for the preceding two weeks (334). 
However, the symptom evaluation scale is similar to the previous version. In clinical work, 
the BDI has been established as a common tool for assessing depressive symptoms and 
progress in the follow-up. Moreover, the mean BDI scores correlate well with the 
prevalence of depression determined by clinical interviews (335).  
Patients choose from a group of sentences the one which best describes how they have 
been feeling during the past two weeks, resulting in total scores from 0 to 63. The cut-off 
point for elevated depressive symptoms was set at 11 points, 0 to 10 indicating normal 
mood and 11 or more indicating elevated depressive symptoms. The same cut-off point was 
used in an earlier intervention study (303). Participants reported the use of antidepressant 
medication at baseline and subsequently at each annual study visit.  There were two study 
centers out of five that carried out the BDI, and therefore the BDI scores were available for 
140 individuals (69 in the intervention group and 71 in the control group; 59 men and 81 
women, respectively). Table 13 presents the baseline characteristics for those participants 
who had BDI scores available, as well as for the rest of the study population. There were no 
statistically significant differences in any of the variables between intervention and control 
groups. 
9.2.5 Assessment of diet and other variables  
Diet was assessed using three-day food records four times a year. Intakes of nutrients were 
calculated using a dietary analysis program, the Finnish Food Composition Database 
(Fineli), developed by the National Public Health Institute (336). The program allows 
modification of database recipes, e.g., the use of skimmed instead of whole milk can be 
coded (330). Participants completed a medical-history questionnaire and underwent a 
physical examination. Participants underwent a 75-g oral glucose tolerance test at baseline 
and at each annual visit, as described previously (329,331). Physical activity was assessed at 
baseline and at each annual visit with the validated the 12-month Leisure-time Physical 
Activity Questionnaire (325). Information on antidepressant prescriptions was obtained 
from a linkage to the medication reimbursement register of the Finnish Social Insurance 
Institution. The weight and height of the participants was measured by a study nurse, and 
the BMI was calculated as the ratio of weight in kilograms to the square of height in meters. 
Anthropometric measurements of height, weight, waist circumference and blood pressure 
measurements have been described in more detail previously (329). Weight was measured 
at every visit, and a weight chart was drawn. 
9.2.6 Statistical methods  
The data were expressed as means ± standard deviations (SD). The α–level was set at ≤0.05. 
The differences in baseline variables between intervention and control group were tested 
by using the ANOVA, Student’s t-test, Mann-Whitney U-test and chi-squared test. Normal 
distributions were tested with the Kolmogorov-Smirnov (Lilliefors) test. The non-
parametric Mann-Whitney U-test was utilized when the distribution of the values was 
skewed. Non-parametric two-related samples test (Wilcoxon) was used to evaluate the 
changes in BDI scores within the intervention and control groups during the intervention. 
Because the BDI scores had skewed distributions, unadjusted differences in mean BDI 
scores between groups were evaluated using Mann-Whitney U-tests both at baseline and at 
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three years. A forward stepwise linear multivariate regression analysis was used to find the 
strongest determinants of the change in BDI scores (P in 0.10, P out 0.20). All statistical tests 
were two-tailed. Data were analyzed using SPSS for Windows version 14.0 statistical 
software (SPSS Inc., Chicago, Illinois, U.S.). 
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10 Results 
10.1 DIETARY FOLATE AND THE RISK OF DEPRESSION (I) 
A total of 47 (2.0%) individuals were hospitalized due to depression during the average 
13.6 years of follow-up and 58 (2.5 %) during the average 18.8 years of follow-up. The men 
who were hospitalized because of depression during the 13.6 years of follow-up period had 
higher intake of energy and higher HPL depression scores at baseline as compared to those 
who remained non-depressed. Participants having developed diagnosed depression during 
the 18.8 years of follow-up had, on the average, higher total energy intake, higher baseline 
HPL depression scores and they were slightly younger at baseline compared to other 
participants (data not shown). 
At the baseline examinations, the mean daily intake of folate was 256 μg/day (SD 76). 
Altogether 24.6% of the participants reached the Finnish recommended daily folate intake 
of 300 μg/day (102). The correlation coefficient between folate intake at the baseline and at 
the 11-year follow-up examinations was 0.30 (P<0.001).  
In multivariate analysis adjusted for adulthood SES, baseline HPL depression score, 
energy-adjusted daily intake of fiber and vitamin C, and total fat intake, when compared 
the lower folate intake median to the higher median, the risk of having a hospital discharge 
diagnosis of depression was two-and-a-half-fold higher (HR: 2.53; 95% CI: 1.17 to 5.48; 
P=0.019) in analyses of 13.6 years of follow-up and two-fold higher (HR: 2.07; 95% CI: 1.07 
to 4.00; P=0.032) in analyses after 18.8 years of follow-up. Further adjustments for marital 
status, education, current smoking habits and alcohol consumption did not alter the 
associations either during the average 13.6 years of follow-up (HR: 2.51; 95% CI: 1.16 to 5.45; 
P=0.020) or during the average 18.8 years of follow-up (HR: 2.11; 95% CI: 1.08 to 4.11; 
P=0.028). Further adjustment for the total energy intake had little effect on the association 
between folate intake and the incidence of depression during 13.6 years of follow-up (HR: 
3.01; 95% CI: 1.56 to 5.82; P=0.001) and after 18.8 years of follow-up (HR: 2.13; 95% CI: 1.10 
to 4.12; P=0.025).   
Table 14 presents the HRs of depression according to the energy-adjusted mean intake of 
folate at different time-points: from 10.3 to 20.7 years of follow-up (from year 2002 to 2011). 
Generally, participants in the lower (below median) folate intake group had higher risk of 
depression compared to men in the higher (above median) folate intake group. However, 
the risk of depression did not reach statistical significance in 10 to 12 follow-up years. In 
addition, the risk flagged with prolonged follow-up, after 19 years of follow-up. 
The mean daily intake of vitamin B12 was 9.5 μg/day (SD 9.3) for the whole population at 
the baseline examinations. Intake of vitamin B12 was not associated with the risk of 
depression in either 13.6 years of follow-up: upper median of intake of B12 vitamin vs. lower 
median (HR: 0.40, 95% CI: 0.43 to 1.39, P=0.401) or in 20.1 years of follow-up (HR: 0.78; 95% 
CI: 0.47 to 1.31; P=0.347) with similar adjustments as in the analyses of folate (Table 15). 
Furthermore, dividing the mean vitamin B12 intake into tertiles or quartiles still revealed no 
association between cobalamin intake and risk of depression (data not shown). 
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Table 14.  The hazard ratios of getting a hospital discharge diagnosis of depression according to 
the energy-adjusted mean dietary intake of folate with the number of follow-up years. 
  
Mean follow-up 
time (years) 
Cases in lower 
half1, n (%) 
Cases in upper 
half, n (%) 
Hazard ratio2  
(95% CI)  
P value  
 
10.3 24 (2.1) 10 (0.9) 2.08 (0.86, 5.07) 0.106 
11.2 29 (2.5) 13 (1.1) 2.04 (0.93, 4.49) 0.076 
12.0 29 (2.5) 13 (1.1) 2.04 (0.93, 4.49) 0.076 
12.8 33 (2.8) 13 (1.1) 2.28 (1.06, 4.89) 0.036 
13.6  35 (3.1) 13 (1.1) 2.53 (1.17,  5.48) 0.019 
14.4 36 (3.1) 15 (1.3) 2.30 (1.12, 4.73) 0.024 
15.2 37 (3.2) 15 (1.3) 2.42 (1.18, 4.96) 0.016 
16.0 37 (3.2) 16 (1.4) 2.25 (1.11, 4.55) 0.024 
16.7 38 (3.3) 17 (1.5) 2.20 (1.11, 4.37) 0.025 
17.4 38 (3.3) 19 (1.6) 2.01 (1.03, 3.91) 0.040 
18.1 39 (3.4) 19 (1.6) 2.07 (1.07, 4.01) 0.032 
18.8 39 (3.4) 19 (1.6) 2.07 (1.07, 4.01) 0.032 
19.5 40 (3.4) 20 (1.7) 1.91 (1.00, 3.66) 0.050 
20.1  40 (3.5) 20 (1.7) 1.91 (1.00, 3.66) 0.050 
20.7 41 (3.5) 22 (1.9) 1.74 (0.93, 3.25) 0.084 
Abbreviations: CI, confidence interval; HPL, Human Population Laboratory  
1According to the median 
2Comparisons: lower median (≤248 μg/day) vs. upper median (>248 μg/day) of energy-adjusted folate 
intake. Models adjusted for age and examination year, current socio-economic status, baseline HPL 
depression score, energy-adjusted daily intake of fibre and vitamin C, and total fat intake 
 
 
Table 15. The hazard ratios of getting a hospital discharge diagnosis of depression during the 
average 13.6 and 20.1 years of follow-up according to the energy-adjusted mean dietary intake 
of vitamin B12. 
  
Follow-up 
time 
(years) 
Cases in 
lower half1  
n (%) 
Cases in 
upper half  
n (%) 
Hazard ratio 
Model 12 
(Model 23) 
95% CI  
Model 1  
(Model 2) 
P-value 
13.6 22 (2.0) 25 (2.2) 0.85 
(0.40) 
0.48, 1.51 
(0.43, 1.39) 
0.590 
(0.401) 
20.1 28 (2.4) 32 (2.8) 0.84 0.51, 1.40 0.505 
   (0.78) (0.47, 1.31) (0.347) 
Abbreviations: CI, confidence interval, HPL, Human Population Laboratory 
1According to the median 
2Adjusted for age and examination year 
3Adjusted for age and examination year, current socio-economic status, baseline HPL depression score, 
energy-adjusted daily intake of fibre and vitamin C, and total fat intake 
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10.2 SERUM POLYUNSATURATED FATTY ACIDS AND THE RISK OF 
DEPRESSION (II) 
There were 46 participants who were given a hospital discharge diagnosis of depression 
during the average 18.3 years of follow-up. The mean baseline serum concentration of n-3 
PUFAs was 4.7% (SD 1.6) for the whole population and 4.5% (SD 1.4) for those with 
diagnosis of depression. The men who were hospitalized due to depression during the 
follow-up had higher intake of energy and higher baseline HPL depression scores. The 
correlation coefficient between the serum n-3 PUFAs (EPA+DPA+DHA) at baseline and at 
11-year follow-up was 0.42 (P<0.001) and for the serum n-6 PUFAs 0.47 (P<0.001).  
Table 16 presents the HRs for the association between serum fatty acids and the risk of 
getting a hospital discharge diagnosis of depression during the follow-up. There were no 
statistically significant associations between the serum concentrations of total n-3 PUFAs, 
total n-6 PUFAs or any individual fatty acids (EPA, DHA, LA, ALA or AA) and the risk of 
depression. Further adjustments for total energy intake, energy-adjusted intake of folate, 
appetite, education, and baseline HPL depression score did not change the association 
markedly (HR change <5%). In addition, the ratio of n-6 to n-3 PUFAs was not associated 
with the risk of depression. 
Evaluations of the interaction between total n-3 and total n-6 PUFAs by using stratified 
analyses (both divided at median) were also conducted. However, no evidence for effect 
modification by total n-6 PUFAs was found (P for interaction 0.72).   
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Table 16. The hazard ratios of getting a hospital discharge diagnosis of depression during the 
average follow-up of 18.3 years according to tertiles of serum fatty acid concentrations. 
 
 Model 11   Model 22   
 HR 95 % CI P for trend  HR 95 % CI 
 
P for trend 
N-3 (EPA+DHA+DPA)   0.29   0.33 
1 (lowest) 1   1   
2 0.41 0.19, 0.91  0.41 0.19, 0.91  
3 (highest) 0.71 0.38, 1.38  0.71 0.38, 1.43  
N-6    0.76   0.55 
1 1   1   
2 0.91 0.43, 1.91  0.96 0.45, 2.04  
3 1.10 0.55, 2.23  1.25 0.59, 2.65  
EPA   0.19   0.17 
1 1   1   
2 0.57 0.28, 1.16  0.55 0.26, 1.12  
3 0.64 0.33, 1.32  0.62 0.31, 1.25  
DHA   0.79   0.98 
1 1   1   
2 0.93 0.46, 1.87  0.96 0.47, 1.96  
3 0.91 0.45, 1.84  0.99 0.48, 2.04  
Linoleic acid   0.47   0.28 
1 1   1   
2 0.62 0.28, 1.37  0.67 0.29, 1.51  
3 1.23 0.63, 2.39  1.43 0.70, 2.91  
Alpha-linolenic acid   0.35   0.22 
1 1   1   
2 1.07 0.50, 2.28  1.16 0.54, 2.51  
3 1.41 0.67, 2.94  1.60 0.75, 3.43  
Arachidonic acid   0.21   0.20 
1 1   1   
2 0.77 0.39, 1.53  0.77 0.39, 1.53  
3 0.64 0.31, 1.30  0.62 0.30, 1.29  
Ratio of n-6 to n-3    0.99   0.98 
1 1   1   
2 0.79 0.38, 1.65  0.77 0.37, 1.62  
3 0.99 0.50, 1.96  0.97 0.49, 2.00  
Abbreviations: BMI, body mass index; CI, confidence interval; HR hazard ratio; EPA, eicosapentaenoic 
acid; DHA, docosahexaenoic acid; DPA, docosapentaenoic acid; SES, socio-economic status;  
1HR derived from Cox proportional hazard’s models. Model 1: adjusted for age and examination years. 
2HR derived from Cox proportional hazard’s models. Model 2: adjusted for age, examination year, BMI, 
adulthood SES, cigarette smoking, alcohol consumption and maximal oxygen uptake. 
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10.3 COFFEE, TEA AND CAFFEINE CONSUMPTION AND THE RISK OF 
DEPRESSION (III) 
There were 49 men who were given a hospital discharge diagnosis of depression during the 
average 17.5 years of follow-up. The mean coffee consumption (SD) was 565 (293) mL/day, 
the mean tea consumption 105 (183) mL/day and mean caffeine intake 494 (221) mg/day for 
the whole cohort. 
The coffee drinkers had a statistically significantly lower intake of folate, and they were 
more likely to be smokers than the non-drinkers at baseline (work III). In addition, coffee 
drinkers had higher energy intake and higher SES compared to non-drinkers. A total of 
4.9% of the coffee non-drinkers, 1.3% of the light coffee drinkers, 2.6% of the moderate 
coffee drinkers and 1.5% of the heavy coffee drinkers received a hospital discharge 
diagnosis of depression during the follow-up. There was a statistically significant 
correlation between the reported coffee drinking at the baseline and at the 11-year follow-
up (r=0.54, P<0.001).  
Heavy coffee drinkers had a 72% (95% CI: 0.02 to 0.98) lower risk of hospitalization due 
to depression as compared to the non-drinkers (Table 17, Model 1). Further adjustments 
(Model 2 and Model 3) did not significantly attenuate the association, nor did further 
adjustment for total energy intake, energy-adjusted intakes of EPA and DHA, use of dairy 
products, marital status, medical co-morbidity (hypertension, diabetes and CVD) and 
leisure-time physical activity. Substituting the intake of PUFA with MUFA and SFA did not 
attenuate the results appreciably. 
Tea drinking or caffeine intake was not associated with the risk of depression (Table 17). 
The results remained consistent regardless of whether caffeine intake groups were 
categorized as medians (HR: 1.31; 95% CI: 0.74 to 2.31; P=0.355) or tertiles (highest tertile v. 
lowest tertile; HR: 1.14; 95% CI: 0.53 to 2.44; P=0.744). 
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Table 17. The hazard ratios of getting a hospital discharge diagnosis of depression during the 
average follow-up of 17.5 years according to mean daily consumption of coffee, tea or caffeine.1  
 
Coffee 
consumption 
category2 
None  
(n=82) 
Light 
(n=517) 
Moderate  
(n=1243) 
Heavy  
(n=390) 
P-value3 
Mean coffee 
consumption 
mL/day 
 
0 
 
250 
 
595 
 
1007 
 
Number of 
events (%) 
4 (4.9) 7 (1.3) 32 (2.6) 6 (1.5)  
Model 14 1 0.27 
(0.08, 0.93) 
0.49 
(0.17, 1.40) 
0.28  
(0.08, 0.98) 
0.047 
Model 25 1 0.28 
(0.08, 0.96) 
0.45 
(0.16, 1.29) 
0.23  
(0.06, 0.83) 
0.025 
Model 36 1 0.29  
(0.08, 0.98) 
0.48 
(0.17, 1.36) 
0.25 
(0.07, 0.91) 
0.035 
Tea 
consumption 
category 
Non-tea 
drinkers 
(n=1264) 
Tea drinkers 
 (n=968) 
  P-value 
Mean tea 
consumption 
mL/day 
0 242 (209)    
Number of 
events (%) 
25 (1.9) 24 (2.5)    
Model 14 1 1.19 
(0.69, 2.08) 
  0.549 
Model 25 1 1.43 
(0.80, 2.56) 
  0.222 
Model 36 1 1.40  
(0.78, 2.51) 
  0.252 
Quartiles of      
caffeine 
intake7 
1 2 3 4 P-value 
Mg/day <425  425-594  595-781  >781   
Number of 
events (%) 
9 (1.6) 12 (2.1) 18 (3.3) 10 (1.8)  
Model 14 1 1.22 
(0.52, 2.91) 
1.97 
(0.89, 4.42) 
0.99  
(0.40, 2.45) 
0.981 
Model 25 1 1.12  
(0.47, 2.67) 
1.83 
(0.82, 4.11) 
0.85 
(0.34, 2.16) 
0.739 
Model6 1 1.07 
(0.45, 2.56) 
1.83 
(0.82, 4.09) 
0.85  
(0.34, 2.15) 
0.732 
Abbreviations: BMI, body mass index; CI, confidence interval; HPL, Human Population Laboratory; HR, 
hazard ratio; PUFA, polyunsaturated fatty acid; SES, socio-economic status  
1All values are HR (95% CI)  
2Light <375 mL/day; moderate 375-813 mL/day; and heavy >813 mL/day.  
3 P-value for the difference between heavy-drinkers and non-drinkers 
4HR: hazard ratio derived from Cox proportional hazard’s models. Model 1: adjusted for age and 
examination years. 
5Model 2: adjusted for Model 1 and adulthood SES, smoking, alcohol consumption, BMI, daily intake of 
folate and PUFAs.  
6Model 3: adjusted for Model 2 and baseline HPL depression scale score. 
7P-value for the difference between the lowest and the highest caffeine intake group  
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10.4 DIETARY PATTERNS AND DEPRESSION (IV)  
Altogether 72 subjects (7.2% of the population) had elevated depressive symptoms at the 
four-year examination. The mean age (SD) of the study subjects was 56.2 (6.7) years (range 
46 to 65 years). The baseline characteristics of the study participants with current 
depressive symptoms and the rest of the cohort showed that depressed participants had 
lower leisure-time energy expenditure compared to non-depressed subjects. In addition, 
depressed subjects had more often a history of CVD and mental illnesses.  
The factor-loading matrix for the three dietary patterns, prudent, Western and mixed, is 
shown in Table 18. Higher factor scores indicated greater consumption of these types of 
foods and lower score indicated lower consumption. Prudent dietary pattern was rich in 
fresh vegetables, cooked vegetables, fruits, berries, whole-grain bread, poultry, fish and 
low-fat cheese. Western dietary pattern was characterized by higher consumption of 
sausages, processed meat, sweet snacks like ice-cream, candies and chocolate, sweet soft 
drinks and juices, baked potatoes and French fries, French rolls, manufactured foods, 
cheese and eggs. Mixed dietary pattern was rich in sweet coffee breads, fresh and frozen 
berries, porridge, sweet snacks, sweet soft drinks and juices and low in alcohol 
consumption.  
Those participants with higher scores of prudent dietary pattern were more likely to 
have better education and they were more likely to be married and non-smokers and have 
higher leisure-time physical activity, compared to those with lower scores (divided 
according to median scores). Those with higher scores in Western dietary pattern had 
higher alcohol consumption and they were more likely to be younger and smokers than 
those with lower scores in this factor. Participants with high loading in the mixed pattern 
had shorter education, lower alcohol consumption, lower BMI and they were younger 
compared to those with lower scores in this pattern.  
Results from the analyses are presented in Table 19. In cross-sectional analyses, after 
adjusting for potential confounders (age, examination year, BMI, alcohol consumption, 
smoking, marital status, education, leisure-time physical activity, history of mental illnesses 
and history of CVD) the prudent, healthy dietary pattern was associated with a decreased 
prevalence of depressive symptoms (OR: 0.75; 95% CI: 0.57 to 0.99; P=0.036), the Western 
dietary pattern was associated with an increased prevalence of depressive symptoms (OR: 
1.41; 95% CI: 1.08 to 1.84; P=0.011) while the mixed dietary pattern showed no association 
(OR: 1.10; 95% CI: 0.83 to 1.47; P=0.492). To explore whether the association between the 
prudent dietary pattern and depression is explained by folate status, we additionally 
adjusted for serum concentrations of folate. This did not attenuate the found inverse 
association between the prudent dietary pattern and depressive symptoms (OR: 0.75; 95% 
CI: 0.57 to 0.99; P=0.044). 
In the prospective analyses with the average follow-up time of 16.5 years and 28 cases of 
depression requiring hospital treatment, the prudent dietary pattern was inversely 
associated with the risk of depression (HR: 0.66; 95% CI: 0.47 to 0.93; P=0.018) after 
adjustment for age, year of examination, four-year HPL depression score, education and 
history of mental illnesses. The Western or mixed dietary patterns were not associated with 
depression risk in prospective analyses.  
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10.5 THE EFFECT OF LIFESTYLE INTERVENTION ON DEPRESSIVE 
SYMPTOMS (V) 
At study entry, the mean BDI scores (SD) of the participants were 6.8 (5.5). The changes in 
the BDI scores and other variables over the follow-up period of three years are presented in 
Table 20. The BDI scores were reduced during the study by 0.82 (4.49) scores (P=0.006). The 
mean (SD, 95% CI) reduction in the BDI scores was 0.90 (4.54, -1.99 to -0.19) in the 
intervention group (P=0.033) and 0.75 (4.47, -1.80 to 0.31) in the control group (P=0.076) 
There was no statistically significant difference in the changes of BDI scores between the 
study groups (P=0.965). The use of antidepressant medication was uncommon in our study 
population both at the beginning (n=1 and n=2 in the intervention and control groups, 
respectively) and at the end of the intervention (n=2 and n=2 in the intervention and control 
groups, respectively).  The mean energy intake and intake of SFAs decreased statistically 
significantly more in the intervention group compared to the control group. The weight 
and BMI of the participants also decreased more in the intervention group than in the 
control group.  
Altogether 30 participants (21.4%) had elevated depressive symptoms (BDI≥11) at 
baseline and 22 (15.7%) after three years of the study entry. The decrease in the prevalence 
of elevated depressive symptoms was 2.9% in the intervention group, 8.5% in the control 
group and 5.7% in all participants with the BDI data available. When analyzing separately 
the participants with elevated depressive symptoms at baseline, the mean reduction of 
depressive symptoms during the study was -2.80 (5.83) points (P=0.015). In the intervention 
group the reduction was -2.00 (6.16) points (P=0.248) and in the control group -3.50 (5.63) 
points (P=0.031) (P=0.307 for the difference). When excluding those who had elevated 
depressive symptoms at baseline, BDI scores decreased by 0.62 (4.06) points (P=0.071) in the 
intervention group and increased with 0.06 (3.77) points (P=0.738) in the control group 
(P=0.321 for the difference). 
In a stepwise linear multivariate regression model, the variables with the strongest 
associations with the change in BDI scores during the three-year study were baseline BDI 
scores (standardized coefficient - 0.392, P<0.001), weight change (0.194, P=0.024) and marital 
status (0.196, P=0.025). This model explained 20% of the change in BDI scores (R2=0.204, 
P<0.001, n=140), indicating that higher BDI scores at the baseline, greater weight reduction 
and being married were associated with greater decrease in BDI scores.  
Variables with the strongest associations with the change in BDI scores in those with 
elevated depressive symptoms at baseline (n=30) were baseline BDI score (-0.762, P=0.010), 
change in total energy intake (0.341, P=0.042), education (0.476, P=0.086) and weight change 
(0.190, P=0.268) (R2=0.378, P=0.002). When specifically examining those who had no 
elevated depressive symptoms at baseline (n=110), the strongest determinants of the change 
in BDI scores during the three-year follow-up were almost the same (baseline BDI score, -
0.685, P<0.001; marital status, 0.267, P=0.101; baseline BMI, 0.331, P=0.133; and weight 
change, 0.130, P=0.179; R2=0.188, P<0.001). Thus, higher baseline BDI scores, greater 
decrease in energy intake, higher education and weight reduction were associated with 
greater decrease in the BDI scores.  
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10.6 SUMMARY OF THE RESULTS  
The summary of the main results is presented in Table 21. 
 
Table 21. Summary of the results. 
 
Sub-work Design Study n No of 
cases 
The main results 
Work I Prospective KIHD 2313 47 and  
58 
Low dietary intake of folate was associated 
with an elevated risk of getting a hospital 
discharge diagnosis of depression both during 
13.6 and 18.8 years of follow-up. Vitamin B12 
intake was not associated with the risk of 
depression. 
Work II Prospective KIHD 2077 46 No observed associations between serum 
concentrations of total long-chain n-3 PUFAs, 
individual serum PUFAs or the serum ratio of 
n-6 to n-3 PUFAs and the risk of depression. 
Work III Prospective KIHD 2232 49 Coffee consumption was non-linearly 
associated with the decreased risk of 
depression, whereas tea or caffeine intake 
showed no associations. 
Work IV Cross-
sectional 
KIHD 1003 72 Healthy, prudent dietary pattern was 
associated with lower prevalence of depressive 
symptoms. Unhealthy Western-type dietary 
pattern was associated with elevated 
prevalence of depressive symptoms.  
 Prospective   28 Prospective analyses showed an inverse 
association between adherence to the healthy 
dietary pattern and the risk of depression. 
Work V Intervention DPS 140 - The BDI scores decreased in both the 
intervention and the control group during three 
years of intervention study. However, there 
was no difference between the groups in the 
magnitude of the change, which was clinically 
non-significant.  
Abbreviations: BDI, Beck Depression Inventory; DPS, Finnish Diabetes Prevention Study; KIHD, Kuopio 
Ischemic Heart Disease Risk Factor Study; PUFA, polyunsaturated fatty acid 
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11 Discussion  
11.1 METHODOLOGICAL CONSIDERATIONS 
11.1.1 Study populations and designs 
 
The KIHD study (works I-IV) 
The KIHD study population is a relatively large and representative population-based 
sample of middle-aged or older men in Finland. High participation rate (83%) is a strength 
and there were practically no losses to follow-up. Controlling of confounding factors was 
possible due to numerous measurements carried out and questionnaires filled in at 
baseline. Baseline and four-year subjects of the KIHD study population consisted only of 
men and hence, the results can only be generalized to male populations. In addition, the 
KIHD participants were middle-aged or older and thus, generalization into younger age 
groups should be done in caution. 
The main strength of works I-III is the use of a prospective follow-up setting with 
population-based recruitment. Compared to cross-sectional studies, prospective studies 
give more reliable information on the relationship as dietary exposures have been 
measured before observed depression. We were able to exclude those with current elevated 
depressive symptoms and those with a history of mental illness, to avoid reverse causation.  
 
The DPS (work V) 
The DPS population consisted of both women and men, which makes the results more 
generalizable. However, the DPS participants were overweight and had IGT, which is why 
generalization to general population must be done with caution. The study population was 
recruited through local advertisements. It is possible that people who were more interested 
in health-relating issue, or had higher education may have been selected more often to 
participate compared to others. The DPS participants have been shown more likely to be 
women and non-smokers compared to general Finnish population (337). The drop-out from 
the follow-up in the DPS was very low (9% for intervention and 7% for the control group), 
which is a strength (338). In addition, the duration of the intervention in the DPS was three 
years, which is considered a long period for commit oneself to an intensive intervention.  
11.1.2 Assessment of dietary intake and serum concentrations  
As suggested earlier (269), discussion of the association between diet and disease should 
include evidence from many different types of studies and should not focus on only one 
method to assess dietary exposure. The works in this thesis utilized different types of 
methods in assessing dietary intakes.  
Food records were collected during four consecutive days. Total energy intake was 
calculated from food records and was used as a potential confounder in works I-III, which 
is a certain strength. With four days of recording, the burden to the participants is modest. 
Unlike the FFQ method, food records are based on the actual intake of foods and beverages, 
and do not rely on memory, which is a strength of this method. However, if delaying 
recording for several hours or more, food records also rely on memory. Pictures of portions 
were used to ease the assessment of portion sizes. In addition, a qualified nutritionist 
provided the necessary instructions and checked the completed food records with the study 
participants, which added validity. Changes in eating while keeping a food record, 
reactivity, is usually caused by participants’ wish to minimize the burden of reporting 
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(136). In addition, a tendency to fill records in a manner that will be viewed favorably by 
others may cause social desirability bias. Only highly motivated participants may keep 
accurate records. Therefore, in our dietary assessments, under-reporting may have been 
present. In addition, day-to-day variation in food intake may be large in individuals, and 
four days is not enough for accurate estimation of long-term mean intake on an individual 
level (136). However, it is probable that four consecutive days are enough to reliably detect 
differences in intake between individuals. 
In work I, as folate is present in food items that are usually consumed daily (vegetables, 
fruits, whole-grain products), four-day food recording may reflect properly the differences 
in folate intake between individuals (136). The energy-adjustment of dietary folate intake is 
a certain strength, as it takes into account the differences in energy requirements among 
individuals. The evidence suggests that error by under- and over-reporting can also be at 
least partly cancelled by adjustments for energy intake (136,339). The Nutrica® software, 
used in the calculations of folate intake, takes into account the losses of folate during food 
preparation, which increases the reliability of the results. Assessment of dietary folate 
intake instead of serum or red-cell concentrations of folate is justified, as serum 
concentrations of vitamins are known to be affected by fluctuations in daily intake, 
smoking, alcohol consumption and physical activity (123,340).  
In work II, we measured serum concentrations of long-chain n-3 PUFAs, which is a 
proper method for assessing the short-term intake of these fatty acids. Serum 
concentrations of long-chain n-3 PUFAs correlate well with fish and fish oil intake, 
reflecting dietary intake over several weeks (341). Generally, food records are suggested as 
a golden standard of dietary intake assessment. However, in our study, using the four-day 
food records to assess intake of long-chain n-3 PUFAs may not have been a proper method, 
as the most important source, fish, is usually not  eaten on a daily basis, and day-to-day 
variation is large. Therefore, a four-day food record may not conclusively assess the intake 
of long-chain n-3 PUFAs. Moreover, serum concentrations reveal not only the actual intake 
of n-3 PUFAs but also reflect individual differences in fatty acid metabolism and storage. 
Sub-group analyses (31% of the study population) at the 11-year examination showed that 
fatty acid concentrations remained relatively similar to the baseline values, suggesting that 
the fatty acid concentrations are fairly stable even during longer follow-up periods.  
In work III, the reliance on four-day food records on coffee consumption may be 
justified, as for foods or drinks typically consumed daily, such as coffee, a limited number 
of days is enough for estimating usual consumption (136). In addition, it has earlier been 
suggested that Finnish individuals usually report accurately their habits concerning coffee 
consumption (342). In addition, it is unlikely that possible misclassification of the exposure 
would be systematical. The volume of the cup mainly used by each participant was 
estimated by showing photographs of four different cup sizes generally available in 
Finland.  
In work IV, the FFQs were utilized in the assessment of food intake and in evaluating 
the dietary patterns. The FFQs were filled at one time-point only, year four in the KIHD 
study. The FFQ was planned especially for the KIHD study cohort and it was not validated. 
The FFQ was relatively short, including only 38 food and beverage items, and the 
consumption frequency of most of the food groups was measured mainly by frequencies. 
However, quantitative assessment of consumption of foods and beverages was committed 
for a few items, such as coffee, tea and eggs. In addition, information on total energy intake, 
a potential confounder, was not available at four-year examinations, which is a limitation.  
The general advantages of FFQ include the ability to assess longer-term food 
consumption. In addition, the advantages include self-administration and a modest burden 
on individuals (136). Moreover, as measured food consumption in preceding 12 months, 
seasonal variation is unlikely to bias the results, though the seasonal point of filling the 
FFQs may affect the retention of foods consumed. The largest challenge of the FFQ is that it 
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is based on memory and is not the best method for assessing the absolute intakes, as it may 
not accurately reflect portion sizes. However, there is no given method for measuring long-
term food consumption available that could avoid the possibility of under- or over-
reporting. In work IV the main aim was, however, not to measure the accurate intakes, but 
instead, to categorize participants according to the frequencies of their food consumption 
and to determine dietary patterns. The FFQ method usually properly divides the 
participants on a relative scale according to food consumption, and relative rankings are 
considered adequate for determination of relative risks (136). In addition, concerning the 
dietary patterns, it may be advantageous to sacrifice precise intake measurements in 
exchange for more crude information relating to an extended period of time, as suggested 
before (136). The FFQ method is known to associate with substantial measurement error 
and these errors may seriously attenuate the power of studies in nutritional epidemiology 
(343). The dietary measurement error associated with the FFQs is, however, suggested to 
lead to an underestimation rather than overestimation of the true association (343).  
The FFQ is considered a good and generally used measurement of food consumption for 
factor analyses (269). A posteriori dietary pattern analysis allows investigation of food 
consumption as it exists within the sample data, using validated methods (344). Factor 
analysis is the most commonly used analysis in the nutritional epidemiology literature 
demonstrating dietary patterns, and it has been shown to perform reasonably well (269). 
Nevertheless, the challenges of dietary pattern analyses include data-based interpretation 
and challenge in objectivity. In addition, based on the results of dietary pattern analyses, it 
is difficult to give recommendations concerning the quantitative consumption of foods and 
beverages. 
11.1.3 Measurements of outcome events 
The outcomes in works I-III were limited to participants with severe depression requiring 
hospitalization and therefore, the number of outcomes was low, about 2% of the whole 
KIHD study population. Unfortunately, we had no national register of outpatients with 
depression available in Finland during the follow-up. The National Hospital Discharge 
Register covers the treatment periods in general and psychiatric hospitals, as well as in 
military, prison and private hospitals. The register data have been shown to be reliable, as 
95% of the primary diagnoses were identical compared to medical records (345). The use of 
the discharge register guaranteed that we were able to detect severely depressed patients, 
but due to overlapping, it simultaneously led to not detecting some of the cases with milder 
depression. Hence, it is a limitation of the register data that though specificity of the 
outcome is excellent, sensitivity is low. Therefore, our findings may be applicable to the 
more serious portion of the wide range of depressive symptoms. Especially, regarding the 
n-3 PUFAs, although we found no statistically significant associations between n-3 PUFAs 
and the risk of depression (work II), we cannot fully exclude the possibility that non-
significance is due to the relatively small number of hospitalizations, or in other words, the 
lack of power in the study (type II error). In addition, due to the low number of cases, it is 
possible that our results considering the association between coffee drinking and the risk of 
depression (work III) may be due to chance (type I error). Moreover, since there were 1,003 
participants present in the four-year re-examination, out of whom only 28 participants 
received a discharge diagnosis of depression, the power of the prospective analyses was 
modest (work IV).  
In the cross-sectional analyses of work IV, we used the HPL depression scores to 
measure depressive symptoms. The HPL depression scale is not commonly used outside 
the KIHD study cohort, but several studies based on this cohort have used this scale to 
assess depressive symptoms (119,155,327). Clinical cases of depression were not identified, 
which can be regarded as a limitation. The challenges in the use of self-rating depression 
scale include social desirability bias, which may lead to under-reporting of depressive 
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symptoms. Nevertheless, several previous studies have demonstrated the validity of self-
demonstrated scales, and potential misclassifications usually bias the association towards 
the null (123). The prevalence of elevated depressive symptoms was 7.2% at four-year 
examinations, which is slightly lower compared to a previous Finnish study estimating the 
prevalence of clinical depressive symptoms to be 10.4% in men (346).  
In work V based on the Finnish DPS, there was a limited number of study participants 
with the BDI scores available, as the BDI questionnaires were filled only at two study 
centers out of five both at baseline and at the three-year examination. Furthermore, there 
were no clinical interview-based diagnoses of depressive symptoms available. However, it 
has been shown that the BDI is a valid tool especially in assessing the change in depressive 
symptoms and that mean BDI scores correlate well with the prevalence of depression 
assessed by clinical interviews (335).  
The Finnish DPS intervention was not designed to prevent or diagnose depression. 
However, in this study the prevalence of elevated depressive symptoms at the baseline 
(21.4%) was higher than the prevalence of depressive symptoms in the previous Finnish 
study (10.4% in men, 16.5% in women) (346). The DPS participants were overweight and 
they had IGT, and therefore at higher risk for depressive symptoms, which may partly 
explain the relatively high prevalence. In addition, the cut-off point used in the DPS (10/11) 
is also relevant for screening sub-clinically depressed individuals, which probably explains 
the relatively high prevalence of depressive symptoms. Originally, Beck suggested that a 
cut-off point of 12/13 would be suitable to detect depression among psychiatric patients, 
while 9/10 should be used among medical non-psychiatric patients (42). In addition, in 
work V, the strengths include the fact that information on both depressive symptoms and 
antidepressant medication use was available. It has previously been recommended that the 
use of both markers could be a sufficient estimate of overall depression rates (303). 
However, the number of participants using antidepressant medication in the DPS was very 
low, only one participant in the intervention group and two participants in the control 
group at the baseline. 
11.2 DIETARY FOLATE AND THE RISK OF DEPRESSION (I) 
We found that low folate intake was associated with an elevated risk of depression. In 
addition, the inverse association was strongest in the follow-up years 13 to 19, after which 
period the association still existed, but became weaker. Finally, the association did not 
reach a statistically significant level after 20 years of follow-up.  
Folate intake in the KIHD cohort was earlier found to have an inverse association with 
depressive symptoms in cross-sectional analyses (119). The present study was the first 
prospective study to show an association between dietary intake of folate and increased 
risk of depression. There are four prospective studies published since on blood 
concentrations of folate, and two studies published on the relation between intake of folate 
and the risk of depression. The prospective studies have shown a similar inverse 
association in some studies assessing dietary intake (9) or blood concentrations (7,8) of 
folate, but not in other studies assessing dietary intake (10) or blood concentrations (11,12) 
of folate. In addition, in a French study, folate deficiency was not associated with the 
depression prevalence in cross-sectional analyses, whereas lower blood concentrations of 
folate were associated with a higher likelihood of depression two years later (9), suggesting 
that folate concentrations could affect the onset of depression, not vice versa. 
It has previously been suggested that only low blood concentrations of folate may 
increase the risk of depression, and once a minimal safety level is reached, further 
elevations in intake do not lead to further reduction in the risk of depression (123). In our 
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study population, only 25% of the participants attained the recommended intake level of 
300 μg of folate, which is in line with this hypothesis. Similarly, in the previous prospective 
study in the elderly participants from the U.S., intakes of folate were much higher (second 
tertile of folate intake from food and supplements was 263 to 397 μg/day) compared to our 
study population (10). The study showed no association between folate and the risk of 
depression, and also suggested that folate may be associated with the risk of depression 
only at insufficient concentrations. However, in the U.S., all grain products and cereals are 
nowadays fortified with folic acid (140 μg of folic acid per 100 g). Moreover, as the use of 
vitamin supplements is more common in the U.S., the mean intake of folate is likely to be 
higher compared to Finland. In the French prospective study with no association between 
folate intake and  risk of any or single depressive episodes (9), the intake of folate was also 
higher compared to our population (the mean for the first, second and third tertiles of folate 
intake was 243 μg/day, 336 μg/day and 441 μg /day, respectively). However, an inverse 
association was observed only with the risk of recurrent depression, only in men. 
Moreover, the prospective studies on blood concentrations of folate and risk of depression 
partly support the hypothesis. In a multinational prospective European study, only 0.3% of 
the participants had deficiency of folate and no associations were detected (12). However, 
in a Korean study, an inverse association was found even though the mean serum 
concentrations of folate were relatively high (mean 24.4 nmol/L) and deficiency of folate 
was uncommon (4.0%) (7). Thus, this hypothesis may not entirely explain the differences. 
Some individuals may be deficient of folate regardless of adequate dietary intake 
because of genetic polymorphisms, diseases or drugs that may cause improper absorption 
and utilization (97). As polymorphisms in the MTHFR gene needed in the metabolism of 
folate have previously been found to associate with depressive symptoms, stratified 
analyses by genotype would give more information on the association between folate 
intake and depression (85). In the KIHD study population, we have information on MTHFR 
genotypes available. Unfortunately, due to the low number of participants stratified 
analyses according to genotype could not be performed. 
We found no association between vitamin B12 intake and the risk of depression. Sufficient 
intake for nearly everyone may affect the results, as 99.9% of the study participants reached 
the recommended Finnish daily vitamin B12 intake of 2.0 μg/day (102). As the intake of B12 
was sufficient in almost all of the KIHD participants, it leads to a more dense value 
distribution and differences in the outcome are less likely observed. Nevertheless, as 
previously suggested, B12 may not be linearly associated with depression, but the 
association may be observed only at low levels (114). 
We are not able to fully exclude the possibility that the relationship between dietary 
folate and depression is explained by other healthy features of a folate-rich diet. Main 
sources of folate in KIHD cohort, vegetables, fruits, berries and whole-grains, are rich in 
many other essential nutrients, and folate intake may be a proxy for other unmeasured 
factors, such as a healthy overall diet. However, adjustment for the intake of vitamin C and 
fiber, which are considered good markers of an overall healthy diet, did not change the 
results. Similarly, poor eating habits easily cluster with other unhealthy habits, such as low 
physical activity, smoking and alcohol consumption, and these factors may confound the 
association (123,340). We tested for total energy intake as being a potential confounder, but 
it did not attenuate the association. Smoking may be an effect modificator, as in a cross-
sectional study with over 9,000 individuals an inverse association between intake of folate 
and prevalence of depressive symptoms was found only among men who were current 
smokers and had lower levels of anxiety symptoms (123). Smokers may be vulnerable to a 
selective folate deficiency as cigarette smoking increases folate requirements by interfering 
with the metabolism of folate and reducing folate utilization (347). Nevertheless, 
adjustments with several possible risk factors associated with lifestyle, including smoking, 
did not alter the main results of our study.  
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11.3 SERUM N-3 FATTY ACIDS AND THE RISK OF DEPRESSION (II) 
We found no association between serum concentrations of total long-chain n-3 PUFAs, total 
n-6 PUFAs, individual fatty acids or the ratio of n-6 to n-3 PUFA and the risk of getting a 
hospital discharge diagnosis of depression. The results are congruent with other 
prospective studies, a Finnish study (90), a North-American study (88) and two French 
studies (19,87), in which no association was found between the intake or serum 
concentrations of n-3 PUFAs and the risk of depression. The NHS (88) may present valid 
research, as the study was carried out with repeated measurements of dietary intake during 
the ten years of follow-up, as well as a rigorous definition of clinical depression. In the 
other French study, however, also cross-sectional analyses showed that higher n-3 PUFA 
consumption associated with lower likelihood of depressive symptoms (87). This reinforces 
the theory that depressive symptoms affect n-3 PUFA intake, rather than the opposite.  
The concentrations of serum n-3 PUFAs were relatively low (mean 4.7%) in our study 
population, which reflects relatively low fish consumption and may affect our results. 
However, previously in the KIHD cohort an inverse association was found between serum 
long-chain n-3 PUFA concentrations and CVD and inflammation-related conditions 
(223,348). In a recent Finnish cross-sectional study combining three different data sets with 
a very wide range of fish consumption and n-3 PUFA intake including the extreme ends, 
the results showed no association between fish consumption and psychological stress in 
either high or low fish consumption categories (178). Therefore, it is probable that our 
results would be similar regardless of the concentrations of serum PUFAs. The potential 
association between n-3 PUFAs and depression is suggested to be non-linear 
(15,18,178,349). Extremely high concentrations of n-3 PUFAs may not show advantages but 
disadvantages, as in the cross-sectional Finnish Fishermen Study, when serum 
concentrations of DHA reached 6%, there was an increase in scores of psychological stress 
(178). Similarly, in a prospective study in Spanish men and women, those with high 
baseline fish consumption and increased consumption during the follow-up had elevated 
risk of depression (18). Further, in a prevention trial, supplementation with EPA and DHA, 
600 mg at a 2:1 ratio, for almost five years elevated depressive symptoms, but in men only 
(137). 
Our study population consisted of men only, and no association was found between n-3 
PUFAs and the risk of depression. Gender has been suggested to be a possible confounder 
as in previous studies, the association between n-3 PUFAs and depression has been 
observed in two prospective studies in women only (17,18). Two Finnish cross-sectional 
studies have also shown a similar gender difference (172,173). In contrast, in a French 
prospective study (15) and in a Finnish cross-sectional study (349), fish consumption 
associated with recurrent depression and MDD, respectively, in men only. Unfortunately, 
none of the RCTs have reported results stratified by gender. The potential gender difference 
might be explained by the differences in neurotransmitter metabolism between the genders 
(173) or by gender-mediated differences in oxidative stress or inflammation (350). 
However, the concentrations of endogenous n-3 PUFAs, especially DHA, are higher in 
women than in men, even when fed identical diets (351). Also other confounders have been 
suggested, as the beneficial effects of fish consumption or intake of n-3 PUFAs may 
manifest mainly in individuals with a harmful lifestyle and health behaviors, such as a 
sedentary lifestyle, high alcohol consumption or smoking (178,349). In contrast, risk of self-
reported depressed mood was elevated with increased fish consumption in smoking men 
in the Alpha-Tocopherol, Beta-Carotene (ATBC) Cancer Prevention Study (90), and strong 
interaction between fatty fish consumption and smoking on recurrent depression risk was 
also found in the SU.VI.MAX cohort, especially in women (15). 
Total energy intake should also be taken into account as a potential confounder. Men 
usually eat more and get more energy and n-3 PUFAs from food compared to women and 
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depressed individuals may eat less than non-depressed persons, which may affect their n-3 
PUFA status (178,352). However, in our study, those who became depressed during the 
follow-up actually obtained more energy from the diet at baseline than those who remained 
non-depressed. We repeated the analyses adjusting for baseline energy intake, but the 
results remained unaltered. 
We observed no statistically significant differences in the ratio of n-6 to n-3 PUFAs 
between the participants who received a hospital discharge diagnosis for depression and 
those who did not. The main dietary sources of the long-chain n-3 PUFAs are fish and 
seafood, whereas the n-6 PUFAs are mainly derived  from vegetable oils (LA), but also from 
animal products (AA). In the early 1980s, the consumption of vegetable oils was relatively 
low in Finland, but has increased three-fold during the recent decades (353). Therefore, it 
may be possible that the serum ratio of n-6 to n-3 has changed during the follow-up time. 
However, the ratio of n-6 to n-3 PUFAs was relatively similar in our study population at 
baseline (6.2:1) to the ratio reported previously in a cross-sectional study with a positive 
association (6.6:1 and 6.9:1 in non-depressed and depressed individuals, respectively) (169). 
In other cross-sectional studies with no association, the ratios were much higher (mean 
8.5:1) in non-clinical population (190) and much lower in a study comparing non-depressed 
and depressed individuals (3.6:1 and 3.9:1, respectively) compared to our results (184). It is 
also possible that the small variation in the fatty acid ratios between the study subjects may 
have affected our finding towards the null. 
 11.4 COFFEE, TEA AND CAFFEINE AND THE RISK OF DEPRESSION (III) 
We found that coffee consumption was associated with a decreased risk of hospitalization 
due to depression. However, the association was non-linear. According to our results, 
participants in the light and heavy drinkers’ groups had a decreased risk of depression, 
while those in the group of moderate drinkers did not. Since our observation was the first 
one published in a prospective setting in a population sample and with adequate follow-up 
time, these findings need to be replicated. Recently, prospective work from the NHS 
population showed that coffee consumption decreased the risk of depression dose-
dependently (250). There were only few participants with very high consumption of coffee; 
only 0.52% drank six or more cups (>900 mL) of caffeinated coffee daily. Therefore, they 
were unable to address the effects of high coffee or high caffeine consumption. In contrast, 
in our study, 17.5% of participants were heavy coffee drinkers (>813 mL/day) and they also 
had a decreased risk of depression compared to non-drinkers. This result gives a relevant 
reason to hypothesize that coffee drinking, also at high amounts, could be safe for mental 
health.  
There were only few men (n=21) in our study sample who did not consume any caffeine. 
Therefore, it is possible that the lack of association is confounded by the relatively high 
caffeine intake observed also in the lowest quartile of our cohort (the mean intake of the 
lowest quartile was 274 mg/d). In the NHS, a decreasing risk of depression was seen with 
increased consumption of caffeinated coffee, but not with decaffeinated coffee (250). The 
mean caffeine intake in their cohort was a lot smaller than ours: 236 mg/day versus 607 
mg/day, respectively. In contrast, an Australian longitudinal study reported that non-
caffeine consumers had better mental well-being compared to regular caffeine consumers 
(249). Nevertheless, there was no quantitative assessment of caffeine intake in their study, 
thus no dose-response analysis were committed. Both of these studies (249,250) were 
conducted only in women, whereas our study population consisted of men only. The 
possible gender differences need further investigations. 
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Tea consumption was not associated with the risk of depression in our study, in contrast 
to previous studies. Although 43% of the participants in our study population drank tea, 
the mean tea consumption was quite low (105 mL/day). In addition, in the KIHD cohort, 
there were 907 participants (40% of the cohort) who consumed both coffee and tea during 
the four-day food recording (mean consumption was 496 mL/day for coffee and 227 
mL/day for tea). Moreover, out of them, 314 men (14% of the cohort) drank more than 200 
mL of both tea and coffee daily (mean for coffee 508 mL/day and for tea 382 mL/day). The 
tea consumed in our study population was mainly black tea. Most of the previous studies 
presenting the protective effect of tea were conducted with green tea and mostly in Asian 
countries, where the consumption of green tea is fairly high (264,265). There are several 
possible explanations for the more promising results for green tea compared to black tea. 
Green tea contains more catechins, has a higher level of antioxidant activity and, 
furthermore, green tea is usually consumed in higher amounts compared to black tea (354).  
We found that the potential protective effect of coffee consumption is not accredited by 
caffeine consumption. Caffeine is traditionally considered to be responsible for the health 
effects of coffee. In a work from the NHS, caffeinated coffee consumption was associated 
with a decreased risk of depression, which gives  good reason to presume that it may be the 
caffeine in coffee that is the affective substance (250). However, as presented earlier in this 
thesis (chapter 5.3.3), coffee contains plenty of other functional components with both anti-
inflammatory and antioxidative effects. Therefore, these effects might, at least partly, 
explain our observations, especially in the heavy coffee drinkers´ group.  
We did not have the information of other sources of caffeine than coffee and tea. 
However, it was highly uncommon to consume caffeine from other sources in the 1980s, 
especially on a daily basis. To minimize the reverse causation bias, we excluded the 
participants with elevated depressive symptoms at the baseline. The most worthy 
limitation is the low number of the cases. Secondly, a possibility of residual confounding 
cannot totally be excluded since coffee consumption is usually associated with other 
lifestyle factors, such as smoking, poor eating habits, low physical activity and higher 
alcohol consumption (355,356). In our study population, there were statistically significant 
differences in smoking, intake of folate and adulthood SES, but not in alcohol consumption 
between coffee drinkers and non-drinkers. However, adjustments for these factors did not 
alter the findings.  
11.5 DIETARY PATTERNS AND DEPRESSION (IV) 
In this study, it was observed that a healthy dietary pattern characterized by consumption 
of vegetables, fruits, berries, whole-grain bread, fish and low-fat cheese was associated with 
a decreased prevalence of elevated depressive symptoms in middle-aged men. In contrast, 
adherence to an unhealthy Western-type dietary pattern, characterized by higher 
consumption of sausages, processed meats, sweet snacks, sweet soft drinks, baked potatoes 
and French fries, wheat bread, cheese and manufactured foods, increased the likelihood of 
being depressed. In addition, prospective analyses showed an inverse association between 
a healthy dietary pattern and the risk of getting a hospital discharge diagnosis of 
depression during the average 16.5 years of follow-up.  
Our results are in line with the previous studies, as it has been shown both in cross-
sectional (95,281,285) and in prospective (24-26) studies that healthy dietary patterns – 
naturally not defined exactly similarly in the different studies – are associated with a lower 
prevalence or risk of depression. Our study population consisted of men only, and we 
found an inverse association. Interestingly, an inverse association between healthy dietary 
patterns and depression has been observed especially in women both in cross-sectional 
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(95,283,285) and in prospective studies (25). In addition, diet quality index also showed an 
inverse association with the incidence of depression only in women (286).  
Total energy intake may be a potential confounder of the association. For example in 
Australian women, a statistically significant association between an unhealthy Western 
dietary pattern and depression was found only in unadjusted models, disappearing once 
overall energy intake was taken into account (285). Adjustments for total energy intake 
were performed in only six of the previous cross-sectional (95,280-283,285) and three of the 
prospective (24,25,284) studies, which may partly explain the inconsistency in the results. 
Unfortunately, in our study, we were not able to adjust for total energy intake, as we used 
the short FFQ, in which the quantitative assessment of total energy intake was impossible.  
Several potential confounding factors were, however, assessed and adjusted for in the 
cross-sectional analyses. Physical inactivity is a potential confounding factor for the 
association between dietary patterns and depression. However, adjustments for leisure-
time physical activity had only minor effect on our results. In addition, the association 
between dietary patterns and depressive symptoms could be attenuated by the fact that the 
study participants may have modified their diet and eating habits after developing a diet-
related disease, such as CVD. To avoid this confounding, we adjusted for a history of CVD. 
Finally, dietary patterns reflect complex interactions between individuals and the culture 
and society in which they live; it is therefore possible and even probable that in addition to 
biological mechanisms, social and psychological mechanisms may be behind the 
associations found (357). These complex interactions could not be tested in our study. 
Depression itself may affect appetite, change dietary patterns and lead to unhealthy 
eating habits. However, the association between dietary patterns and depressive symptoms 
may be bi-directional: dietary patterns affect mood and mood affects dietary patterns and 
eating behavior (357). Previous prospective studies on diet quality (24,284) did not, 
however, support the reverse causality as an explanation for the association. Prospective 
analyses to clarify the association can be considered as a strength. Results from prospective 
analyses support the hypothesis that a healthy dietary pattern may lead to reduced risk of 
depression. However, the Western dietary pattern did not associate with the risk of 
hospitalization due to depression in our prospective analyses, which supports the direction 
of the relationship to be reversed.  
11.6 LIFESTYLE INTERVENTION AND DEPRESSIVE SYMPTOMS (V) 
We found that participation in the intervention study lowered depression scores both in the 
intervention and the control groups, although the mean decreases were clinically non-
significant. Furthermore, regardless of group status or the level of depression scores, the 
participants who succeeded in weight reduction showed greater reduction in the BDI 
scores.  
Similar to the present results, the DPP found no association between participation in the 
intensive lifestyle modification group and changes in the levels of depression (358). It was 
reported that the median BDI score at the baseline was three points, whereas in our study it 
was six points. The mean BMI of the participants was over 30 kg/m2 in both studies (358). A 
study in overweight women observed that diet alone or a combination of diet and exercise 
had identical benefits on depressive symptoms (307). The effect was not specific to the 
intervention type, and exercise did not produce any additional advantage, at least when the 
weight loss was about the same in all groups. In contrast, a trial with three treatment arms 
showed that a combination of diet and exercise was more effective than diet alone in 
overweight women (311). Unfortunately, we were unable to differentiate between the 
specific effects of diet and exercise on depressive symptoms, because the dietary and 
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exercise interventions were combined in our study. However, it seems that rather than the 
content of the intervention, participation and achieving social support are the key issues. 
Obesity is a commonly distinguished risk factor for depression especially in women 
(359) and there is also a positive association between weight and depression (360). A 
reciprocal link between depression and obesity was confirmed by a recent meta-analysis 
(361). The DPS participants were mostly obese at baseline and therefore, they were high-
risk subjects for depressive symptoms. In previous intervention studies, weight change has 
been suggested to be a mediator of the treatment effects on the BDI score (308) and to be 
associated with a small but statistically significant reduction in the risk of elevated 
depressive symptoms (303). Weight change was one of the strongest determinants of the 
change in the BDI scores also in the DPS. However, the studies described above mainly 
aimed at weight reduction, whereas the intervention program in the DPS focused on the 
quality of diet in general, combined with weight reduction and physical exercise.  
The prevalence of elevated depressive symptoms decreased both in the intervention and 
the control groups. Moreover, among those who had the elevated depressive symptoms at 
baseline, we found a reduction of depressive symptoms in both groups, but the reduction 
was statistically significant only in the control group. This may be due to chance because of 
the small sample size, or it may reflect the benefit from meeting with health care 
professionals without the need of more intensive intervention. Actually, an intensive 
lifestyle intervention may be even more demanding for individuals with depressive 
symptoms, and general lifestyle advice or a mini-intervention may be more beneficial in 
these cases. In line with this, it was found in the Look AHEAD trial that individuals who 
reported incident symptoms of depression had more than seven points of increase in the 
BDI scores during the trial (309), which is regarded as a clinically significant change. 
Weight loss aim was the main focus of the study.  
It is a commonly known phenomenon that in lifestyle intervention studies both the 
intervention and the control group benefit from participation (337). The Hawthorne effect 
(362), which reflects the magnitude of regular follow-up and appointments with health care 
professionals, may affect our results and narrow the differences. Participants in the DPS 
control group gave blood samples and were examined by the study physician annually. 
They also received general health advice due to ethical reasons (330). Thus, they might also 
have benefited from lifestyle advice.   
In the previous lifestyle intervention studies demonstrating the effect on depressive 
symptoms, the time period has varied from 20 weeks up to four years (303,307,308). In the 
shortest study (307), depressive symptoms decreased statistically significantly during the 
first ten weeks, but increased during the next ten weeks, even though weight reduction 
continued until 20 weeks of the study. In the DPS, measurements of depressive symptoms 
were available at baseline and at three-year examination. It should, however, be noticed 
that earlier assessment may be biased as a result of changes made only because participants 
are conscious of being studied (331). In addition, as was recommended earlier, longer study 
periods are needed to observe the stability of improvements, especially when it is probable 
that participants will regain some weight during long follow-up studies (308). 
The DPP showed that while the prevalence of elevated depressive symptoms decreased 
from 10.3% at baseline to 8.4% at year three, the proportion of antidepressant medicine 
users increased from 5.7% to 8.7% (303). In the DPS, with the same cut-off (BDI≥11), the 
prevalence of elevated depressive symptoms was higher both at baseline (21.4%) and at 
year three (15.7%), and use of antidepressants was uncommon both at baseline (2.3%) and 
at three-year visit (3.6%). As the use of antidepressants was uncommon in our study 
population, it was not possible to examine the association between intervention and the use 
of antidepressants. It is also very unlikely that the use of antidepressant medication has 
affected our results. In addition, the use of antidepressants was uncommon compared to 
the number of those who had depressive symptoms at baseline (21.4%). Low rates of 
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antidepressant treatment can be explained by the fact that it was fairly uncommon to treat 
mild depression with drugs during the DPS in the 1990s in Finland.  
Even though in the DPS, based on the range of the reported BDI values, some of the 
individuals shifted from the category of severe depression to mild or non-depressed, and 
the proportion of participants with elevated depressive symptoms decreased from 21.4% to 
15.7%, we cannot  draw reliable conclusions about the clinical significance on group level. 
However, the clinical meaning of our observations remains suggestive regarding the 
clinical benefits. Nevertheless, the mean reductions of the BDI scores during the three-year 
intervention (-0.90 points in the intervention group, -0.75 points in the control group) are 
not regarded as clinically significant. 
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12 Conclusions  
Based on the findings in the works I to V, the following five conclusions can be drawn: 
 
1. Low intake of folate increases the long-term, up to 20 years, risk of getting a hospital 
discharge diagnosis of depression in middle-aged men, at least in a population with 
generally low mean intake of folate and a large variance in it. Therefore, improving 
folate status could be beneficial in the prevention of depression. Dietary intake of 
vitamin B12 is not related to the risk of depression in men whose intake of vitamin B12 
is sufficient. 
 
2. Serum concentrations of the long-chain n-3 PUFAs, single fatty acids or the ratio of 
n-6 to n-3 PUFAs are not associated with the risk of depression in middle-aged men. 
These results support the hypothesis that the prevention of depression with long-
chain n-3 PUFAs may prove unsuccessful.  
 
3. Coffee consumption, but not tea consumption or caffeine intake as such, may be 
preventive against depression.  
 
4. Adherence to a healthy dietary pattern associates with a lower prevalence of 
depressive symptoms, whereas adherence to an unhealthy dietary pattern associates 
with elevated depressive symptoms in middle-aged men. Moreover, adherence to a 
healthy dietary pattern reduces the risk of depression requiring hospital treatment. 
 
5. Participation in the lifestyle intervention study improves the BDI scores with no 
specific group effect, although not clinically significantly. Therefore, regardless of 
the intensity of the treatment, participation and success in executing alterations in 
one’s lifestyle and behavior is associated with beneficial changes in mood. Among 
the lifestyle changes in intervention study, successful reduction of body weight 
associates particularly with a greater reduction of depressive symptoms.   
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13 Implications  
13.1 IMPLICATIONS FOR PREVENTION AND CLINICAL PRACTICE  
Our results indicate that diet may have a role in the prevention of depression. On the basis 
of this work and previously published studies it can be stated that eating a healthy diet rich 
in folate sources, such as vegetables, fruits, berries and whole-grains is beneficial in the 
prevention of depression. In addition, a dietary pattern characterized by consumption of 
vegetables, fruits, berries, whole-grains, poultry, fish and low-fat cheese may be protective 
against depression. 
Generally, primary prevention strategies of depression should include lifestyle choices, 
including a healthy diet. Sufficient intake of folate is recommendable as low intake of folate 
may be an independent risk factor for depression. An increase in the consumption of 
especially vegetables, fruits and berries that may elevate the dietary intake of folate and 
various other nutrients is recommended. Our results suggested no benefit of n-3 PUFAs in 
the prevention of depression, at least in middle-aged men with generally low circulating 
concentrations of n-3 PUFAs. Nevertheless, there is no need to change the current dietary 
guidelines that recommend eating fish at least twice a week, as fish consumption is 
beneficial, especially for cardiovascular health. In the light of the evidence, it is probable 
that coffee drinking may have advantages, but not as many harmful effects on mood as 
previously thought. Still, it is far too premature to recommend coffee consumption for the 
prevention of depression. 
Based on the literature, dietary habits among depressed individuals are often poor and 
dietary intakes insufficient, which may cause deficiencies. Therefore, continuous nutrition 
education and counseling for healthy dietary patterns and balanced nutrition status are 
needed. Sufficient intake of folate and long-chain n-3 PUFAs is especially important for 
depressed individuals. Folate or EPA and DHA augmentation may enhance the efficacy of 
antidepressant medication in non-responders, to enable those who partially respond to 
antidepressant monotherapy to achieve remission, or to alleviate residual symptoms during 
antidepressant treatment. However, there are no specific unanimous augmentation 
guidelines for clinical practice. Although a healthy diet is naturally the most 
recommendable option, supplements should not be avoided if needed.  
13.2 IMPLICATIONS FOR FUTURE RESEARCH  
The possibilities to prevent depression by healthier dietary patterns or elevated intake of 
healthy foods and nutrients should be studied more extensively. Firstly, more well-
designed, large, population-based prospective studies with long follow-up periods are 
warranted. In prospective designs, multiple exposure assessments throughout the follow-
up period and evaluation of depression status both at baseline and during the follow-up 
should be emphasized. Secondly, population-based RCTs in non-depressed or high-risk 
participants are warranted, as previous studies have mainly consisted of clinically 
depressed patients. However, the effects of diet on the prevention of recurrent depression 
should also be investigated, as there may be differences in the effects of diet between the 
first episode of depression and recurrent depression. Studies with stratified age groups and 
gender groups should be emphasized, as there may also be differences in the effects of diet 
depending on age or gender. Lifestyle factors, especially total energy intake and smoking, 
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should be more often taken into account as potential confounders. Moreover, RCTs 
investigating the differences in the effects of elevated intakes of nutrients from dietary 
sources compared to supplementation with nutrients are warranted. Finally, specific diet-
related randomized interventions with interventions based on the changes in the overall 
dietary pattern are needed to form primary prevention strategies for depression. As 
depression is a systemic disease and diet may affect several pathways in the pathogenesis 
of depression, the mechanisms behind the possible predisposing or protecting effects of 
dietary factors require further investigations. Individual differences and genetic 
background behind the sensitivity to the effects of diet should especially be studied in more 
detail.  
 
 
95 
 
 
 
References 
(1) Bromet E, Andrade LH, Hwang I, Sampson NA, Alonso J, de Girolamo G, de Graaf R, Demyttenaere K, Hu 
C, Iwata N, et al. Cross-national epidemiology of DSM-IV major depressive episode. BMC Med 2011;9:90. 
 (2) Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS, 
National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the 
National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095-3105.  
(3) Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 
2006;3:e442.  
(4) Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, 
Abdalla S, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a 
systematic analysis for the Global Burden of Disease Study 2010. Lancet 2013;380:2197-2223.  
(5) Jacka FN, Maes M, Pasco JA, Williams LJ, Berk M. Nutrient intakes and the common mental disorders in 
women. J Affect Disord 2012;141:79-85.  
(6) Sanhueza C, Ryan L, Foxcroft DR. Diet and the risk of unipolar depression in adults: systematic review of 
cohort studies. J Hum Nutr Diet 2012;26:56-70.  
(7) Kim JM, Stewart R, Kim SW, Yang SJ, Shin IS, Yoon JS. Predictive value of folate, vitamin B12 and 
homocysteine levels in late-life depression. Br J Psychiatry 2008;192:268-274.  
(8) Nanri A, Hayabuchi H, Ohta M, Sato M, Mishima N, Mizoue T. Serum folate and depressive symptoms 
among Japanese men and women: a cross-sectional and prospective study. Psychiatry Res 2012;200:349-353.  
(9) Astorg P, Couthouis A, de Courcy GP, Bertrais S, Arnault N, Meneton P, Galan P, Hercberg S. Association 
of folate intake with the occurrence of depressive episodes in middle-aged French men and women. Br J Nutr 
2008;100:183-187.  
(10) Skarupski KA, Tangney C, Li H, Ouyang B, Evans DA, Morris MC. Longitudinal association of vitamin B-
6, folate, and vitamin B-12 with depressive symptoms among older adults over time. Am J Clin Nutr 
2010;92:330-335.  
(11) Kendrick T, Dunn N, Robinson S, Oestmann A, Godfrey K, Cooper C, Inskip H, Southampton Women's 
Survey Study Group. A longitudinal study of blood folate levels and depressive symptoms among young 
women in the Southampton Women's Survey. J Epidemiol Community Health 2008;62:966-972.  
(12) Eussen SJ, Ferry M, Hininger I, Haller J, Matthys C, Dirren H. Five year changes in mental health and 
associations with vitamin B12/folate status of elderly Europeans. J Nutr Health Aging 2002;6:43-50.  
(13) Papakostas GI, Shelton RC, Zajecka JM, Etemad B, Rickels K, Clain A, Baer L, Dalton ED, Sacco GR, 
Schoenfeld D, et al. (L)-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two 
randomized, double-blind, parallel-sequential trials. Am J Psychiatry 2012;169:1267-1274.  
96 
 
 
(14) Coppen A, Bailey J. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, 
placebo controlled trial. J Affect Disord 2000;60:121-130.  
(15) Astorg P, Couthouis A, Bertrais S, Arnault N, Meneton P, Guesnet P, Alessandri JM, Galan P, Hercberg S. 
Association of fish and long-chain n-3 polyunsaturated fatty acid intakes with the occurrence of depressive 
episodes in middle-aged French men and women. Prostaglandins Leukot Essent Fatty Acids 2008;78:171-182.  
(16) Appleton KM, Woodside JV, Yarnell JW, Arveiler D, Haas B, Amouyel P, Montaye M, Ferrieres J, 
Ruidavets JB, Ducimetiere P, et al. Depressed mood and dietary fish intake: direct relationship or indirect 
relationship as a result of diet and lifestyle? J Affect Disord 2007;104:217-223.  
(17) Colangelo LA, He K, Whooley MA, Daviglus ML, Liu K. Higher dietary intake of long-chain omega-3 
polyunsaturated fatty acids is inversely associated with depressive symptoms in women. Nutrition 
2009;25:1011-1019.  
(18) Sanchez-Villegas A, Henriquez P, Figueiras A, Ortuno F, Lahortiga F, Martinez-Gonzalez MA. Long-
chain omega-3 fatty acids intake, fish consumption and mental disorders in the SUN cohort study. Eur J Nutr 
2007;46:337-346.  
(19) Astorg P, Bertrais S, Alessandri JM, Guesnet P, Kesse-Guyot E, Linard A, Lallemand MS, Galan P, 
Hercberg S. Long-chain n-3 fatty acid levels in baseline serum phospholipids do not predict later occurrence 
of depressive episodes: a nested case-control study within a cohort of middle-aged French men and women. 
Prostaglandins Leukot Essent Fatty Acids 2009;81:265-271.  
(20) Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. 2002;56:365-379.  
(21) Appleton KM, Rogers PJ, Ness AR. Updated systematic review and meta-analysis of the effects of n-3 
long-chain polyunsaturated fatty acids on depressed mood. Am J Clin Nutr 2010;91:757-770.  
(22) Smith A. Effects of caffeine on human behavior. Food Chem Toxicol 2002;40:1243-1255.  
(23) Butt MS, Sultan MT. Coffee and its consumption: benefits and risks. Crit Rev Food Sci Nutr 2011;51:363-
373.  
(24) Akbaraly TN, Brunner EJ, Ferrie JE, Marmot MG, Kivimäki M, Singh-Manoux A. Dietary pattern and 
depressive symptoms in middle age. Br J Psychiatry 2009;195:408-413.  
(25) Rienks J, Dobson AJ, Mishra GD. Mediterranean dietary pattern and prevalence and incidence of 
depressive symptoms in mid-aged women: results from a large community-based prospective study. Eur J 
Clin Nutr 2013;67:75-82.  
(26) Le Port A, Gueguen A, Kesse-Guyot E, Melchior M, Lemogne C, Nabi H, Goldberg M, Zins M, 
Czernichow S. Association between dietary patterns and depressive symptoms over time: a 10-year follow-up 
study of the GAZEL cohort. PLoS One 2012;7:e51593.  
(27) Rimer J, Dwan K, Lawlor DA, Greig CA, McMurdo M, Morley W, Mead GE. Exercise for depression. 
Cochrane Database Syst Rev 2012;7:CD004366.  
(28) Lindeman S, Hämäläinen J, Isometsä E, Kaprio J, Poikolainen K, Heikkinen M, Aro H. The 12-month 
prevalence and risk factors for major depressive episode in Finland: representative sample of 5993 adults. 
Acta Psychiatr Scand 2000;102:178-184.  
97 
 
 
(29) Pirkola SP, Isometsä E, Suvisaari J, Aro H, Joukamaa M, Poikolainen K, Koskinen S, Aromaa A, Lönnqvist 
JK. DSM-IV mood-, anxiety- and alcohol use disorders and their comorbidity in the Finnish general 
population--results from the Health 2000 Study. Soc Psychiatry Psychiatr Epidemiol 2005;40:1-10.  
(30) Ahola K, Virtanen M, Honkonen T, Isometsä E, Aromaa A, Lönnqvist J. Common mental disorders and 
subsequent work disability: a population-based Health 2000 Study. J Affect Disord 2011;134:365-372.  
(31) Honkonen T, Gould R. Masennusperusteisen työkyvyttömyyden määrä on taittunut. Suomen 
Lääkärilehti 2011;66:3296-3297.  
(32) Majed B, Arveiler D, Bingham A, Ferrieres J, Ruidavets JB, Montaye M, Appleton K, Haas B, Kee F, 
Amouyel P, et al. Depressive symptoms, a time-dependent risk factor for coronary heart disease and stroke in 
middle-aged men: the PRIME Study. Stroke 2012;43:1761-1767.  
(33) Renn BN, Feliciano L, Segal DL. The bidirectional relationship of depression and diabetes: a systematic 
review. Clin Psychol Rev 2011;31:1239-1246.  
(34) Weisenbach SL, Boore LA, Kales HC. Depression and cognitive impairment in older adults. Curr 
Psychiatry Rep 2012;14:280-288.  
(35) Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5™). Arlington, VA: American 
Psychiatric Association; 2013.  
(36) Nordentoft M, Mortensen PB, Pedersen CB. Absolute risk of suicide after first hospital contact in mental 
disorder. Arch Gen Psychiatry 2011;68:1058-1064.  
(37) Melartin TK, Isometsä ET. Why does a person become depressed? Duodecim 2009;125:1771-1779.  
(38) Titelman D, Oskarsson H, Wahlbeck K, Nordentoft M, Mehlum L, Jiang GX, Erlangsen A, Nrugham L, 
Wasserman D. Suicide mortality trends in the Nordic countries 1980-2009. Nord J Psychiatry 2013;published 
online ahead of print January 7, 2013.  
(39) Belmaker RH, Agam G. Major depressive disorder. N Engl J Med 2008;358:55-68.  
(40) The Finnish Current Care Guidelines. The Finnish Medical Society Duodecim and the Finnish Psychiatric 
Association. 2010; Available at: http://www.kaypahoito.fi/web/kh/suositukset/naytaartikkeli/.../hoi50023. 
Accessed 05/25, 2013.  
(41) The ICD-10 Classification of Mental and Behavioural Disorders; World Health Organization Clinical 
Descriptions and Diagnostic Guidelines. Geneva: World Health Organization; 1992.  
(42) Beck A, Ward C, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen 
Psychiatry 1961;4:561-571.  
(43) Salokangas RK, Stengard E, Poutanen O. DEPS--a new tool in screening for depression. Duodecim 
1994;110:1141-1148.  
(44) Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). Washington DC: 
American Psychiatric Association; 2000.  
(45) Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ 
primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 
1999;282:1737-1744.  
98 
 
 
(46) Suija K, Rajala U, Jokelainen J, Liukkonen T, Härkönen P, Keinänen-Kiukaanniemi S, Timonen M. 
Validation of the Whooley questions and the Beck Depression Inventory in older adults. Scand J Prim Health 
Care 2012;30:259-264.  
(47) Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 
1979;134:382-389.  
(48) Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.  
(49) Kaplan GA, Roberts RE, Camacho TC, Coyne JC. Psychosocial Predictors of Depression - Prospective 
Evidence from the Human-Population Laboratory Studies. Am J Epidemiol 1987;125:206-220.  
(50) Kendler KS, Gardner CO, Prescott CA. Toward a comprehensive developmental model for major 
depression in men. Am J Psychiatry 2006;163:115-124.  
(51) Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: review and meta-
analysis. Am J Psychiatry 2000;157:1552-1562.  
(52) Pasco JA, Williams LJ, Jacka FN, Ng F, Henry MJ, Nicholson GC, Kotowicz MA, Berk M. Tobacco 
smoking as a risk factor for major depressive disorder: population-based study. Br J Psychiatry 2008;193:322-
326.  
(53) Heim C, Binder EB. Current research trends in early life stress and depression: review of human studies 
on sensitive periods, gene-environment interactions, and epigenetics. Exp Neurol 2012;233:102-111.  
(54) McCrory E, De Brito SA, Viding E. The link between child abuse and psychopathology: a review of 
neurobiological and genetic research. J R Soc Med 2012;105:151-156.  
(55) Heim C, Newport DJ, Mletzko T, Miller AH, Nemeroff CB. The link between childhood trauma and 
depression: insights from HPA axis studies in humans. Psychoneuroendocrinology 2008;33:693-710.  
(56) Kendler KS, Gardner CO, Prescott CA. Clinical characteristics of major depression that predict risk of 
depression in relatives. Arch Gen Psychiatry 1999;56:322-327.  
(57) Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite 
A, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 
2003;301:386-389.  
(58) Lopresti AL, Hood SD, Drummond PD. A review of lifestyle factors that contribute to important 
pathways associated with major depression: Diet, sleep and exercise. J Affect Disord 2013;148:12-27.  
(59) Stone EA, Lin Y, Quartermain D. A final common pathway for depression? Progress toward a general 
conceptual framework. Neurosci Biobehav Rev 2008;32:508-524.  
(60) Syvälahti E, Hietala J. Farmakologia ja toksikologia. Masennuslääkkeet ja mielialan tasaajat. 8th ed. 
Porvoo, Finland: Kustannusosakeyhtiö Medicina, Kuopio. Bookwell Oy; 2012.  
(61) Maes M. Evidence for an immune response in major depression: a review and hypothesis. Prog 
Neuropsychopharmacol Biol Psychiatry 1995;19:11-38.  
(62) Maes M. Depression is an inflammatory disease, but cell-mediated immune activation is the key 
component of depression. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:664-675.  
99 
 
 
(63) Pasco JA, Nicholson GC, Williams LJ, Jacka FN, Henry MJ, Kotowicz MA, Schneider HG, Leonard BE, 
Berk M. Association of high-sensitivity C-reactive protein with de novo major depression. Br J Psychiatry 
2010;197:372-377.  
(64) Karlsson H. Depression as a systemic disease. Duodecim 2012;128:622-626.  
(65) Soczynska JK, Kennedy SH, Woldeyohannes HO, Liauw SS, Alsuwaidan M, Yim CY, McIntyre RS. Mood 
disorders and obesity: understanding inflammation as a pathophysiological nexus. Neuromolecular Med 
2011;13:93-116.  
(66) Chopra K, Kumar B, Kuhad A. Pathobiological targets of depression. Expert Opin Ther Targets 
2011;15:379-400.  
(67) Hansel A, Hong S, Camara RJ, von Kanel R. Inflammation as a psychophysiological biomarker in chronic 
psychosocial stress. Neurosci Biobehav Rev 2010;35:115-121.  
(68) Parker KJ, Schatzberg AF, Lyons DM. Neuroendocrine aspects of hypercortisolism in major depression. 
Horm Behav 2003;43:60-66.  
(69) Viinamäki H, Lehto SM, Palvimo JJ, Harvima I, Valkonen-Korhonen M, Koivumaa-Honkanen H, 
Hintikka J, Honkalampi K, Niskanen L. Glucocorticoids and aetiopathogenesis of depression. Duodecim 
2012;128:1022-1029.  
(70) Maes M, Bosmans E, Meltzer HY, Scharpe S, Suy E. Interleukin-1 beta: a putative mediator of HPA axis 
hyperactivity in major depression? Am J Psychiatry 1993;150:1189-1193.  
(71) Castren E, Rantamäki T. Role of brain-derived neurotrophic factor in the aetiology of depression: 
implications for pharmacological treatment. CNS Drugs 2010;24:1-7.  
(72) Leistedt SJ, Linkowski P. Brain, networks, depression, and more. Eur Neuropsychopharmacol 2012;23:55-
62.  
(73) Bocchio-Chiavetto L, Bagnardi V, Zanardini R, Molteni R, Nielsen MG, Placentino A, Giovannini C, 
Rillosi L, Ventriglia M, Riva MA, et al. Serum and plasma BDNF levels in major depression: a replication 
study and meta-analyses. World J Biol Psychiatry 2010;11:763-773.  
(74) Sanchez-Villegas A, Martinez-Gonzalez MA. Diet, a new target to prevent depression? BMC Med 
2013;11:3.  
(75) Schneider B, Prvulovic D. Novel biomarkers in major depression. Curr Opin Psychiatry 2013;26:47-53.  
(76) Fava M. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry 2003;53:649-659.  
(77) Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, Fawcett J. Antidepressant 
drug effects and depression severity: a patient-level meta-analysis. JAMA 2010;303:47-53.  
(78) Castren E. Neuronal Network Plasticity and Recovery From Depression. JAMA Psychiatry 2013.  
(79) Lucassen PJ, Meerlo P, Naylor AS, van Dam AM, Dayer AG, Fuchs E, Oomen CA, Czeh B. Regulation of 
adult neurogenesis by stress, sleep disruption, exercise and inflammation: Implications for depression and 
antidepressant action. Eur Neuropsychopharmacol 2010;20:1-17.  
100 
 
 
(80) Sharpley CF. A review of the neurobiological effects of psychotherapy for depression. Psychotherapy 
(Chic) 2010;47:603-615.  
(81) Maddock J, Berry DJ, Geoffroy MC, Power C, Hypponen E. Vitamin D and common mental disorders in 
mid-life: Cross-sectional and prospective findings. Clin Nutr 2013 Jan 21.  
(82) Shabbir F, Patel A, Mattison C, Bose S, Krishnamohan R, Sweeney E, Sandhu S, Nel W, Rais A, Sandhu R, 
et al. Effect of diet on serotonergic neurotransmission in depression. Neurochem Int 2013;62:324-329.  
(83) Payne ME, Steck SE, George RR, Steffens DC. Fruit, vegetable, and antioxidant intakes are lower in older 
adults with depression. J Acad Nutr Diet 2012;112:2022-2027.  
(84) Herbert V. Experimental nutritional folate deficiency in man. Trans Assoc Am Physicians 1961;75:307-320.  
(85) Gilbody S, Lightfoot T, Sheldon T. Is low folate a risk factor for depression? A meta-analysis and 
exploration of heterogeneity. J Epidemiol Community Health 2007;61:631-637.  
(86) Hibbeln JR. Fish consumption and major depression. Lancet 1998;351:1213.  
(87) Kesse-Guyot E, Touvier M, Andreeva VA, Jeandel C, Ferry M, Hercberg S, Galan P. Cross-sectional but 
not longitudinal association between n-3 fatty acid intake and depressive symptoms: results from the 
SU.VI.MAX 2 study. Am J Epidemiol 2012;175:979-987.  
(88) Lucas M, Mirzaei F, O'Reilly EJ, Pan A, Willett WC, Kawachi I, Koenen K, Ascherio A. Dietary intake of n-
3 and n-6 fatty acids and the risk of clinical depression in women: a 10-y prospective follow-up study. Am J 
Clin Nutr 2011;93:1337-1343.  
(89) Jacka FN, Pasco JA, Henry MJ, Kotowicz MA, Nicholson GC, Berk M. Dietary omega-3 fatty acids and 
depression in a community sample. Nutr Neurosci 2004;7:101-106.  
(90) Hakkarainen R, Partonen T, Haukka J, Virtamo J, Albanes D, Lönnqvist J. Is low dietary intake of omega-
3 fatty acids associated with depression? Am J Psychiatry 2004;161:567-569.  
(91) Kendler KS, Myers J, O Gardner C. Caffeine intake, toxicity and dependence and lifetime risk for 
psychiatric and substance use disorders: an epidemiologic and co-twin control analysis. Psychol Med 
2006;36:1717-1725.  
(92) Smith AP. Caffeine, cognitive failures and health in a non-working community sample. 2009;24:29-34.  
(93) Hintikka J, Tolmunen T, Honkalampi K, Haatainen K, Koivumaa-Honkanen H, Tanskanen A, Viinamäki 
H. Daily tea drinking is associated with a low level of depressive symptoms in the Finnish general population. 
Eur J Epidemiol 2005;20:359-363.  
(94) Hodge A, Almeida OP, English DR, Giles GG, Flicker L. Patterns of dietary intake and psychological 
distress in older Australians: benefits not just from a Mediterranean diet. Int Psychogeriatr 2013;25:456-466.  
(95) Jacka FN, Mykletun A, Berk M, Bjelland I, Tell GS. The association between habitual diet quality and the 
common mental disorders in community-dwelling adults: the Hordaland Health study. Psychosom Med 
2011;73:483-490.  
(96) Jacka FN, Rothon C, Taylor S, Berk M, Stansfeld SA. Diet quality and mental health problems in 
adolescents from East London: a prospective study. Soc Psychiatry Psychiatr Epidemiol 2012;published online 
ahead of print November 18.  
101 
 
 
(97) Mischoulon D, Raab MF. The role of folate in depression and dementia. J Clin Psychiatry 2007;68 Suppl 
10:28-33.  
(98) van de Rest O, van Hooijdonk LW, Doets E, Schiepers OJ, Eilander A, de Groot LC. B vitamins and n-3 
fatty acids for brain development and function: review of human studies. Ann Nutr Metab 2012;60:272-292.  
(99) Mattson MP, Shea TB. Folate and homocysteine metabolism in neural plasticity and neurodegenerative 
disorders. Trends Neurosci 2003;26:137-146.  
(100) Reynolds EH. Folic acid, ageing, depression, and dementia. BMJ 2002;324:1512-1515.  
(101) Freeman MP, Fava M, Lake J, Trivedi MH, Wisner KL, Mischoulon D. Complementary and alternative 
medicine in major depressive disorder: the American Psychiatric Association Task Force report. J Clin 
Psychiatry 2010;71:669-681.  
(102) Finnish recommendations for nutrition. Committee report of National Committee of Nutrition. Helsinki; 
Finland: Edita Oy; 2005.  
(103) The National FINDIET 2007 -survey. Publications of National Public Health Institute B 23/2008. 
Yliopistopaino; Helsinki; Finland; 2008.  
(104) Lazarou C, Kapsou M. The role of folic acid in prevention and treatment of depression: an overview of 
existing evidence and implications for practice. Complement Ther Clin Pract 2010;16:161-166.  
(105) Markus HS, Ali N, Swaminathan R, Sankaralingam A, Molloy J, Powell J. A common polymorphism in 
the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease. Stroke 
1997;28:1739-1743.  
(106) Gaysina D, Cohen S, Craddock N, Farmer A, Hoda F, Korszun A, Owen MJ, Craig IW, McGuffin P. No 
association with the 5,10-methylenetetrahydrofolate reductase gene and major depressive disorder: results of 
the depression case control (DeCC) study and a meta-analysis. Am J Med Genet B Neuropsychiatr Genet 
2008;147B:699-706.  
(107) Laboratory Centre of Eastern Finland; web-based manual. Itä-Suomen laboratoriokeskuksen 
liikelaitoskuntayhtymä (ISLAB). Kuopio. 2013; Available at: http://www.islab.fi/index.asp?tz=-3. Accessed 
07/24, 2013.  
(108) Hawkes JG, Villota R. Folates in foods: reactivity, stability during processing, and nutritional 
implications. Crit Rev Food Sci Nutr 1989;28:439-538.  
(109) Lee S, Wing YK, Fong S. A controlled study of folate levels in Chinese inpatients with major depression 
in Hong Kong. J Affect Disord 1998;49:73-77.  
(110) Allen LH. How common is vitamin B-12 deficiency? Am J Clin Nutr 2009;89:693S-6S.  
(111) Toh BH, Chan J, Kyaw T, Alderuccio F. Cutting edge issues in autoimmune gastritis. Clin Rev Allergy 
Immunol 2012;42:269-278.  
(112) Alpert JE, Mischoulon D, Nierenberg AA, Fava M. Nutrition and depression: focus on folate. Nutrition 
2000;16:544-546.  
102 
 
 
(113) Dimopoulos N, Piperi C, Salonicioti A, Psarra V, Gazi F, Papadimitriou A, Lea RW, Kalofoutis A. 
Correlation of folate, vitamin B12 and homocysteine plasma levels with depression in an elderly Greek 
population. Clin Biochem 2007;40:604-608.  
(114) Ng TP, Feng L, Niti M, Kua EH, Yap KB. Folate, vitamin B12, homocysteine, and depressive symptoms 
in a population sample of older Chinese adults. J Am Geriatr Soc 2009;57:871-876.  
(115) Park JY, You JS, Chang KJ. Dietary taurine intake, nutrients intake, dietary habits and life stress by 
depression in Korean female college students: a case-control study. J Biomed Sci 2010;17 Suppl 1:S40.  
(116) Robinson DJ, O'Luanaigh C, Tehee E, O'Connell H, Hamilton F, Chin AV, Coen R, Molloy AM, Scott J, 
Cunningham CJ, et al. Associations between holotranscobalamin, vitamin B12, homocysteine and depressive 
symptoms in community-dwelling elders. Int J Geriatr Psychiatry 2011;26:307-313.  
(117) Fava M, Borus JS, Alpert JE, Nierenberg AA, Rosenbaum JF, Bottiglieri T. Folate, vitamin B12, and 
homocysteine in major depressive disorder. Am J Psychiatry 1997;154:426-428.  
(118) Murakami K, Mizoue T, Sasaki S, Ohta M, Sato M, Matsushita Y, Mishima N. Dietary intake of folate, 
other B vitamins, and omega-3 polyunsaturated fatty acids in relation to depressive symptoms in Japanese 
adults. Nutrition 2008;24:140-147.  
(119) Tolmunen T, Voutilainen S, Hintikka J, Rissanen T, Tanskanen A, Viinamäki H, Kaplan GA, Salonen JT. 
Dietary folate and depressive symptoms are associated in middle-aged Finnish men. J Nutr 2003;133:3233-
3236.  
(120) Sanchez-Villegas A, Doreste J, Schlatter J, Pla J, Bes-Rastrollo M, Martinez-Gonzalez MA. Association 
between folate, vitamin B-6 and vitamin B-12 intake and depression in the SUN cohort study. 2009;22:122-133.  
(121) Hakkarainen R, Partonen T, Haukka J, Virtamo J, Albanes D, Lönnqvist J. Food and nutrient intake in 
relation to mental wellbeing. Nutr J 2004;3:14.  
(122) Kamphuis MH, Geerlings MI, Grobbee DE, Kromhout D. Dietary intake of B(6-9-12) vitamins, serum 
homocysteine levels and their association with depressive symptoms: the Zutphen Elderly Study. Eur J Clin 
Nutr 2008;62:939-945.  
(123) Sanchez-Villegas A, Doreste J, Schlatter J, Pla J, Bes-Rastrollo M, Martinez-Gonzalez MA. Association 
between folate, vitamin B(6) and vitamin B(12) intake and depression in the SUN cohort study. J Hum Nutr 
Diet 2009;22:122-133.  
(124) Seppälä J, Koponen H, Kautiainen H, Eriksson JG, Kampman O, Männistö S, Mäntyselkä P, Oksa H, 
Ovaskainen Y, Viikki M, et al. Association between folate intake and melancholic depressive symptoms. A 
Finnish population-based study. J Affect Disord 2012;138:473-478.  
(125) Ebly EM, Schaefer JP, Campbell NRC, Hogan DB. Folate status, vascular disease and cognition in elderly 
Canadians. Age Ageing 1998;27:485-491.  
(126) Sachdev PS, Parslow RA, Lux O, Salonikas C, Wen W, Naidoo D, Christensen H, Jorm AF. Relationship 
of homocysteine, folic acid and vitamin B12 with depression in a middle-aged community sample. Psychol 
Med 2005;35:529-538.  
(127) Morris MS, Fava M, Jacques PF, Selhub J, Rosenberg IH. Depression and folate status in the US 
Population. Psychother Psychosom 2003;72:80-87.  
103 
 
 
(128) Ramos MI, Allen LH, Haan MN, Green R, Miller JW. Plasma folate concentrations are associated with 
depressive symptoms in elderly Latina women despite folic acid fortification. Am J Clin Nutr 2004;80:1024-
1028.  
(129) Bjelland I, Tell G, Vollset S, Refsum H, Ueland P. Folate, vitamin B-12, homocysteine, and the MTHFR 
677C -> T polymorphism in anxiety and depression - The Hordaland Homocysteine Study. Arch Gen 
Psychiatry 2003;60:618-626.  
(130) Lindeman RD, Romero LJ, Koehler KM, Liang HC, LaRue A, Baumgartner RN, Garry PJ. Serum vitamin 
B12, C and folate concentrations in the New Mexico elder health survey: correlations with cognitive and 
affective functions. J Am Coll Nutr 2000;19:68-76.  
(131) Penninx BW, Guralnik JM, Ferrucci L, Fried LP, Allen RH, Stabler SP. Vitamin B(12) deficiency and 
depression in physically disabled older women: epidemiologic evidence from the Women's Health and Aging 
Study. Am J Psychiatry 2000;157:715-721.  
(132) Tiemeier H, van Tuijl HR, Hofman A, Meijer J, Kiliaan AJ, Breteler MM. Vitamin B12, folate, and 
homocysteine in depression: the Rotterdam Study. Am J Psychiatry 2002;159:2099-2101.  
(133) Carney MW, Chary TK, Laundy M, Bottiglieri T, Chanarin I, Reynolds EH, Toone B. Red cell folate 
concentrations in psychiatric patients. J Affect Disord 1990;19:207-213.  
(134) Refsum H, Smith AD, Ueland PM, Nexo E, Clarke R, McPartlin J, Johnston C, Engbaek F, Schneede J, 
McPartlin C, et al. Facts and recommendations about total homocysteine determinations: an expert opinion. 
Clin Chem 2004;50:3-32.  
(135) Hintikka J, Tolmunen T, Tanskanen A, Viinamäki H. High vitamin B12 level and good treatment 
outcome may be associated in major depressive disorder. BMC Psychiatry 2003;3:17.  
(136) Willett WC. Nutritional Epidemiology 3rd edition. New York: Oxford University Press; 2013. Pages: 38-
56, 70-85, 183-191, 274-278.  
(137) Andreeva VA, Galan P, Torres M, Julia C, Hercberg S, Kesse-Guyot E. Supplementation with B vitamins 
or n-3 fatty acids and depressive symptoms in cardiovascular disease survivors: ancillary findings from the 
SUpplementation with FOLate, vitamins B-6 and B-12 and/or OMega-3 fatty acids (SU.FOL.OM3) randomized 
trial. Am J Clin Nutr 2012;96:208-214.  
(138) Ford AH, Flicker L, Thomas J, Norman P, Jamrozik K, Almeida OP. Vitamins B12, B6, and folic acid for 
onset of depressive symptoms in older men: results from a 2-year placebo-controlled randomized trial. J Clin 
Psychiatry 2008;69:1203-1209.  
(139) Almeida OP, Marsh K, Alfonso H, Flicker L, Davis TM, Hankey GJ. B-vitamins reduce the long-term risk 
of depression after stroke: The VITATOPS-DEP trial. Ann Neurol 2010;68:503-510.  
(140) Harris E, Kirk J, Rowsell R, Vitetta L, Sali A, Scholey AB, Pipingas A. The effect of multivitamin 
supplementation on mood and stress in healthy older men. Hum Psychopharmacol 2011;26:560-567.  
(141) Carroll D, Ring C, Suter M, Willemsen G. The effects of an oral multivitamin combination with calcium, 
magnesium, and zinc on psychological well-being in healthy young male volunteers: a double-blind placebo-
controlled trial. Psychopharmacology (Berl) 2000;150:220-225.  
(142) Long SJ, Benton D. The effect of docosahexaenoic acid, vitamin and mineral supplementation on mood 
and mild-psychiatric symptoms. Submitted for publication in 2012.  
104 
 
 
(143) Long SJ, Benton D. Effects of vitamin and mineral supplementation on stress, mild psychiatric 
symptoms, and mood in nonclinical samples: a meta-analysis. Psychosom Med 2013;75:144-153.  
(144) Godfrey PS, Toone BK, Carney MW, Flynn TG, Bottiglieri T, Laundy M, Chanarin I, Reynolds EH. 
Enhancement of recovery from psychiatric illness by methylfolate. Lancet 1990;336:392-395.  
(145) Passeri M, Cucinotta D, Abate G, Senin U, Ventura A, Stramba Badiale M, Diana R, La Greca P, Le 
Grazie C. Oral 5'-methyltetrahydrofolic acid in senile organic mental disorders with depression: results of a 
double-blind multicenter study. Aging (Milano) 1993;5:63-71.  
(146) Guaraldi GP, Fava M, Mazzi F, la Greca P. An open trial of methyltetrahydrofolate in elderly depressed 
patients. Ann Clin Psychiatry 1993;5:101-105.  
(147) Alpert JE, Mischoulon D, Rubenstein GE, Bottonari K, Nierenberg AA, Fava M. Folinic acid (Leucovorin) 
as an adjunctive treatment for SSRI-refractory depression. Ann Clin Psychiatry 2002;14:33-38.  
(148) Resler G, Lavie R, Campos J, Mata S, Urbina M, Garcia A, Apitz R, Lima L. Effect of folic acid combined 
with fluoxetine in patients with major depression on plasma homocysteine and vitamin B12, and serotonin 
levels in lymphocytes. Neuroimmunomodulation 2008;15:145-152.  
(149) Christensen H, Aiken A, Batterham PJ, Walker J, Mackinnon AJ, Fenech M, Hickie IB. No clear 
potentiation of antidepressant medication effects by folic acid+vitamin B12 in a large community sample. J 
Affect Disord 2011;130:37-45.  
(150) Morris DW, Trivedi MH, Rush AJ. Folate and unipolar depression. 2008;14:277-285.  
(151) Taylor MJ, Carney S, Geddes J, Goodwin G. Folate for depressive disorders. Cochrane Database Syst Rev 
2003;2:CD003390.  
(152) Bottiglieri T. Homocysteine and folate metabolism in depression. Prog Neuropsychopharmacol Biol 
Psychiatry 2005;29:1103-1112.  
(153) Folstein M, Liu T, Peter I, Buell J, Arsenault L, Scott T, Qiu WW. The homocysteine hypothesis of 
depression. Am J Psychiatry 2007;164:861-867.  
(154) Coppen A, Bolander-Gouaille C. Treatment of depression: time to consider folic acid and vitamin B12. J 
Psychopharmacol 2005;19:59-65.  
(155) Tolmunen T, Hintikka J, Voutilainen S, Ruusunen A, Alfthan G, Nyyssönen K, Viinamäki H, Kaplan GA, 
Salonen JT. Association between depressive symptoms and serum concentrations of homocysteine in men: a 
population study. Am J Clin Nutr 2004;80:1574-1578.  
(156) Mischoulon D, Fava M. Role of S-adenosyl-L-methionine in the treatment of depression: a review of the 
evidence. Am J Clin Nutr 2002;76:1158S-61S.  
(157) Bressa GM. S-adenosyl-l-methionine (SAMe) as antidepressant: meta-analysis of clinical studies. Acta 
Neurol Scand Suppl 1994;154:7-14.  
(158) Mischoulon D, Burger JK, Spillmann MK, Worthington JJ, Fava M, Alpert JE. Anemia and macrocytosis 
in the prediction of serum folate and vitamin B12 status, and treatment outcome in major depression. J 
Psychosom Res 2000;49:183-187.  
105 
 
 
(159) Appleton KM, Rogers PJ, Ness AR. Is there a role for n-3 long-chain polyunsaturated fatty acids in the 
regulation of mood and behaviour? A review of the evidence to date from epidemiological studies, clinical 
studies and intervention trials. Nutr Res Rev 2008;21:13-41.  
(160) Tur JA, Bibiloni MM, Sureda A, Pons A. Dietary sources of omega 3 fatty acids: public health risks and 
benefits. Br J Nutr 2012;107 Suppl 2:S23-52.  
(161) Parker G, Gibson NA, Brotchie H, Heruc G, Rees AM, Hadzi-Pavlovic D. Omega-3 fatty acids and mood 
disorders. Am J Psychiatry 2006;163:969-978.  
(162) Holub BJ. Clinical nutrition: 4. Omega-3 fatty acids in cardiovascular care. CMAJ 2002;166:608-615.  
(163) Goyens PL, Spilker ME, Zock PL, Katan MB, Mensink RP. Conversion of alpha-linolenic acid in humans 
is influenced by the absolute amounts of alpha-linolenic acid and linoleic acid in the diet and not by their 
ratio. Am J Clin Nutr 2006;84:44-53.  
(164) Brenna JT. Efficiency of conversion of alpha-linolenic acid to long-chain n-3 fatty acids in man. Curr 
Opin Clin Nutr Metab Care 2002;5:127-132.  
(165) Decsi T, Kennedy K. Sex-specific differences in essential fatty acid metabolism. Am J Clin Nutr 
2011;94:1914-1919.  
(166) Burdge GC, Calder PC. Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in 
human adults. Reprod Nutr Dev 2005;45:581-597.  
(167) Liperoti R, Landi F, Fusco O, Bernabei R, Onder G. Omega-3 polyunsaturated fatty acids and 
depression: a review of the evidence. Curr Pharm Des 2009;15:4165-4172.  
(168) Su K. Mind-body interface: the role of n-3 fatty acids in psychoneuroimmunology, somatic presentation, 
and medical illness comorbidity of depression. Asia Pac J Clin Nutr 2008;17:151-157.  
(169) Tiemeier H, van Tuijl HR, Hofman A, Kiliaan AJ, Breteler MMB. Plasma fatty acid composition and 
depression are associated in the elderly: The Rotterdam Study. Am J Clin Nutr 2003;78:40-46.  
(170) Feart C, Peuchant E, Letenneur L, Samieri C, Montagnier D, Fourrier-Reglat A, Barberger-Gateau P. 
Plasma eicosapentaenoic acid is inversely associated with severity of depressive symptomatology in the 
elderly: data from the Bordeaux sample of the Three-City Study. Am J Clin Nutr 2008;87:1156-1162.  
(171) Davison KM, Kaplan BJ. Food intake and blood cholesterol levels of community-based adults with mood 
disorders. BMC Psychiatry 2012;12:10.  
(172) Tanskanen A, Hibbeln JR, Tuomilehto J, Uutela A, Haukkala A, Viinamäki H, Lehtonen J, Vartiainen E. 
Fish consumption and depressive symptoms in the general population in Finland. 2001;52:529-531.  
(173) Timonen M, Horrobin D, Jokelainen J, Laitinen J, Herva A, Räsänen P. Fish consumption and 
depression: the Northern Finland 1966 birth cohort study. J Affect Disord 2004;82:447-452.  
(174) Kamphuis MH, Geerlings MI, Tijhuis MA, Kalmijn S, Grobbee DE, Kromhout D. Depression and 
cardiovascular mortality: a role for n-3 fatty acids? Am J Clin Nutr 2006;84:1513-1517.  
(175) Silvers KM, Scott KM. Fish consumption and self-reported physical and mental health status. Public 
Health Nutr 2002;5:427-431.  
106 
 
 
(176) Bountziouka V, Polychronopoulos E, Zeimbekis A, Papavenetiou E, Ladoukaki E, Papairakleous N, 
Gotsis E, Metallinos G, Lionis C, Panagiotakos D. Long-term fish intake is associated with less severe 
depressive symptoms among elderly men and women: the MEDIS (MEDiterranean ISlands Elderly) 
epidemiological study. J Aging Health 2009;21:864-880.  
(177) Hoffmire CA, Block RC, Thevenet-Morrison K, van Wijngaarden E. Associations between omega-3 poly-
unsaturated fatty acids from fish consumption and severity of depressive symptoms: an analysis of the 2005-
2008 National Health and Nutrition Examination Survey. Prostaglandins Leukot Essent Fatty Acids 
2012;86:155-160.  
(178) Suominen-Taipale AL, Turunen AW, Partonen T, Kaprio J, Männistö S, Montonen J, Jula A, Tiittanen P, 
Verkasalo PK. Fish consumption and polyunsaturated fatty acids in relation to psychological distress. Int J 
Epidemiol 2010;39:494-503.  
(179) Sanchez-Villegas A, Henriquez P, Bes-Rastrollo M, Doreste J. Mediterranean diet and depression. Public 
Health Nutr 2006;9:1104-1109.  
(180) Frasure-Smith N, Lesperance F, Julien P. Major depression is associated with lower omega-3 fatty acid 
levels in patients with recent acute coronary syndromes. Biol Psychiatry 2004;55:891-896.  
(181) Maes M, Christophe A, Delanghe J, Altamura C, Neels H, Meltzer HY. Lowered omega 3 
polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry 
Res 1999;85:275-291.  
(182) Panagiotakos DB, Mamplekou E, Pitsavos C, Kalogeropoulos N, Kastorini CM, Papageorgiou C, 
Papadimitriou GN, Stefanadis C. Fatty acids intake and depressive symptomatology in a Greek sample: an 
epidemiological analysis. J Am Coll Nutr 2010;29:586-594.  
(183) Edwards R, Peet M, Shay J, Horrobin D. Omega-3 polyunsaturated fatty acid levels in the diet and in red 
blood cell membranes of depressed patients. J Affect Disord 1998;48:149-155.  
(184) Peet M, Murphy B, Shay J, Horrobin D. Depletion of omega-3 fatty acid levels in red blood cell 
membranes of depressive patients. Biol Psychiatry 1998;43:315-319.  
(185) Mamalakis G, Tornaritis M, Kafatos A. Depression and adipose essential polyunsaturated fatty acids. 
Prostaglandins Leukot Essent Fatty Acids 2002;67:311-318.  
(186) Mamalakis G, Kiriakakis M, Tsibinos G, Jansen E, Cremers H, Strien C, Hatzis C, Moschandreas J, 
Linardakis M, Kromhout D, et al. Lack of an association of depression with n-3 polyunsaturated fatty acids in 
adipose tissue and serum phospholipids in healthy adults. Pharmacol Biochem Behav 2008;89:6-10.  
(187) Maes M, Smith R, Christophe A, Cosyns P, Desnyder R, Meltzer H. Fatty acid composition in major 
depression: Decreased omega 3 fractions in cholesteryl esters and increased C20:4 omega 6/C20:5 omega 3 
ratio in cholesteryl esters and phospholipids. J Affect Disord 1996;38:35-46.  
(188) Endres S, Meydani SN, Ghorbani R, Schindler R, Dinarello CA. Dietary supplementation with n-3 fatty 
acids suppresses interleukin-2 production and mononuclear cell proliferation. J Leukoc Biol 1993;54:599-603.  
(189) Dinan T, Siggins L, Scully P, O'Brien S, Ross P, Stanton C. Investigating the inflammatory phenotype of 
major depression: Focus on cytokines and polyunsaturated fatty acids. J Psychiatr Res 2009;43:471-476.  
107 
 
 
(190) Appleton KM, Gunnell D, Peters TJ, Ness AR, Kessler D, Rogers PJ. No clear evidence of an association 
between plasma concentrations of n-3 long-chain polyunsaturated fatty acids and depressed mood in a non-
clinical population. Prostaglandins Leukot Essent Fatty Acids 2008;78:337-342.  
(191) Sacks FM, Campos H. Polyunsaturated fatty acids, inflammation, and cardiovascular disease: time to 
widen our view of the mechanisms. J Clin Endocrinol Metab 2006;91:398-400.  
(192) Liou YA, King DJ, Zibrik D, Innis SM. Decreasing linoleic acid with constant alpha-linolenic acid in 
dietary fats increases (n-3) eicosapentaenoic acid in plasma phospholipids in healthy men. J Nutr 
2007;137:945-952.  
(193) van de Rest O, Geleijnse JM, Kok FJ, van Staveren WA, Hoefnagels WH, Beekman AT, de Groot LC. 
Effect of fish-oil supplementation on mental well-being in older subjects: a randomized, double-blind, 
placebo-controlled trial. Am J Clin Nutr 2008;88:706-713.  
(194) Nemets B, Stahl Z, Belmaker RH. Addition of omega-3 fatty acid to maintenance medication treatment 
for recurrent unipolar depressive disorder. Am J Psychiatry 2002;159:477-479.  
(195) Su KP, Huang SY, Chiu CC, Shen WW. Omega-3 fatty acids in major depressive disorder. A preliminary 
double-blind, placebo-controlled trial. Eur Neuropsychopharmacol 2003;13:267-271.  
(196) Jazayeri S, Tehrani-Doost M, Keshavarz SA, Hosseini M, Djazayery A, Amini H, Jalali M, Peet M. 
Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and 
in combination, in major depressive disorder. Aust N Z J Psychiatry 2008;42:192-198.  
(197) Sinn N, Milte CM, Street SJ, Buckley JD, Coates AM, Petkov J, Howe PR. Effects of n-3 fatty acids, EPA v. 
DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild 
cognitive impairment: a 6-month randomised controlled trial. Br J Nutr 2012;107:1682-1693.  
(198) Gertsik L, Poland RE, Bresee C, Rapaport MH. Omega-3 fatty acid augmentation of citalopram treatment 
for patients with major depressive disorder. J Clin Psychopharmacol 2012;32:61-64.  
(199) Rondanelli M, Giacosa A, Opizzi A, Pelucchi C, La Vecchia C, Montorfano G, Negroni M, Berra B, Politi 
P, Rizzo AM. Long-chain omega 3 polyunsaturated fatty acids supplementation in the treatment of elderly 
depression: effects on depressive symptoms, on phospholipids fatty acids profile and on health-related 
quality of life. J Nutr Health Aging 2011;15:37-44.  
(200) Peet M, Horrobin DF. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with 
ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 
2002;59:913-919.  
(201) Lesperance F, Frasure-Smith N, St-Andre E, Turecki G, Lesperance P, Wisniewski SR. The efficacy of 
omega-3 supplementation for major depression: a randomized controlled trial. J Clin Psychiatry 2011;72:1054-
1062.  
(202) Rogers PJ, Appleton KM, Kessler D, Peters TJ, Gunnell D, Hayward RC, Heatherley SV, Christian LM, 
McNaughton SA, Ness AR. No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) 
supplementation on depressed mood and cognitive function: a randomised controlled trial. Br J Nutr 
2008;99:421-431.  
(203) Marangell LB, Martinez JM, Zboyan HA, Kertz B, Kim HF, Puryear LJ. A double-blind, placebo-
controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J 
Psychiatry 2003;160:996-998.  
108 
 
 
(204) Silvers KM, Woolley CC, Hamilton FC, Watts PM, Watson RA. Randomised double-blind placebo-
controlled trial of fish oil in the treatment of depression. Prostaglandins Leukot Essent Fatty Acids 
2005;72:211-218.  
(205) Carney RM, Freedland KE, Rubin EH, Rich MW, Steinmeyer BC, Harris WS. Omega-3 augmentation of 
sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial. 
JAMA 2009;302:1651-1657.  
(206) Grenyer BF, Crowe T, Meyer B, Owen AJ, Grigonis-Deane EM, Caputi P, Howe PR. Fish oil 
supplementation in the treatment of major depression: a randomised double-blind placebo-controlled trial. 
Prog Neuropsychopharmacol Biol Psychiatry 2007;31:1393-1396.  
(207) Mischoulon D, Papakostas GI, Dording CM, Farabaugh AH, Sonawalla SB, Agoston AM, Smith J, 
Beaumont EC, Dahan LE, Alpert JE, et al. A double-blind, randomized controlled trial of ethyl-
eicosapentaenoate for major depressive disorder. J Clin Psychiatry 2009;70:1636-1644.  
(208) Bot M, Pouwer F, Assies J, Jansen EH, Beekman AT, de Jonge P. Supplementation with eicosapentaenoic 
omega-3 fatty acid does not influence serum brain-derived neurotrophic factor in diabetes mellitus patients 
with major depression: a randomized controlled pilot study. Neuropsychobiology 2011;63:219-223.  
(209) Ross BM, Seguin J, Sieswerda LE. Omega-3 fatty acids as treatments for mental illness: which disorder 
and which fatty acid? Lipids Health Dis 2007;6:21.  
(210) Martins JG. EPA but not DHA appears to be responsible for the efficacy of omega-3 long-chain 
polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized 
controlled trials. J Am Coll Nutr 2009;28:525-542.  
(211) Lin P, Su K. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy 
of omega-3 fatty acids. J Clin Psychiatry 2007;68:1056-1061.  
(212) Martins JG, Bentsen H, Puri BK. Eicosapentaenoic acid appears to be the key omega-3 fatty acid 
component associated with efficacy in major depressive disorder: a critique of Bloch and Hannestad and 
updated meta-analysis. Mol Psychiatry 2012;17:1144-9; discussion 1163-7.  
(213) Sublette ME, Ellis SP, Geant AL, Mann JJ. Meta-analysis of the effects of eicosapentaenoic acid (EPA) in 
clinical trials in depression. J Clin Psychiatry 2011;72:1577-1584.  
(214) Bot M, Pouwer F, Assies J, Jansen EH, Diamant M, Snoek FJ, Beekman AT, de Jonge P. Eicosapentaenoic 
acid as an add-on to antidepressant medication for co-morbid major depression in patients with diabetes 
mellitus: a randomized, double-blind placebo-controlled study. J Affect Disord 2010;126:282-286.  
(215) Hibbeln JR, Salem N,Jr. Dietary polyunsaturated fatty acids and depression: when cholesterol does not 
satisfy. Am J Clin Nutr 1995;62:1-9.  
(216) Philbrick DJ, Mahadevappa VG, Ackman RG, Holub BJ. Ingestion of fish oil or a derived n-3 fatty acid 
concentrate containing eicosapentaenoic acid (EPA) affects fatty acid compositions of individual 
phospholipids of rat brain, sciatic nerve and retina. J Nutr 1987;117:1663-1670.  
(217) Su KP. Biological mechanism of antidepressant effect of omega-3 fatty acids: how does fish oil act as a 
'mind-body interface'? Neurosignals 2009;17:144-152.  
(218) Yehuda S, Rabinovitz S, Mostofsky DI. Modulation of learning and neuronal membrane composition in 
the rat by essential fatty acid preparation: time-course analysis. Neurochem Res 1998;23:627-634.  
109 
 
 
(219) Obajimi O, Black KD, MacDonald DJ, Boyle RM, Glen I, Ross BM. Differential effects of eicosapentaenoic 
and docosahexaenoic acids upon oxidant-stimulated release and uptake of arachidonic acid in human 
lymphoma U937 cells. Pharmacol Res 2005;52:183-191.  
(220) Horrobin DF, Jenkins K, Bennett CN, Christie WW. Eicosapentaenoic acid and arachidonic acid: 
collaboration and not antagonism is the key to biological understanding. Prostaglandins Leukot Essent Fatty 
Acids 2002;66:83-90.  
(221) Kiecolt-Glaser JK, Belury MA, Porter K, Beversdorf DQ, Lemeshow S, Glaser R. Depressive symptoms, 
omega-6 : omega-3 fatty acids, and inflammation in older adults. Psychosom Med 2007;69:217-224.  
(222) Zampelas A, Panagiotakos DB, Pitsavos C, Das UN, Chrysohoou C, Skoumas Y, Stefanadis C. Fish 
consumption among healthy adults is associated with decreased levels of inflammatory markers related to 
cardiovascular disease: the ATTICA study. J Am Coll Cardiol 2005;46:120-124.  
(223) Reinders I, Virtanen JK, Brouwer IA, Tuomainen TP. Association of serum n-3 polyunsaturated fatty 
acids with C-reactive protein in men. Eur J Clin Nutr 2012;66:736-741.  
(224) Schmitz G, Ecker J. The opposing effects of n-3 and n-6 fatty acids. Prog Lipid Res 2008;47:147-155.  
(225) Lopez-Garcia E, Schulze MB, Manson JE, Meigs JB, Albert CM, Rifai N, Willett WC, Hu FB. 
Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation 
in women. J Nutr 2004;134:1806-1811.  
(226) Jazayeri S, Keshavarz SA, Tehrani-Doost M, Djalali M, Hosseini M, Amini H, Chamari M, Djazayery A. 
Effects of eicosapentaenoic acid and fluoxetine on plasma cortisol, serum interleukin-1beta and interleukin-6 
concentrations in patients with major depressive disorder. Psychiatry Res 2010;178:112-115.  
(227) Matsuoka Y, Nishi D, Yonemoto N, Hamazaki K, Hamazaki T, Hashimoto K. Potential role of brain-
derived neurotrophic factor in omega-3 Fatty Acid supplementation to prevent posttraumatic distress after 
accidental injury: an open-label pilot study. Psychother Psychosom 2011;80:310-312.  
(228) Turunen AW, Männistö S, Suominen AL, Tiittanen P, Verkasalo PK. Fish consumption in relation to 
other foods in the diet. Br J Nutr 2011;106:1570-1580.  
(229) Freeman MP, Hibbeln JR, Wisner KL, Davis JM, Mischoulon D, Peet M, Keck PE,Jr, Marangell LB, 
Richardson AJ, Lake J, et al. Omega-3 fatty acids: evidence basis for treatment and future research in 
psychiatry. J Clin Psychiatry 2006;67:1954-1967.  
(230) Historical Coffee Statistics. International Coffee Organization ICO, London. 2013; Available at: 
http://www.ico.org/countries/finland.pdf. Accessed 05/20, 2013.  
(231) Dorea JG, da Costa THM. Is coffee a functional food? Br J Nutr 2005;93:773-782.  
(232) Bravo J, Juaniz I, Monente C, Caemmerer B, Kroh LW, De Pena MP, Cid C. Evaluation of spent coffee 
obtained from the most common coffeemakers as a source of hydrophilic bioactive compounds. J Agric Food 
Chem 2012;60:12565-12573.  
(233) Minamisawa M, Yoshida S, Takai N. Determination of biologically active substances in roasted coffees 
using a diode-array HPLC system. 2004;20:325-328.  
(234) Bonita JS, Mandarano M, Shuta D, Vinson J. Coffee and cardiovascular disease: in vitro, cellular, animal, 
and human studies. Pharmacol Res 2007;55:187-198.  
110 
 
 
(235) Mukhtar H, Ahmad N. Tea polyphenols: prevention of cancer and optimizing health. Am J Clin Nutr 
2000;71:1698S-1704S.  
(236) Hodgson JM, Croft KD. Tea flavonoids and cardiovascular health. Mol Aspects Med 2010;31:495-502.  
(237) Balentine DA, Wiseman SA, Bouwens LC. The chemistry of tea flavonoids. Crit Rev Food Sci Nutr 
1997;37:693-704.  
(238) Frary CD, Johnson RK, Wang MQ. Food sources and intakes of caffeine in the diets of persons in the 
United States. J Am Diet Assoc 2005;105:110-113.  
(239) McCusker RR, Goldberger BA, Cone EJ. Caffeine content of specialty coffees. J Anal Toxicol 2003;27:520-
522.  
(240) Barone JJ, Roberts HR. Caffeine consumption. Food Chem Toxicol 1996;34:119-129.  
(241) Nawrot P, Jordan S, Eastwood J, Rotstein J, Hugenholtz A, Feeley M. Effects of caffeine on human 
health. 2003;20:1-30.  
(242) Valsta L, Borg P, Heiskanen S, Keskinen H, Männistö S, Rautio T, et al. Beverages in diet. The National 
Nutrition Council. Helsinki: Yliopistopaino; 2008.  
(243) Harland BF. Caffeine and nutrition. Nutrition 2000;16:522-526.  
(244) Broderick P, Benjamin AB. Caffeine and psychiatric symptoms: a review. J Okla State Med Assoc 
2004;97:538-542.  
(245) Silverman K, Evans SM, Strain EC, Griffiths RR. Withdrawal syndrome after the double-blind cessation 
of caffeine consumption. N Engl J Med 1992;327:1109-1114.  
(246) Rogers PJ, Dernoncourt C. Regular caffeine consumption: a balance of adverse and beneficial effects for 
mood and psychomotor performance. Pharmacol Biochem Behav 1998;59:1039-1045.  
(247) Smith AP. Caffeine, caffeine withdrawal and psychomotor performance: a reply to James. 
Neuropsychobiology 1995;31:200-201.  
(248) Haskell CF, Kennedy DO, Wesnes KA, Scholey AB. Cognitive and mood improvements of caffeine in 
habitual consumers and habitual non-consumers of caffeine. Psychopharmacology (Berl) 2005;179:813-825.  
(249) Xu Q, Anderson D, Courtney M. A longitudinal study of the relationship between lifestyle and mental 
health among midlife and older women in Australia: findings from the Healthy Aging of Women Study. 
Health Care Women Int 2010;31:1082-1096.  
(250) Lucas M, Mirzaei F, Pan A, Okereke OI, Willett WC, O'Reilly EJ, Koenen K, Ascherio A. Coffee, caffeine, 
and risk of depression among women. Arch Intern Med 2011;171:1571-1578.  
(251) Pham NM, Nanri A, Kurotani K, Kuwahara K, Kume A, Sato M, Hayabuchi H, Mizoue T. Green tea and 
coffee consumption is inversely associated with depressive symptoms in a Japanese working population. 
Public Health Nutr 2013:1-9.  
(252) Lara DR. Caffeine, mental health, and psychiatric disorders. J Alzheimers Dis 2010;20 Suppl 1:239-248.  
(253) Hawton K, van Heeringen K. Suicide. Lancet 2009;373:1372-1381.  
111 
 
 
(254) Tanskanen A, Tuomilehto J, Viinamäki H, Vartiainen E, Lehtonen J, Puska P. Heavy coffee drinking and 
the risk of suicide. Eur J Epidemiol 2000;16:789-791.  
(255) Kawachi I, Willett WC, Colditz GA, Stampfer MJ, Speizer FE. A prospective study of coffee drinking and 
suicide in women. Arch Intern Med 1996;156:521-525.  
(256) Klatsky AL, Armstrong MA, Friedman GD. Coffee, tea, and mortality. Ann Epidemiol 1993;3:375-381.  
(257) Szekely T. Caffeine as a stimulant against suicide. Arch Intern Med 1997;157:243-244.  
(258) Kaasinen V, Aalto S, Nagren K, Rinne JO. Dopaminergic effects of facceine in the human striatum and 
thalamus. Neuroreport 2004;15:281-285.  
(259) Natella F, Nardini M, Giannetti I, Dattilo C, Scaccini C. Coffee drinking influences plasma antioxidant 
capacity in humans. J Agric Food Chem 2002;50:6211-6216.  
(260) David dos Santos M, Camila Almeida M, Peporine Lopes N, Emilia Petto de Souza G. Evaluation of the 
anti-inflammatory, analgesic and antipyretic activities of the natural polyphenol chlorogenic acid. Biol Pharm 
Bull 2006;29:2236-2240.  
(261) Sarandol A, Sarandol E, Eker SS, Erdinc S, Vatansever E, Kirli S. Major depressive disorder is 
accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative 
systems. 2007;22:67-73.  
(262) Scalbert A, Williamson G. Dietary intake and bioavailability of polyphenols. J Nutr 2000;130:2073S-
2085S.  
(263) Yanik M, Erel O, Kati M. The relationship between potency of oxidative stress and severity of 
depression. Acta Neuropsychiatr 2004;16:200-203.  
(264) Hozawa A, Kuriyama S, Nakaya N, Ohmori-Matsuda K, Kakizaki M, Sone T, Nagai M, Sugawara Y, 
Nitta A, Tomata Y, et al. Green tea consumption is associated with lower psychological distress in a general 
population: the Ohsaki Cohort 2006 Study. Am J Clin Nutr 2009;90:1390-1396.  
(265) Niu K, Hozawa A, Kuriyama S, Ebihara S, Guo H, Nakaya N, Ohmori-Matsuda K, Takahashi H, 
Masamune Y, Asada M, et al. Green tea consumption is associated with depressive symptoms in the elderly. 
Am J Clin Nutr 2009;90:1615-1622.  
(266) Chen X, Lu W, Zheng Y, Gu K, Chen Z, Zheng W, Shu XO. Exercise, tea consumption, and depression 
among breast cancer survivors. J Clin Oncol 2010;28:991-998.  
(267) Singal A, Tirkey N, Muragundla A, Chopra K. Green tea [Camellia sinensis (L.) O. Kuntze] extract 
reverses the despair behaviour in reserpinised and diabetic mice. Indian J Exp Biol 2006;44:913-917.  
(268) Nathan PJ, Lu K, Gray M, Oliver C. The neuropharmacology of L-theanine(N-ethyl-L-glutamine): a 
possible neuroprotective and cognitive enhancing agent. J Herb Pharmacother 2006;6:21-30.  
(269) Newby PK, Tucker KL. Empirically derived eating patterns using factor or cluster analysis: a review. 
Nutr Rev 2004;62:177-203.  
(270) Hu FB. Dietary pattern analysis: a new direction in nutritional epidemiology. Curr Opin Lipidol 
2002;13:3-9.  
112 
 
 
(271) Chiuve SE, Fung TT, Rimm EB, Hu FB, McCullough ML, Wang M, Stampfer MJ, Willett WC. Alternative 
dietary indices both strongly predict risk of chronic disease. J Nutr 2012;142:1009-1018.  
(272) Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean diet and survival 
in a Greek population. N Engl J Med 2003;348:2599-2608.  
(273) Mila-Villarroel R, Bach-Faig A, Puig J, Puchal A, Farran A, Serra-Majem L, Carrasco JL. Comparison and 
evaluation of the reliability of indexes of adherence to the Mediterranean diet. Public Health Nutr 
2011;14:2338-2345.  
(274) Kanerva N, Kaartinen NE, Schwab U, Lahti-Koski M, Männistö S. Adherence to the Baltic Sea diet 
consumed in the Nordic countries is associated with lower abdominal obesity. Br J Nutr 2012:1-9.  
(275) Appelhans BM, Whited MC, Schneider KL, Ma Y, Oleski JL, Merriam PA, Waring ME, Olendzki BC, 
Mann DM, Ockene IS, et al. Depression severity, diet quality, and physical activity in women with obesity and 
depression. J Acad Nutr Diet 2012;112:693-698.  
(276) Konttinen H, Männistö S, Sarlio-Lähteenkorva S, Silventoinen K, Haukkala A. Emotional eating, 
depressive symptoms and self-reported food consumption. A population-based study. Appetite 2010;54:473-
479.  
(277) Sarlio-Lahteenkorva S, Lahelma E, Roos E. Mental health and food habits among employed women and 
men. Appetite 2004;42:151-156.  
(278) Christensen L, Somers S. Comparison of nutrient intake among depressed and nondepressed 
individuals. Int J Eat Disord 1996;20:105-109.  
(279) Thase ME. Recognition and diagnosis of atypical depression. J Clin Psychiatry 2007;68:11-16.  
(280) Oddy WH, Robinson M, Ambrosini GL, O'Sullivan TA, de Klerk NH, Beilin LJ, Silburn SR, Zubrick SR, 
Stanley FJ. The association between dietary patterns and mental health in early adolescence. Prev Med 
2009;49:39-44.  
(281) Nanri A, Kimura Y, Matsushita Y, Ohta M, Sato M, Mishima N, Sasaki S, Mizoue T. Dietary patterns and 
depressive symptoms among Japanese men and women. Eur J Clin Nutr 2010;64:832-839.  
(282) Sugawara N, Yasui-Furukori N, Tsuchimine S, Kaneda A, Tsuruga K, Iwane K, Okubo N, Takahashi I, 
Kaneko S. No association between dietary patterns and depressive symptoms among a community-dwelling 
population in Japan. Ann Gen Psychiatry 2012;11:24.  
(283) Samieri C, Jutand MA, Feart C, Capuron L, Letenneur L, Barberger-Gateau P. Dietary patterns derived 
by hybrid clustering method in older people: association with cognition, mood, and self-rated health. J Am 
Diet Assoc 2008;108:1461-1471.  
(284) Sanchez-Villegas A, Delgado-Rodriguez M, Alonso A, Schlatter J, Lahortiga F, Serra Majem L, Martinez-
Gonzalez MA. Association of the Mediterranean dietary pattern with the incidence of depression: the 
Seguimiento Universidad de Navarra/University of Navarra follow-up (SUN) cohort. Arch Gen Psychiatry 
2009;66:1090-1098.  
(285) Jacka FN, Pasco JA, Mykletun A, Williams LJ, Hodge AM, O'Reilly SL, Nicholson GC, Kotowicz MA, 
Berk M. Association of Western and traditional diets with depression and anxiety in women. Am J Psychiatry 
2010;167:305-311.  
113 
 
 
(286) Akbaraly TN, Sabia S, Shipley MJ, Batty GD, Kivimäki M. Adherence to healthy dietary guidelines and 
future depressive symptoms: evidence for sex differentials in the Whitehall II study. Am J Clin Nutr 
2013;97:419-427.  
(287) Weng TT, Hao JH, Qian QW, Cao H, Fu JL, Sun Y, Huang L, Tao FB. Is there any relationship between 
dietary patterns and depression and anxiety in Chinese adolescents? Public Health Nutr 2012;15:673-682.  
(288) Kuczmarski MF, Cremer Sees A, Hotchkiss L, Cotugna N, Evans MK, Zonderman AB. Higher Healthy 
Eating Index-2005 scores associated with reduced symptoms of depression in an urban population: findings 
from the Healthy Aging in Neighborhoods of Diversity Across the Life Span (HANDLS) study. J Am Diet 
Assoc 2010;110:383-389.  
(289) Jacka FN, Kremer PJ, Berk M, de Silva-Sanigorski AM, Moodie M, Leslie ER, Pasco JA, Swinburn BA. A 
prospective study of diet quality and mental health in adolescents. PLoS One 2011;6:e24805.  
(290) Skarupski KA, Tangney CC, Li H, Evans DA, Morris MC. Mediterranean Diet and Depressive 
Symptoms among Older Adults over Time. J Nutr Health Aging 2013;17:441-445.  
(291) Beezhold BL, Johnston CS. Restriction of meat, fish, and poultry in omnivores improves mood: a pilot 
randomized controlled trial. Nutr J 2012;11:9-2891-11-9.  
(292) Garriguet D. Diet quality in Canada. Health Rep 2009;20:41-52.  
(293) White BA, Horwath CC, Conner TS. Many apples a day keep the blues away - Daily experiences of 
negative and positive affect and food consumption in young adults. Br J Health Psychol 2013.  
(294) Pascoe MC, Crewther SG, Carey LM, Crewther DP. What you eat is what you are -- a role for 
polyunsaturated fatty acids in neuroinflammation induced depression? Clin Nutr 2011;30 Suppl 8:407-415.  
(295) Jacka FN, Pasco JA, McConnell S, Williams LJ, Kotowicz MA, Nicholson GC, Berk M. Self-reported 
depression and cardiovascular risk factors in a community sample of women. Psychosomatics 2007;48:54-59.  
(296) Garcia-Prieto MD, Tebar FJ, Nicolas F, Larque E, Zamora S, Garaulet M. Cortisol secretary pattern and 
glucocorticoid feedback sensitivity in women from a Mediterranean area: relationship with anthropometric 
characteristics, dietary intake and plasma fatty acid profile. Clin Endocrinol (Oxf) 2007;66:185-191.  
(297) Sanchez-Villegas A, Galbete C, Martinez-Gonzalez MA, Martinez JA, Razquin C, Salas-Salvado J, 
Estruch R, Buil-Cosiales P, Marti A. The effect of the Mediterranean diet on plasma brain-derived 
neurotrophic factor (BDNF) levels: the PREDIMED-NAVARRA randomized trial. Nutr Neurosci 2011;14:195-
201.  
(298) Kosova EC, Auinger P, Bremer AA. The Relationships between Sugar-Sweetened Beverage Intake and 
Cardiometabolic Markers in Young Children. J Acad Nutr Diet 2013;113:219-227.  
(299) Micha R, Michas G, Mozaffarian D. Unprocessed red and processed meats and risk of coronary artery 
disease and type 2 diabetes--an updated review of the evidence. Curr Atheroscler Rep 2012;14:515-524.  
(300) Molteni R, Barnard RJ, Ying Z, Roberts CK, Gomez-Pinilla F. A high-fat, refined sugar diet reduces 
hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning. Neuroscience 2002;112:803-
814.  
(301) Ekmekcioglu C. Are proinflammatory cytokines involved in an increased risk for depression by 
unhealthy diets? Med Hypotheses 2012;78:337-340.  
114 
 
 
(302) Quirk SE, Williams LJ, O Neil A, Pasco JA, Jacka FN, Housden S, Berk M, Brennan SL. The association 
between diet quality, dietary patterns and depression in adults: a systematic review. BMC Psychiatry 
2013;13:175.  
(303) Rubin RR, Knowler WC, Ma Y, Marrero DG, Edelstein SL, Walker EA, Garfield SA, Fisher EB, Diabetes 
Prevention Program Res. Depression symptoms and antidepressant medicine use in diabetes prevention 
program participants. Diabetes Care 2005;28:830-837.  
(304) Lund A, Michelet M, Sandvik L, Wyller T, Sveen U. A lifestyle intervention as supplement to a physical 
activity programme in rehabilitation after stroke: a randomized controlled trial. Clin Rehabil 2012;26:502-512.  
(305) Matthews MM, Hsu FC, Walkup MP, Barry LC, Patel KV, Blair SN. Depressive symptoms and physical 
performance in the lifestyle interventions and independence for elders pilot study. J Am Geriatr Soc 
2011;59:495-500.  
(306) Bogaerts AF, Devlieger R, Nuyts E, Witters I, Gyselaers W, Van den Bergh BR. Effects of lifestyle 
intervention in obese pregnant women on gestational weight gain and mental health: a randomized 
controlled trial. Int J Obes (Lond) 2012;published online ahead of print October 2, 2012.  
(307) Thomson RL, Buckley JD, Lim SS, Noakes M, Clifton PM, Norman RJ, Brinkworth GD. Lifestyle 
management improves quality of life and depression in overweight and obese women with polycystic ovary 
syndrome. Fertil Steril 2010;94:1812-1816.  
(308) Williamson DA, Rejeski J, Lang W, Van Dorsten B, Fabricatore AN, Toledo K, Look AHEAD Res Grp. 
Impact of a Weight Management Program on Health-Related Quality of Life in Overweight Adults With Type 
2 Diabetes. Arch Intern Med 2009;169:163-171.  
(309) Faulconbridge LF, Wadden TA, Rubin RR, Wing RR, Walkup MP, Fabricatore AN, Coday M, Van 
Dorsten B, Mount DL, Ewing LJ, et al. One-year changes in symptoms of depression and weight in 
overweight/obese individuals with type 2 diabetes in the Look AHEAD study. Obesity (Silver Spring) 
2012;20:783-793.  
(310) Kieffer EC, Caldwell CH, Welmerink DB, Welch KB, Sinco BR, Guzman JR. Effect of the Healthy MOMs 
Lifestyle Intervention on Reducing Depressive Symptoms Among Pregnant Latinas. Am J Community 
Psychol 2013;51:76-89.  
(311) Imayama I, Alfano CM, Kong A, Foster-Schubert KE, Bain CE, Xiao L, Duggan C, Wang CY, Campbell 
KL, Blackburn GL, et al. Dietary weight loss and exercise interventions effects on quality of life in 
overweight/obese postmenopausal women: a randomized controlled trial. Int J Behav Nutr Phys Act 
2011;8:118-5868-8-118.  
(312) Garcia-Toro M, Ibarra O, Gili M, Serrano MJ, Vives M, Monzon S, Bauza N, Olivan B, Vicens E, Roca M. 
Adherence to lifestyle recommendations by patients with depression. Rev Psiquiatr Salud Ment 2012;5:236-
240.  
(313) Casanas R, Catalan R, Del Val JL, Real J, Valero S, Casas M. Effectiveness of a psycho-educational group 
program for major depression in primary care: a randomized controlled trial. BMC Psychiatry 2012;12:230.  
(314) Garcia-Toro M, Ibarra O, Gili M, Serrano MJ, Olivan B, Vicens E, Roca M. Four hygienic-dietary 
recommendations as add-on treatment in depression: a randomized-controlled trial. J Affect Disord 
2012;140:200-203.  
115 
 
 
(315) O'Neil A, Berk M, Itsiopoulos C, Castle D, Opie R, Pizzinga J, Brazionis L, Hodge A, Mihalopoulos C, 
Chatterton ML, et al. A randomised, controlled trial of a dietary intervention for adults with major depression 
(the "SMILES" trial): study protocol. BMC Psychiatry 2013;13:114-244X-13-114.  
(316) Komulainen T, Keranen AM, Rasinaho E, Hakko H, Savolainen MJ, Kujari ML, Reponen A, Lindeman S. 
Quitting a weight loss program is associated with anhedonia: preliminary findings of the Lifestyle 
Intervention Treatment Evaluation Study in northern Finland. Int J Circumpolar Health 2011;70:72-78.  
(317) Sarbadhikari SN, Saha AK. Moderate exercise and chronic stress produce counteractive effects on 
different areas of the brain by acting through various neurotransmitter receptor subtypes: a hypothesis. Theor 
Biol Med Model 2006;3:33.  
(318) Salonen JT. Is there a Continuing Need for Longitudinal Epidemiologic Research - the Kuopio Ischemic 
Heart-Disease Risk Factor Study. Ann Clin Res 1988;20:46-50.  
(319) Roberts RE, Okeefe SJ. Sex-Differences in Depression Reexamined. J Health Soc Behav 1981;22:394-400.  
(320) Roberts RE. Prevalence of Depressive Symptoms among Mexican-Americans. J Nerv Ment Dis 
1981;169:213-219.  
(321) Salonen JT, Nyyssönen K, Korpela H, Tuomilehto J, Seppänen R, Salonen R. High Stored Iron Levels are 
Associated with Excess Risk of Myocardial-Infarction in Eastern Finnish Men. Circulation 1992;86:803-811.  
(322) Lynch J, Helmrich SP, Lakka TA, Kaplan GA, Cohen RD, Salonen R, Salonen JT. Moderately intense 
physical activities and high levels of cardiorespiratory fitness reduce the risk of non-insulin-dependent 
diabetes mellitus in middle-aged men. Arch Intern Med 1996;156:1307-1314.  
(323) Lynch JW, Kaplan GA, Cohen RD, Kauhanen J, Wilson TW, Smith NL, Salonen JT. Childhood and Adult 
Socioeconomic-Status as Predictors of Mortality in Finland. Lancet 1994;343:524-527.  
(324) Kauhanen J, Julkunen J, Salonen JT. Coping with inner feelings and stress: heavy alcohol use in the 
context of alexithymia. Behav Med 1992;18:121-126.  
(325) Lakka TA, Salonen JT. Intraperson Variability of various Physical-Activity Assessments in the Kuopio 
Ischemic-Heart-Disease Risk Factor Study. Int J Epidemiol 1992;21:467-472.  
(326) Laukkanen JA, Laaksonen D, Lakka TA, Savonen K, Rauramaa R, Mäkikallio T, Kurl S. Determinants of 
cardiorespiratory fitness in men aged 42 to 60 years with and without cardiovascular disease. Am J Cardiol 
2009;103:1598-1604.  
(327) Lehto SM, Ruusunen A, Niskanen L, Tolmunen T, Voutilainen S, Viinamäki H, Kaplan GA, Kauhanen J. 
Elevated depressive symptoms and compositional changes in LDL particles in middle-aged men. Eur J 
Epidemiol 2010;25:403-409.  
(328) Happonen P, Voutilainen S, Salonen JT. Coffee drinking is dose-dependently related to the risk of acute 
coronary events in middle-aged men. J Nutr 2004;134:2381-2386.  
(329) Eriksson J, Lindström J, Valle T, Aunola S, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, 
Laakso M, Lauhkonen M, Lehto P, et al. Prevention of Type II diabetes in subjects with impaired glucose 
tolerance: the Diabetes Prevention Study (DPS) in Finland - Study design and 1-year interim report on the 
feasibility of the lifestyle intervention programme. Diabetologia 1999;42:793-801.  
116 
 
 
(330) Lindström J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, Uusitupa M, Tuomilehto J. 
The Finnish Diabetes Prevention Study (DPS). Diabetes Care 2003;26:3230-3236.  
(331) Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-
Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, et al. Prevention of type 2 diabetes mellitus by changes 
in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350.  
(332) Beck AT, Steer RA, Garbin MG. Psychometric Properties of the Beck Depression Inventory - 25 Years of 
Evaluation. Clin Psychol Rev 1988;8:77-100.  
(333) Raitasalo R. Depression and its connections with the need for psychotherapy. Vammala,Finland: 
Kansaneläkelaitoksen julkaisuja A:13; 1979.  
(334) Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive therapy of depression. New York: Guilford; 1979.  
(335) Veerman JL, Dowrick C, Ayuso-Mateos JL, Dunn G, Barendregt JJ. Population prevalence of depression 
and mean Beck Depression Inventory score. 2009;195:516-519.  
(336) Ovaskainen M-, Valsta L, Lauronen J. The compilation of food analysis values as a database for dietary 
studies: the Finnish experience. Food Chemistry 1996;57:133-136.  
(337) Uusitupa M, Peltonen M, Lindström J, Aunola S, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Valle TT, 
Eriksson JG, Tuomilehto J. Ten-Year Mortality and Cardiovascular Morbidity in the Finnish Diabetes 
Prevention Study-Secondary Analysis of the Randomized Trial. 2009;4:e5656.  
(338) Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemiö K, Hämäläinen H, Härkönen 
P, Keinänen-Kiukaanniemi S, Laakso M, et al. Sustained reduction in the incidence of type 2 diabetes by 
lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006;368:1673-1679.  
(339) Murakami K, Sasaki S. Dietary intake and depressive symptoms: a systematic review of observational 
studies. Mol Nutr Food Res 2010;54:471-488.  
(340) Chiuve SE, Giovannucci EL, Hankinson SE, Hunter DJ, Stampfer MJ, Willett WC, Rimm EB. Alcohol 
intake and methylenetetrahydrofolate reductase polymorphism modify the relation of folate intake to plasma 
homocysteine. Am J Clin Nutr 2005;82:155-162.  
(341) Nikkari T, Luukkainen P, Pietinen P, Puska P. Fatty-Acid Composition of Serum-Lipid Fractions in 
Relation to Gender and Quality of Dietary-Fat. Ann Med 1995;27:491-498.  
(342) Bidel S, Hu G, Jousilahti P, Pukkala E, Hakulinen T, Tuomilehto J. Coffee consumption and risk of 
gastric and pancreatic cancer--a prospective cohort study. Int J Cancer 2013;132:1651-1659.  
(343) Kipnis V, Midthune D, Freedman L, Bingham S, Day NE, Riboli E, Ferrari P, Carroll RJ. Bias in dietary-
report instruments and its implications for nutritional epidemiology. Public Health Nutr 2002;5:915-923.  
(344) Hu FB, Rimm E, Smith-Warner SA, Feskanich D, Stampfer MJ, Ascherio A, Sampson L, Willett WC. 
Reproducibility and validity of dietary patterns assessed with a food-frequency questionnaire. Am J Clin Nutr 
1999;69:243-249.  
(345) Keskimäki I, Aro S. The accuracy of data on diagnoses, procedures and accidents in the Finnish Hospital 
Discharge Register. Int J Health Serv 1991;2:15-21.  
117 
 
 
(346) Herva A, Räsänen P, Miettunen J, Timonen M, Läksy K, Veijola J, Laitinen J, Ruokonen A, Joukamaa M. 
Co-occurrence of metabolic syndrome with depression and anxiety in young adults: the Northern Finland 
1966 Birth Cohort Study. Psychosom Med 2006;68:213-216.  
(347) Piyathilake CJ, Macaluso M, Hine RJ, Richards EW, Krumdieck CL. Local and systemic effects of 
cigarette smoking on folate and vitamin B-12. Am J Clin Nutr 1994;60:559-566.  
(348) Virtanen JK, Mursu J, Voutilainen S, Tuomainen TP. Serum long-chain n-3 polyunsaturated fatty acids 
and risk of hospital diagnosis of atrial fibrillation in men. Circulation 2009;120:2315-2321.  
(349) Suominen-Taipale AL, Partonen T, Turunen AW, Männistö S, Jula A, Verkasalo PK. Fish consumption 
and omega-3 polyunsaturated fatty acids in relation to depressive episodes: a cross-sectional analysis. PLoS 
One 2010;5:e10530.  
(350) Kher A, Wang M, Tsai BM, Pitcher JM, Greenbaum ES, Nagy RD, Patel KM, Wairiuko GM, Markel TA, 
Meldrum DR. Sex differences in the myocardial inflammatory response to acute injury. Shock 2005;23:1-10.  
(351) Giltay EJ, Gooren LJ, Toorians AW, Katan MB, Zock PL. Docosahexaenoic acid concentrations are higher 
in women than in men because of estrogenic effects. Am J Clin Nutr 2004;80:1167-1174.  
(352) Sontrop J, Campbell MK. omega-3 polyunsaturated fatty acids and depression: A review of the evidence 
and a methodological critique. Prev Med 2006;42.  
(353) Balance sheet for Food Communities. Information Centre of the Ministry of agriculture and forestry in 
Finland. Helsinki; Finland; 2008.  
(354) Binns CW, Lee AH, Fraser ML. Tea or coffee? A case study on evidence for dietary advice. Public Health 
Nutr 2008;11:1132-1141.  
(355) Schwarz B, Bischof HP, Kunze M. Coffee, Tea, and Life-Style. Prev Med 1994;23:377-384.  
(356) Brice CF, Smith AP. Factors associated with caffeine consumption. Int J Food Sci Nutr 2002;53:55-64.  
(357) Gibson EL. Emotional influences on food choice: sensory, physiological and psychological pathways. 
Physiol Behav 2006;89:53-61.  
(358) Rubin RR, Ma Y, Marrero DG, Peyrot M, Barrett-Connor EL, Kahn SE, Haffner SM, Price DW, Knowler 
WC, Diabet Prevention Program Res Grp. Elevated depression symptoms, antidepressant medicine use, and 
risk of developing diabetes during the diabetes prevention program. Diabetes Care 2008;31:420-426.  
(359) Atlantis E, Baker M. Obesity effects on depression: systematic review of epidemiological studies. Int J 
Obes 2008;32:881-891.  
(360) Herva A, Laitinen J, Miettunen J, Veijola J, Karvonen JT, Läksy K, Joukamaa M. Obesity and depression: 
results from the longitudinal Northern Finland 1966 Birth Cohort Study. Int J Obes 2006;30:520-527.  
(361) Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BWJH, Zitman FG. Overweight, 
Obesity, and Depression A Systematic Review and Meta-analysis of Longitudinal Studies. Arch Gen 
Psychiatry 2010;67:220-229.  
(362) Braunholtz DA, Edwards SJL, Lilford RJ. Are randomized clinical trials good for us (in the short term)? 
Evidence for a "trial effect". J Clin Epidemiol 2001;54:217-224.  
118 
 
 
 
 
 
 
APPENDICES 
APPENDIX 1. Beck Depression Inventory (BDI) depression scale 
(version Ia) 
 
1 (Mood)  0     I do not feel sad. 
1 I feel blue or sad. 
2     I am blue or sad all the time and I can’t snap out of it. 
3     I am so sad or unhappy that I can’t stand it. 
 
2 (Pessimism) 0     I am not particularly pessimistic or discouraged about the 
future. 
  1     I feel discouraged about the future. 
  2     I feel I have nothing to look forward to. 
3     I feel that the future is hopeless and that things cannot 
improve. 
 
3 (Sense of Failure) 0     I do not feel like a failure. 
1 I feel I have failed more than the average person. 
2    As I look back on my life all I can see is a lot of failures. 
3     I feel I am a complete failure as a person. 
 
4 (Lack of Satisfaction) 0     I am not particularly dissatisfied.. 
  1     I don’t enjoy things the way I used to. 
2     I don’t get satisfaction out of anything anymore. 
3     I am dissatisfied with everything.  
 
5 (Guilty Feeling) 0     I don’t feel particularly guilty. 
1 I feel bad or unworthy a good part of the time. 
2     I feel bad or unworthy practically all the time now. 
3     I feel as though I am very bad or worthless. 
 
6 (Sense of Punishment) 0     I don’t feel I am being punished. 
1 I have a feeling that something bad may happen to me. 
2 I feel I am being punished or will be punished. 
3 I feel I deserve to be punished. 
 
7 (Self Hate) 0     I don’t feel disappointed in myself. 
  1     I am disappointed in myself. 
2     I am disgusted with myself. 
4 I hate myself. 
 
8 (Self Accusations) 0     I don’t feel I am any worse than anybody else. 
1 I am very critical of myself for my weakness or mistakes. 
 
 
 
2 I blame myself for my mistakes. 
3     I blame myself for everything that goes wrong. 
 
9 (Self-punitive Wishes) 0     I don’t have any thoughts of harming myself. 
1 I have thoughts of harming myself but I would not carry them 
out. 
2     I feel I would be better off dead. 
3     I would kill myself if I could. 
 
10 (Crying Spells) 0     I don’t cry any more than usual. 
1 I cry more now than I used to.   
2 I cry all the time nowadays.  
3 I used to be able to cry but now I can’t cry at all even though I 
want to. 
 
11 (Irritability) 0     I am no more irritated now than I ever am. 
1 I get annoyed or irritated more easily than I used to. 
2 I feel irritated all the time. 
3 I don’t get irritated at all at the things that used to irritate me. 
 
12 (Social Withdrawal) 0     I have not lost interest in other people. 
1 I am less interested in other people now than I used to be. 
2 I have lost most of my interest in other people and have little 
feeling for them. 
3 I have lost all my interest in other people and don’t care about 
them at all. 
 
13 (Indecisiveness) 0     I make decisions about as well as ever. 
1 I am less sure of myself now and try to put off making 
decisions. 
2 It is very difficult to me to make any decisions. 
3 I can’t make any decisions at all anymore. 
 
14 (Body Image) 0     I feel my appearance hasn’t changed. 
1 I am worried that I am looking old or unattractive. 
2 I feel that there are permanent changes in my appearance and 
they make me look unattractive. 
3 I feel that I am ugly or repulsive looking. 
 
15 (Work Inhibition) 0     I can work about as well as before. 
  1     It takes extra effort to get started at doing something. 
2 I have to push myself very hard to do anything. 
3 I can’t do any work at all. 
 
 
 
 
 
 
 
16 (Sleep Disturbance) 0     I can sleep as well as usual. 
1 I wake up more tired in the morning than I used to. 
2 I wake up 1-2 hours earlier than usual and find it hard to get 
back to sleep. 
3 I wake up several hours earlier than before and can’t get 
myself back to sleep. 
 
17 (Fatigability) 0     I don’t get any more tired than usual. 
1 I get tired more easily than I used to. 
2 I get tired from doing anything. 
3 I get too tired to do anything. 
 
18 (Loss of Appetite) 0     My appetite is no worse than usual. 
1 My appetite is not as good as it used to be. 
2 My appetite is much worse now. 
3 I have no appetite at all anymore. 
 
19 (Weight Loss) 0     I haven’t loss much weight, if any, lately. 
1 I have lost more than 3 kilograms. 
2 I have lost more than 5 kilograms. 
3 I have lost more than 8 kilograms. 
 
I am trying to lose my weight on purpose by eating less 
  Yes____________ No____________ 
 
20 (Somatic Preoccupation) 
0     I am no more concerned about my health than usual. 
1 I am concerned about aches and pains or upset stomach or  
constipation. 
2 I am so concerned with how I feel or what I feel that it’s hard 
to  
think of much else. 
3 I am completely absorbed in what I feel. 
 
21 (Loss of Libido) 0     I have not noticed any recent change in my interest in sex. 
1 I am less interested in sex than I used to be. 
2 I am much less interested in sex now. 
3 I have lost interest in sex completely. 
 
Modified from Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An Inventory 
for Measuring Depression. Archives of General Psychiatry 4: 561-571 and Beck AT, Rush 
AJ, Shaw BF, Emery G. Cognitive therapy of depression. New York: Guilford 1979. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX 2. Human Population Laboratory (HPL) depression scale 
SCALE  
Items of HPL depression scale. Possible answers were “never”, “sometimes” and “often”. 
Answers “never” or “often” (whichever is appropriate) were considered to be indicative of 
a depressed response.  
 
Felt depressed or very unhappy 
Appetite poor 
Trouble getting to sleep or staying asleep 
Felt lonely or remote from other people 
Felt happiness 
Little enjoyment from leisure time 
Less energy than other people 
Felt pleased about accomplishing something 
Felt bored 
Felt so restless than could not sit still long 
Felt excited or interested in something 
Cannot relax easily 
Felt vaguely uneasy without knowing why 
Feeling too tired to do the things wishing to 
Social withdrawal even from the people who also close to 
Difficulties while being with others 
Never satisfied with things which one has done 
Getting tired easily 
Modified from Kaplan GA, Roberts RE, Camacho TC, Coyne JC. Psychosocial predictors of 
depression. Prospective evidence from the human population laboratory studies. 
Am J Epidemiol. 1987 Feb;125(2):206-20. 
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Depression is one of the leading 
health concerns worldwide, and it 
significantly affects public health, 
quality of life and economics. Diet 
influences the risk of many non-
communicable diseases, but there is 
limited evidence on the association 
between diet and the risk of 
depression in general population. 
This is an epidemiological study 
that aims to clarify the association 
between diet and depression in 
cross-sectional, prospective and 
intervention settings.
